After facing acute myeloid leukemia, Dr. Joseph Ashburn rode 150 miles to Nashville to thank the team that cared for him. Read his inspiring story from Men’s Fitness, featuring SCRI’s Dr. Stephen Strickland. www.mensfitness.com/wellness/after-leukemia-this-doctor-r…
Sarah Cannon Research Institute
Sarah Cannon Research Institute (SCRI) is a research organization focusing on therapies for patients which include drugs that are in development. With corporate headquarters in Nashville, Tennessee, United States, it conducts community-based clinical trials in oncology, cardiology, gastroenterology, and other therapeutic areas. The current CEO is Dee Anna Smith. More on Wikipedia
-
Sarah Cannon Docs
@SarahCannonDocs
-
Sarah Cannon Docs reposted
Blood Cancers Today
@Blood_Cancers
🤝 Community oncology can be a powerful engine for innovation in blood cancer care.
🗨️ @KrishPatelMD, of @SarahCannonDocs, discusses how community practices can shape treatment delivery, research priorities, and partnerships to make advances more practical and accessible.
▶️ Watch here: www.bloodcancerstoday.com/videos/rethinking-blood-cancer-… -
Sarah Cannon Docs
@SarahCannonDocs
SCRI will have a strong presence at #triple2026 in Barcelona, with investigators delivering several first-author oral presentations, including first-in-human FGFR3 research and two studies exploring emerging approaches to targeting RAS. #cancerresearch #oncology
-
Sarah Cannon Docs
@SarahCannonDocs
Looking back at #esmo2026: SCRI investigators contributed 85+ abstracts and presentations, w/ 3 Phase III studies featured in the Presidential Symposium & published simultaneously in @TheLancet or @NEJM. Thanks to the teams & pts advancing cancer research. www.scri.com/news/scri-esmo-2026-research-highlights/
-
Sarah Cannon Docs reposted
BoWangMD
@BoWangMD1
SCRI/WVCI enrolled 10-15% of the total North American population to this positive global study for lung cancer.
Divarasib as Compared with Sotorasib or Adagrasib in KRAS G12C–Mutated NSCLC | New England Journal of Medicine www.nejm.org/doi/full/10.1056/NEJMoa2605703?referrer=http…
@OncoAlert -
Sarah Cannon Docs
@SarahCannonDocs
Proud to contribute to the Phase III Krascendo 1 study, presented at #esmo2026 and published in @NEJM. Co-author @BoWangMD1 called the findings “potentially practice-changing” for patients with KRAS G12C-mutated lung cancer. www.scri.com/news/sarah-cannon-research-institute-showcas…
-
Sarah Cannon Docs reposted
David R. Spigel, MD, FASCO
@DavidRSpigel
@MLJohnsonMD2 gives a perfect discussion of #adcs in NSCLC oral session at #esmo26 - a fast-evolving and important next chapter in LC research @SarahCannonDocs
-
Sarah Cannon Docs reposted
David R. Spigel, MD, FASCO
@DavidRSpigel
@BGarmezy presenting incredible Ph I data in mCRPC with JNJ-6143 (RIPTAC): 75% ORR (incl CRs - heavily pretreated). Ph 2 underway. #esmo26 @SarahCannonDocs
-
Sarah Cannon Docs reposted
David R. Spigel, MD, FASCO
@DavidRSpigel
@ErikaHamilton9 discussing innovative drugs in mBC - expert review of emerging landscape! #esmo26 @SarahCannonDocs
-
Sarah Cannon Docs reposted
David R. Spigel, MD, FASCO
@DavidRSpigel
@MeredithMcKean delivering state-of-the-art talk on advances in uveal melanoma at #esmo26
-
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
Fantastic summary slide of metastatic #bcsm #adc landscape by @BarbaraPistill2 in her #esmo26 discussion
#esmoambassadors
@OncoAlert
What do we need next???
📍novel payloads
📍novel targets
📍data on sequencing -
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
TALENT- neoadj T-DXd in HR+/HER2-low #bcsm
RCB0/1:
🔹 T-DXd alone: 16%
🔹 T-DXd + anastrozole: 17%
🔹 T-DXd → TC chemo: 17%
*no pCRs w/out 8 cycles
Despite high ORR ~66%, pCR LOW! We know w/ HR+ we don't get high pCRs rates, but still disappointing
#esmo26 #esmoambassadors -
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
#bstronger 🤯 that 95.1% of pts w/ stage I-III TNBC had ctDNA at baseline!!!
Wow.
By C3, >80% pts had cleared ctDNA in response to chemo
Molecular response was associated with tumor burden:
100% stage I
85% stage II
44% stage III, cleared
#esmo26 #esmoambassadors @OncoAlert -
Sarah Cannon Docs
@SarahCannonDocs
Congratulations to @IMFmyeloma on the launch of the US Myeloma Network! We are honored to serve as the CRO and support clinical trials designed to advance research and expand opportunities for patients w/ multiple myeloma. Looking forward to this collaboration in #cancerresearch.
Vincent Rajkumar
@VincentRK
I am proud to announce the launch of the US Myeloma Network (USMN) by the International Myeloma Foundation. @IMFmyeloma
The USMN will conduct clinical trials including phase III randomized controlled trials. @JNJInnovMed is our first industry partner. @SarahCannonDocs will be our CRO.
@SagarLonialMD @TomMartinMD @szusmani @myelomaMD @NikhilMunshiMD
www.prnewswire.com/news-releases/the-international-myelom… -
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
#esmo26 is upon us, start your meeting with the #openingsession!
@myESMO
ESMO - Eur. Oncology
@myESMO
Want to get a sense of what #esmo26 will bring to you?
Start with the Opening Session. Featuring addresses from the ESMO President and Scientific Co-Chairs, followed by the 2026 ESMO Society Award recipients lectures.
➡️ cslide.ctimeetingtech.com/esmo2026/attendee/confcal/sessi…
@FAndreMD @YJanjigianMD -
Sarah Cannon Docs
@SarahCannonDocs
Expanding access to clinical trials remains a critical priority in oncology research. @SPremji7866 of SCRI recently shared insights with @TargetedOnc on the importance of community-based research and the evolving breast cancer landscape.
www.targetedonc.com/view/dr-premji-community-clinical-tri… -
Sarah Cannon Docs
@SarahCannonDocs
When oncology experts tackle the questions shaping the future of cancer research, @mljohnsonmd is part of the conversation. In a recent @Medscape article, she shared insights on evidence gaps and treatment sequencing challenges in oncology.
www.medscape.com/viewarticle/wild-west-cancer-drug-advanc… -
Sarah Cannon Docs
@SarahCannonDocs
At #esmo26, SCRI will present 85+ abstracts and presentations across antibody drug conjugates, immunotherapies, and bispecific antibodies, with work from 40 authors across our network of research sites. www.scri.com/news/sarah-cannon-research-institute-showcas…
-
Sarah Cannon Docs
@SarahCannonDocs
The HER2+ metastatic breast cancer landscape continues to evolve. In a recent @TargetedOnc interview, @ErikaHamilton9 shares insights from the HER2CLIMB-05 analysis and key considerations for clinicians and researchers. www.targetedonc.com/view/tucatinib-maintenance-extends-pf…
-
Sarah Cannon Docs
@SarahCannonDocs
How can clinical trials be designed with accessibility in mind? In a recent @TargetedOnc interview, @KrishPatelMD shares perspectives on purpose-built trials, community oncology partnerships, and expanding access to clinical research opportunities. www.targetedonc.com/view/purpose-built-trials-designing-f…
-
Sarah Cannon Docs
@SarahCannonDocs
Dr. Joseph Ashburn celebrated his follow-up appointment by riding 150+ miles from Paducah, KY, to @TriStarCentennial in Nashville, where he participated in a clinical trial through SCRI. Stories of survivorship highlight the impact of cancer research.
🔗www.wsmv.com/video/2026/10/14/kentucky-man-rides-bike-150… -
Sarah Cannon Docs
@SarahCannonDocs
We’re heading to #esmo with 85+ abstracts and presentations spanning multiple tumor types and therapeutic approaches. Follow along next week for highlights from Madrid.
-
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
Breast cancer care has changed dramatically in recent yrs. Tx is more #personalized than ever before, and #clinicalresearch is creating new possibilities for pts.
For #breastcancerawarenessmonth, I'm answering a few of the most common 🙋♀️ I hear about #bcsm.
@SarahCannonDocs -
Sarah Cannon Docs
@SarahCannonDocs
What can we learn from HER2CLIMB-05? @ErikaHamilton9 discusses the analysis and its implications for HER2+ metastatic breast cancer research and care in a recent @TargetedOnc interview. www.targetedonc.com/view/tucatinib-maintenance-extends-pf…
-
Sarah Cannon Docs
@SarahCannonDocs
In a recent @AJMC_Journal interview, @DavidRSpigel, shares how AI will reshape trial design, patient matching and the future of precision medicine. www.ajmc.com/view/ai-poised-to-reshape-drug-development-d…
-
Sarah Cannon Docs
@SarahCannonDocs
Community-based clinical trials are critical to advancing breast cancer care and expanding patient access. In @TargetedOnc, @SPremji7866 shares insights on biomarker-driven research and key studies shaping the future of treatment.www.targetedonc.com/view/dr-premji-community-clinical-tri…
-
Sarah Cannon Docs
@SarahCannonDocs
The FDA-approved TUKYSA regimen expands options for people with HER2-positive metastatic breast cancer through a chemotherapy-free maintenance approach. @ErikaHamilton9 helped lead the HER2CLIMB-05 trial behind this advance.
www.fiercepharma.com/pharma/pfizers-tukysa-snags-first-li… -
Sarah Cannon Docs reposted
Sarah Premji, MD
@SPremji7866
I got a chance to sit down with Targeted Oncology for Breast Cancer Awareness Month to discuss clinical trials in the community and a few of the many ongoing trials that may shape how we treat breast cancer!
@SCRIOncology
@SarahCannonDocs
#targetedoncology
#bcsm
Targeted Onc
@TargetedOnc
For #breastcancerawarenessmonth, Sarah Premji, MD (@SarahCannonDocs @SCRIOncology) discussed community trial access, biomarker-driven drug development, and key #breastcancer studies to watch.
💬 Full interview: www.targetedonc.com/view/dr-premji-community-clinical-tri…
#oncology #clinicaltrials | @SPremji7866 -
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
#her2climb05 regimen now @FDA approved for 1st line #her2 #bcsm maintenance!
Amazing to now have a maintenence option for patients that have HR- tumors as well!
www.pfizer.com/news/press-release/press-release-detail/pf…
@OncBrothers
@oncodaily
@OncoAlert
@SarahCannonDocs -
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
My Top 10 List for #esmo26 in #bcsm... sorted by day, session, and a "why it matters" context for our field!
@myESMO
#esmoambassadors
@SarahCannonDocs
*disclaimer: not official, just my two cents* -
Sarah Cannon Docs reposted
Lymphoma Research Foundation
@lymphoma
Dr. Krish Patel, a Foundation grantee and the executive director of Hematologic Cancer Research at @SarahCannonDocs, explains the indications for CAR T-cell therapy for different lymphomas.
#bloodcancerawarenessmonth #cartcelltherapy #lymphoma #cll -
Sarah Cannon Docs reposted
OncLive.com
@OncLive
WATCH 🎥: @MeredithPelster, of @SarahCannonDocs, discusses the biomarker-agnostic design of the phase 3 MAPKeeper 301 trial of atebimetinib in metastatic pancreatic cancer. #pancsm #oncology
Full video ➡️: www.onclive.com/view/dr-pelster-on-the-mapkeeper-301-tria… -
Sarah Cannon Docs
@SarahCannonDocs
"The promise of innovation is only realized when patients can access it."
Hans Lee, MD discusses how bispecific antibodies are transforming multiple myeloma treatment.
Read the article: oncdata.com/blog/bringing-bispecific-antibodies-into-comm… -
Sarah Cannon Docs
@SarahCannonDocs
In a recent epiosde of Oncology Decoded, @BGarmezy and @mkbupathi share insights on how AI is shaping cancer research and care delivery, and why thoughtful implementation will be key to supporting patients and clinicians.
www.cancernetwork.com/view/what-role-will-artificial-inte… -
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
10 new @FDA indications in #bcsm in 20 weeks - May to September, 2026.
Three firsts in there: first PROTAC in any cancer, first CDK4/6 inhibitor in HER2+ #bcsm, first drug approval triggered by ctDNA prior radiographic progression.
#clinicaltrials win! Patients win! -
Sarah Cannon Docs
@SarahCannonDocs
A clinical trial at SCRI Mary Crowley gave Greg a new path forward. More than 3 years later, his cancer remains controlled and he's back to an active life. Read his story in the @AACR Cancer Progress Report 2026:cancerprogressreport.aacr.org/report/survivor-journeys/gr…
-
Sarah Cannon Docs
@SarahCannonDocs
The FDA approved daraxonrasib for metastatic pancreatic cancer. SCRI researchers participated across multiple stages, from early studies through the pivotal trial and Expanded Access Program. Learn how SCRI supported this treatment advance. www.scri.com/news/from-early-research-to-fda-approval-scr…
-
Sarah Cannon Docs
@SarahCannonDocs
In a recent interview w/ @Blood_Cancers, Dr. Hans Lee of @SCRIOncology discusses how cellular therapies are changing care for patients with advanced multiple myeloma and the importance of expanding access.
Read the Q&A:
Blood Cancers Today
@Blood_Cancers
The next step in advanced #myeloma is improving access to therapies such as CAR-T and bispecific antibodies, according to Hans Lee, MD, of @SarahCannonDocs.
📖 Read more from this exclusive Q&A: www.bloodcancerstoday.com/post/qa-the-next-step-is-really… -
Sarah Cannon Docs reposted
OncoDaily
@oncodaily
Radiation Therapy Has Transformed, but Outdated Myths Still Mislead Patients - Dave Buck
@SarahCannonDocs
oncodaily.com/voices/dave-buck-569822 -
Sarah Cannon Docs reposted
The US Oncology Network
@TheUSONetwork
We're always excited to see new #cancerresearch that leads to better outcomes! In this interview with @AJMC_Journal, Dr. Lee of @SarahCannonDocs discusses the initial results of a study on linvoseltamab and what it means for patients with AL #amyloidosis:
-
Sarah Cannon Docs
@SarahCannonDocs
SCRI’s @ForsbergMD discusses the feasibility of community-based outpatient delivery of bispecific therapies in an @OncLearnNetwork interview, improving accessibility to innovative therapies for patients with multiple myeloma.
www.hmpgloballearningnetwork.com/site/onc/videos/feasibil… -
Sarah Cannon Docs
@SarahCannonDocs
What could new frontMIND data mean for patients with high-risk DLBCL? Dr. John Burke of SCRI shares insights in an @OncLearnNetwork interview on findings from the phase 3 study and their potential implications for treatment.
www.hmpgloballearningnetwork.com/site/onc/videos/adding-t…
#asco2026 -
Sarah Cannon Docs
@SarahCannonDocs
How could the #libretto432 findings shape care for patients with RET fusion-positive #nsclc? @MLJohnsonMD2 discusses the data, clinical implications, and remaining questions in a recent @Lung_Cancers interview: www.lungcancerstoday.com/post/libretto-432-dr-melissa-joh… #asco2026
-
Sarah Cannon Docs
@SarahCannonDocs
SCRI’s @SPremji7866 spoke with @cancer_nurses on a CDH6-targeting ADC in gynecologic cancers, covering efficacy, safety & clinical potential. Learn more: www.cancernursingtoday.com/post/targeting-cdh6-a-new-adc-… #oncology #clinicalresearch
-
Sarah Cannon Docs
@SarahCannonDocs
Dr. John Burke MD of SCRI at Rocky Mountain Cancer Centers discusses FrontMIND results from #asco2026, showing improved outcomes with tafasitamab + lenalidomide added to R-CHOP in high-risk DLBCL. Watch to learn more: www.bloodcancerstoday.com/videos/moving-beyond-r-chop-onl…
#lymphoma #hematology #clinicaltrials -
Sarah Cannon Docs
@SarahCannonDocs
“I think there are a variety of different clinically significant elements—we do learn from both negative and positive trials.” Hear more from SCRI’s @mabelonc of RMCC on the phase III persevERA BC trial presented at #asco2026: ecancer.org/en/video/12998-giredestrant-plus-palbociclib-…
-
Sarah Cannon Docs
@SarahCannonDocs
SCRI's Director of Melanoma & Skin Cancer Research, @MeredithMcKean , shares thoughts on an impactful study presented at #asco26 with @OncLive : www.onclive.com/view/experts-weigh-in-on-some-of-the-most…
-
Sarah Cannon Docs
@SarahCannonDocs
A @OncologyDecoded episode recaps key ASCO 2026 prostate cancer updates, highlighting late-breaking data that may shape future standards of care. Listen here: www.cancernetwork.com/view/asco-2026-translating-the-top-…
#prostatecancer #oncology #asco2026 -
Sarah Cannon Docs
@SarahCannonDocs
Dr. @SPremji7866 shares phase 3 insights on anbenitamab + nab-docetaxel ± carboplatin vs standard HER2-targeted therapy in early/locally advanced HER2+ breast cancer with @BreastCancersTd.
🔗 www.docwirenews.com/post/biparatopic-her2-targeting-in-ac…
#breastcancer #asco2026 -
Sarah Cannon Docs
@SarahCannonDocs
Dr. @ErikaHamilton9 shares updated HER2CLIMB-05 results from #asco26 with @OncEd. Watch her highlights: www.oncologyeducation.com/videos/asco-2026-highlights-pre…
-
Sarah Cannon Docs reposted
Lung Cancers Today
@Lung_Cancers
🫁 Catching up on news from #asco26?
🌟 Don't miss this insightful interview with @MLJohnsonMD2 of @SarahCannonDocs, who joined us to unpack the LIBRETTO-432 plenary data, the clinical implications, and the remaining questions.
➡️ Watch: www.lungcancerstoday.com/videos/libretto-432-dr-melissa-j… -
Sarah Cannon Docs
@SarahCannonDocs
SCRI's Dr. @ErikaHamilton9 shares key #asco2026 breast cancer updates with @VJOncology . Watch to learn more: www.vjoncology.com/video/sqquthwjfo4-breast-cancer-update…
#breastcancer #oncology #clinicalresearch -
Sarah Cannon Docs
@SarahCannonDocs
SCRI's Dr. Hans Lee shares early LINKER-AL2 results at #asco2026: linvoseltamab shows encouraging safety and strong activity in R/R systemic light chain amyloidosis. Watch here on @VJHemOnc: www.vjhemonc.com/video/ivln2ngxsdy-first-results-of-linke… #amyloidosis #clinicaltrials
-
Sarah Cannon Docs
@SarahCannonDocs
SCRI's Dr. @ErikaHamilton9 shares insights on HER2+ metastatic breast cancer maintenance strategies with @VJOncology , including key takeaways from #asco26. Hear her perspective: www.vjoncology.com/video/l3v2gopddds-optimizing-sequencin… #breastcancer #oncology #clinicalresearch
-
Sarah Cannon Docs
@SarahCannonDocs
In a new @people exclusive, SCRI’s Dr. @MeredithMcKean shares the story behind one patient's remarkable journey with metastatic uveal melanoma, who enrolled in a clinical trial at @SCRIOncology when options were limited. Discover more below.
People
@people
Golfer Dad Loses His Vision Due to Rare Cancer, Finds Hope in a Clinical Trial: 'I Turned My Body Over to Science' (Exclusive) people.com/gollfer-dad-vision-loss-eye-cancer-clinical-tr…
-
Sarah Cannon Docs
@SarahCannonDocs
Dr. John Burke from SCRI at Rocky Mountain Cancer Centers shares insights on frontMIND data presented at #asco26, including safety, rationale & real-world use in community settings. Read @AJMC_Journal to learn more: www.ajmc.com/view/frontmind-results-with-tafasitamab-impr…
#dlbcl #hematology -
Sarah Cannon Docs
@SarahCannonDocs
SCRI's @KrishPatelMD shared his expert perspective on frontMIND presented at #asco26 Read more:
www.medpagetoday.com/meetingcoverage/asco/121508 #lymphoma #clinicaltrials -
Sarah Cannon Docs reposted
HCA Healthcare
@HCAhealthcare
New #research published in @NEJM highlights promising results for CRISPR-based gene-editing therapy in children ages 5-11 with severe #sicklecelldisease and beta thalassemia. Learn how HCA Healthcare is advancing research: hcahealthcaretoday.com/2026/06/29/hca-healthcare-announce…. #improvemorelives
-
Sarah Cannon Docs
@SarahCannonDocs
Dr. @MeredithMcKean highlights early ASCO 2026 data for a novel approach for advanced melanoma.
www.targetedonc.com/view/targeting-il-2-pathway-overcome-…
#melanoma #immunotherapy #asco2026 -
Sarah Cannon Docs
@SarahCannonDocs
Early LINKER-AL2 data from #asco26 highlight linvoseltamab as a promising “off-the-shelf” option for relapsed AL amyloidosis. Learn more in this @AJMC_Journal interview with Hans Lee MD:
www.ajmc.com/view/hans-lee-md-discusses-off-the-shelf-sol…
#amyloidosis #hematology #clinicaltrials -
Sarah Cannon Docs
@SarahCannonDocs
In a recent @SurvivorNetTeam feature, SCRI’s @SPremji7866 discusses datopotamab deruxtecan, a newly approved targeted therapy for triple negative breast cancer.
Read more: www.survivornet.com/articles/for-triple-negative-breast-c… -
Sarah Cannon Docs
@SarahCannonDocs
Don't miss this important event on understanding CAR T Therapy with @KrishPatelMD.
Lymphoma Research Foundation
@lymphoma
Join us TOMORROW!
Webinar: Understanding and Accessing Chimeric Antigen Receptor (CAR) T-Cell Therapy, in partnership with @SarahCannonDocs
Featuring @KrishPatelMD
Date: Wednesday, June 24, 2026
Time: 2:00 – 3:00 PM ET
lymphoma.org/cartcellwebinar/ -
Sarah Cannon Docs
@SarahCannonDocs
ASCO 2026 delivered new clarity—and new questions—in breast cancer care. Read key takeaways in an article authored by SCRI breast cancer experts on @BreastCancersTd.
🔗 www.docwirenews.com/post/asco-2026-brings-wins-in-persona…
#asco2026 #breastcancer #oncology -
Sarah Cannon Docs
@SarahCannonDocs
In a recent @cure_today story, SCRI’s @BGarmezy , answers common questions about bladder cancer, discussing symptoms, risk factors, and evolving treatment options. Read more: www.curetoday.com/view/bladder-cancer-faq-signs-symptoms-…
-
Sarah Cannon Docs
@SarahCannonDocs
Proud to share Dr. @hfrangoul of SCRI at @TriStarHealth is first author in a NEJM original article showing exagamglogene autotemcel achieved transfusion independence or freedom from VOCs in children 5–11 with SCD or TDT. Read more: www.nejm.org/doi/full/10.1056/NEJMoa2603387?query=feature…
-
Sarah Cannon Docs
@SarahCannonDocs
SCRI’s Director of Breast Cancer Research and Chief Development Officer, Late Phase, @ErikaHamilton9 discusses her oral presentation from the ASCO Annual Meeting with The @ASCOPost .
Watch the interview here: ascopost.com/videos/asco-2026/erika-p-hamilton-on-her2-po… -
Sarah Cannon Docs
@SarahCannonDocs
Big news from #asco26 is shaping the future of cancer care. In a @cure_today article, Dr. @DavidRSpigel shares key takeaways, and we’re proud that SCRI researchers contributed to studies highlighted!
Read more: www.curetoday.com/view/top-5-takeaways-from-asco-2026-tha…
#cancerresearch #clinicaltrials -
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
#db05 update on #ild with T-DXd
10% ILD 🫁 , 2 cases fatal
Radiation pneumonitis ☢️ (RP) incidence ~ 30%
Having ILD did not ⬆️ chance of RP
📌No diff in ILD 🫁 based on sequential or concurrent radiotherapy ☢️
Moderate renal dysfunction ⬆️ risk ILD
#asco26 -
Sarah Cannon Docs
@SarahCannonDocs
Wrapping up strong at #asco26 with SCRI Meet the Expert sessions in GI, breast, and innovation in trial delivery through Accelero. Come connect with our teams! @GHannafantastic @MeredithPelster @ErikaHamilton9 @SPremji7866
-
Sarah Cannon Docs
@SarahCannonDocs
Tomorrow is the final day at #asco26 and we're ending strong! Dr. @ErikaHamilton9 presents on HER2-targeted combination therapy in metastatic breast cancer.
#innovationincancercare #scri #asco26 www.scri.com/asco/ -
Sarah Cannon Docs
@SarahCannonDocs
Coming Up! @MeredithMcKean co-authors Darovasertib Plus Crizotinib vs Investigator’s Choice as First-Line Treatment for Pts w/ HLA-A2 Negative Metastatic Uveal Melanoma: Primary Results from OptimUM-02 Trial presented today at 9am in S100bc @SCRIOncology
-
Sarah Cannon Docs
@SarahCannonDocs
Inspiring discussion around how we can have greater impact in the community for veterans w/ our colleagues at #fcs & the VA @Dee_Anna_Smith @LucioGordanMD #asco26
-
Sarah Cannon Docs
@SarahCannonDocs
SCRI contributed to research leading to upcoming plenary on Daraxonrasib, a RAS(ON) multi-selective inhibitor, vs chemotherapy in previously treated patients with met pancreatic adenocarcinoma: Primary analysis from the phase 3 RASolute 302 @MeredithPelster @SCRIOncology #asco26
-
Sarah Cannon Docs
@SarahCannonDocs
Coming up! @MLJohnsonMD2 is coauthor on Event-Free Survival with Adjuvant Selpercatinib in Stage IB-IIIA RET Fusion-Positive NSCLC: Primary Results of the Phase 3 LIBRETTO-432 Trial that will be presented during the Plenary Session at 2:13 p.m. CDT in Hall B1 #asco26
-
Sarah Cannon Docs reposted
David R. Spigel, MD, FASCO
@DavidRSpigel
189: adeno
H-6: squamous
Better comparison is subset of Empower3 -
Sarah Cannon Docs reposted
Sarah Premji, MD
@SPremji7866
DB09 TDXd + P exploratory analysis of response by subgroups - 55% achieved CR, 47.5% achieved deep PR, pts who achieved CR and deep PR had longest tx duration 28 and 25 mo respectively, 24 mo PFS rates 85% CR and 80% deep PR, this tells us you should not use a 6 cycle induction approach with TDXd +P
@OncoAlert -
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
#ascent04 subgroups saci + pembro in 1L PD-L1 #bcsm
PFS longer with saci regardless of:
📌TROP-2 quartile
📌BRCA status
📌 HER low or 0
#asco26 @stolaney1 -
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
@stage4kelly speaks from an advocates perspective in the CSS on #clinicaltrial endpoints
👭Include advocates while the trial is being DESIGNED!
🗣️ Patient centered language matters
📊 Incorporate PROs
⚠️ OS is NOT always most important
#asco26 -
Sarah Cannon Docs
@SarahCannonDocs
Meet SCRI experts at #asco26 for a lymphoma session led by @KrishPatelMD . Join the conversation and learn how we are advancing research for patients.
-
Sarah Cannon Docs reposted
Sarah Premji, MD
@SPremji7866
Absolutely thrilled to be a @JCO_ASCO editorial fellow this year alongside this wonderful group! And we were joined by last years group!
#asco26 @SCRIOncology @SarahCannonDocs @KalantriShreyas -
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
Attending the CSS this morning at #asco26? I will be 🙋♀️ !
📍 "Choosing the Right Patient-Centered Endpoints in Modern Clinical Trials"
🗺️ Hall D1
⏰ 9:45 am - 11:15 am
I'll never miss an opportunity to learn from our patient advocates like @stage4kelly !
#bcsm -
Sarah Cannon Docs
@SarahCannonDocs
Tomorrow is Day 4 at #asco26. Catch SCRI experts leading key sessions and sharing insights on advancing cancer care in community settings.
From trial innovation to real-world impact, we’re proud to help shape what’s next in oncology. -
Sarah Cannon Docs
@SarahCannonDocs
Tomorrow is Day 3 at #asco26.
Catch SCRI experts presenting the latest research in hematologic cancers and solid tumors, including @MLJohnsonMD2 @ForsbergMD @dapattmd Dr. Elisa Fontana and Dr. James Essell. -
Sarah Cannon Docs
@SarahCannonDocs
Even the overflow rooms are at capacity to hear @MLJohnsonMD2 update on KRAS Directed Therapy at #asco26
-
Sarah Cannon Docs reposted
Sarah Premji, MD
@SPremji7866
We just kicked off the first panel discussion in a series happening at @ASCOTECAG with @royaryam, @realbowtiedoc and @DrSapnaPatel! Absolutely phenomenal conversation about academic/hybrid careers!
@ASCO @SCRIOncology @SarahCannonDocs
ASCO TECAG
@ASCOTECAG
⭐️@ASCOTECAG lounge spotlight @ASCO #asco26 ⭐️
Excellent discussion at by a star line up of panelists @DrSapnaPatel @royaryam @realbowtiedoc with @SPremji7866 👏👏
“Identify what interests you early, share your goals with potential employers, and craft the career you want!”
@OncoAlert @ASCOTECAG @montypal @IMG_Oncologists @DrChoueiri @jrgralow @COlazagasti @FionnualaCrowle @ja_ocejo @noha_soror @royaryam @OncoAlert @urotoday @PCF_Science @BladderCancerUS @kidneycan @KidneyCancer @Uromigos @OncBrothers @urologysummit @crisbergerot @PauloBergerot @realbowtiedoc @DVAraujoMD @DrBarbiOnc @LauraEsfeller @FunchainMD @YGaritaonaindia @jgong15 @DrSAHaddad @GIMedOnc @iandresmeraz @SakditadMD @RamilaShilpakar @RohitBanwar @lungoncdoc @BHuffmanMD -
Sarah Cannon Docs reposted
McKesson Corporation
@McKesson
Day 2 of #asco26 continues with experts across @SarahCannonDocs, @TheUSONetwork and Ontada presenting a combined 171 abstracts on their latest research and innovations — showcasing our commitment to advancing cancer care across the continuum. Together, #cancerdoesntstandachance.
-
Sarah Cannon Docs
@SarahCannonDocs
Come meet our research experts & leaders at Booth 22035 #asco26
-
Sarah Cannon Docs reposted
Sarah Premji, MD
@SPremji7866
Honored to be recognized as a Founding Capstone of the MJH Life Sciences Distinction Program, a new program recognizing healthcare professionals who go above and beyond in their specialty. Looking forward to seeing this grow! @MJHLifeSciences
@SCRIOncology, @SarahCannonDocs -
Sarah Cannon Docs
@SarahCannonDocs
Our experts are sharing their latest insights through onsite & virtual interviews. Dr. Hans Lee shares the impact of research with @cancer_nurses
-
Sarah Cannon Docs
@SarahCannonDocs
Join SCRI at #asco26 for Meet the Expert sessions on head and neck cancer, myeloma, leukemia and melanoma. Connect with our investigators at booth 22035. @CesarAPerezMD, @EricLanderMD @LFletcherMD15 @SAStricklandMD @MeredithMcKean @jeffyoriomd @BoWangMD1
-
Sarah Cannon Docs
@SarahCannonDocs
We look forward to seeing more of you on day two of the Annual #asco26 Meeting. Stop by both #22035 to meet our scientific leaders. www.scri.com/asco
-
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
Honored to be recognized as a Founding Capstone of the MJH Life Sciences Distinction Program, a new program recognizing healthcare professionals who go above and beyond in their specialty. @MJHLifeSciences
-
Sarah Cannon Docs
@SarahCannonDocs
At #asco26, join us for Conquering Veteran Cancer, Together — Sun, May 31 | 9:30–11:30 a.m. CT at Hyatt Regency. @Dee_Anna_Smith @LucioGordanMD will be sharing their insights
Register: bmsmeetings.cventevents.com/gqmKoN -
Sarah Cannon Docs
@SarahCannonDocs
Day 1 of #asco26 is almost here. Our experts are presenting the latest research in hematologic disorders & more.
Dr. Hans Lee will share first results from the Phase 1/2 LINKER-AL2 trial.
#scri #oncologyleadership #cancerresearch -
Sarah Cannon Docs
@SarahCannonDocs
What research is generating buzz heading into #asco26? In a new @biospace feature, Dr. @MeredithPelster of Sarah Cannon Research Institute shares insights on promising advances in pancreatic cancer research and targeted therapies.
www.biospace.com/drug-development/all-eyes-on-revolution-… -
Sarah Cannon Docs
@SarahCannonDocs
We are pleased to announce that SCRI experts will highlight our latest research insights through 155+ accepted abstracts and presentations at the 2026 @ASCO Annual Meeting. For more information, read the press release:
www.scri.com/news/sarah-cannon-research-institute-deliver…
#asco26 #cancerresearch -
Sarah Cannon Docs
@SarahCannonDocs
Meet the SCRI experts heading to #asco26!
scriasco.com -
Sarah Cannon Docs
@SarahCannonDocs
SCRI announces a strategic oncology collaboration w/ @Pfizer to accelerate clinical trials and expand patient access to promising therapies—marking #clinicaltrialsday and advancing research w/ our Accelero™ model, delivering trials faster, closer to home.
www.scri.com/news/sarah-cannon-research-institute-announc… -
Sarah Cannon Docs
@SarahCannonDocs
When U.S. representation in global oncology trials falls short, access and approvals can be affected. Hans Lee MD, (SCRI) highlights the need to expand clinical trial access in community settings.
🔗 sohoinsider.com/news/when-us-representation-falls-short-i…
#oncology #clinicaltrials #cancerresearch -
Sarah Cannon Docs
@SarahCannonDocs
We are looking forward to a great year at #asco26. Stay tuned for more on the latest breakthroughs!
The US Oncology Network
@TheUSONetwork
Excited to head to #asco26 with @McKesson Oncology & Multispecialty, @OntadaOncology, and @SarahCannonDocs! We'll discuss new innovations and how we can work together to shape the future of cancer care. Learn more:
www.linkedin.com/posts/mckesson-oncology-multispecialty_a…
#cancerdoesntstandachance -
Sarah Cannon Docs
@SarahCannonDocs
FDA approval milestone: vepdegestrant is now approved for ER+/HER2- advanced breast cancer with ESR1 mutations. SCRI’s @ErikaHamilton9 is closely involved in the research that helped lead to this advancement.
🔗www.biopharminternational.com/view/fda-approves-first-pro…
#oncology #breastcancer -
Sarah Cannon Docs
@SarahCannonDocs
Why is the phase 3 KEYNOTE-522 study one to watch? @ErikaHamilton9 shares her perspective ahead of #asco26. Read more in the @OncLive article: www.onclive.com/view/asco-2026-tnbc-deep-dive-breast-canc…
#cancerresearch #asco26 -
Sarah Cannon Docs
@SarahCannonDocs
Ahead of #asco26, @ErikaHamilton9 weighs in on the phase III persevERA BC trial, raising key questions about endocrine backbones, CDK4/6 combinations, & whether oral SERDs may benefit pts beyond ESR1 mutations.
🔗 www.onclive.com/view/asco-2026-breast-cancer-preview-read…
#breastcancer #clinicaltrials #oncology -
Sarah Cannon Docs reposted
Comprehensive Cancer Centers
@CCCNevada
Comprehensive Cancer Centers has collaborated with Sarah Cannon Research Institute (SCRI) to expand access to innovative, community-based clinical trials. Together, we’re bringing cutting-edge therapies and personalized trial matching directly to patients.
-
Sarah Cannon Docs
@SarahCannonDocs
SCRI has enrolled & treated the first patients worldwide in a first‑of‑its‑kind Phase III CAR T‑cell clinical trial for aggressive large B‑cell lymphoma—bringing innovative treatment options to patients through community‑based research. @StDavidsHC #car_t #lymphoma #scri
-
Sarah Cannon Docs
@SarahCannonDocs
🎙️ New @VJHemOnc podcast: @KrishPatelMD of @SCRIOncology discusses how key biologic and patient-specific factors guide frontline MCL treatment decisions, and how BTK inhibitors are used across different patient populations.
🎧 www.vjhemonc.com/podcast/the-evolving-treatment-landscape…
#mcl #hemeonc #btkinhibitors -
Sarah Cannon Docs
@SarahCannonDocs
We’re pleased to announce leadership updates at SCRI. @KrishPatelMD has been appointed executive director of Hematologic Cancer Research, and we welcome Shaolin Paul as chief financial officer—supporting SCRI’s research priorities and continued growth. 🔗www.scri.com/news/scri-announces-leadership-appointments-…
-
Sarah Cannon Docs
@SarahCannonDocs
A MARIPOSA analysis shows improved 2L PFS w/ frontline amivantamab + lazertinib vs osimertinib in EGFR‑mutant NSCLC. Led by @DavidRSpigel from @SCRIOncology & presented @ AACR 2026, results suggest durable benefit & possible disease biology modification.🔗www.onclive.com/view/amivantamab-plus-lazertinib-extends-…
-
Sarah Cannon Docs
@SarahCannonDocs
Oncology Decoded: Drs. Bupathi & Garmezy discuss KEYNOTE‑B15/EV‑304 data on enfortumab vedotin + pembrolizumab in MIBC, highlighting transformational potential, & open questions on histology, sequencing, ctDNA, & real‑world use. @SCRIOncology @CancerNetwrk bit.ly/4uhwCH1-
-
Sarah Cannon Docs
@SarahCannonDocs
Bispecific antibodies are changing #dlbcl—but evidence, implementation, and access matter. In @CancerNetwrk, @jeff_sharman shares what’s needed to bring these therapies into practice.
🔗 www.cancernetwork.com/view/elucidating-bispecific-impact-… -
Sarah Cannon Docs
@SarahCannonDocs
Advanced therapies are redefining outcomes in metastatic CRC. After systemic chemo, @MeredithPelster of @SCRIOncology used HAI chemotherapy to shrink extensive liver metastases—making surgery possible.
www.today.com/health/disease/mom-stage-4-colorectal-cance… -
Sarah Cannon Docs
@SarahCannonDocs
New in @NEJM: Phase 1 data on setigrasib, a first‑in‑class #kras G12D degrader, showed encouraging early activity in NSCLC and #pancreaticcancer, with a manageable safety profile. Proud to see #scri's Drs. Pelster & Wang contribute to this study.
www.nejm.org/doi/full/10.1056/NEJMoa2600752?query=feature… -
Sarah Cannon Docs
@SarahCannonDocs
On #doctorsday, we celebrate the physicians across #scri who are driving innovation, advancing clinical research, and putting patients first every day.
Your leadership and commitment are shaping the future of cancer care. Thank you for all you do.
#voicesofscri #clinicaltrials -
Sarah Cannon Docs
@SarahCannonDocs
🧬 Dr. @BGarmezy discusses emerging prostate cancer strategies and highlights molecular glues & T‑cell engagers in a new @CancerNetwork interview.
🔗 www.cancernetwork.com/view/emerging-strategies-in-prostat…
#prostatecancer #oncology #precisionmedicine #scri -
Sarah Cannon Docs
@SarahCannonDocs
#scri expert, Dr. @MeredithPelster joined @NC5's Let Me Help to discuss #colorectalcancer and the importance of early screening.
Watch the segment:
www.newschannel5.com/news/let-me-help/let-me-help-learnin…
@SCRIOncology -
Sarah Cannon Docs
@SarahCannonDocs
At 83, Bill traveled from CO to #nashville to join a #clinicaltrial at #scri in collaboration with TriStar Centennial.
Today, he shows no active sign of disease — a testament to research, expertise, and resilience.
Read his story: www.scri.com/patients/bill-myelofibrosis/ -
Sarah Cannon Docs reposted
HealthTree Foundation
@HealthTree
Join leading myeloma experts from @SarahCannonDocs @washumedicine @UABHemOncFellow to discuss bispecifics, CAR-T, CELMoDs & first-line care.
Featuring Hans Lee, MD, @DrBattiwalla , MD @MMBaljevicMD, Mark Schroeder, MD & Gayathri Ravi, MD.
Nashville Myeloma Roundtable | March 7, 2026 | Hutton Hotel Nashville | $25 (meals & parking included). Financial assistance available.
Register: htree.org/nashvillemyelomaroundtable
#multiplemyeloma #myeloma -
Sarah Cannon Docs
@SarahCannonDocs
#scri’s Dr. Balanchivadze explains the mental health gaps in #oncology and how a “frictionless” virtual collaborative care model helps patients stay on treatment by embedding #behavioralhealth into oncology workflows.
www.targetedonc.com/view/how-virtual-collaborative-care-i…
#cancercare #integratedcare -
Sarah Cannon Docs
@SarahCannonDocs
In a new Scrip Asks, SCRI’s @DavidRSpigel, discusses what 2026 holds for biopharma—especially in oncology R&D and the push to operationalize complex therapies.
Read more: insights.citeline.com/scrip/scrip-asks/scrip-asks-what-do…
#oncology #biopharma #randd #cancerresearch #clinicalresearch #innovation -
Sarah Cannon Docs
@SarahCannonDocs
As #scri enters a new chapter, Drs. @DavidRSpigel, @MLJohnsonMD2, and @ErikaHamilton9 share how scientific momentum is making community‑based research more important than ever.
Read the new @AJMCjournal feature:
www.ajmc.com/view/as-new-leaders-rise-at-scri-the-mission…
#oncology #cancerresearch -
Sarah Cannon Docs
@SarahCannonDocs
SCRI and @SCRIOncology expert, Dr. Meredith Pelster joined @Pharmacy_Times to discuss emerging data that could meaningfully change the treatment landscape for #pancreaticcancer.
Watch to learn more:
www.pharmacytimes.com/view/atebimetinib-signals-a-potenti…
#scri #oncologyresearch -
Sarah Cannon Docs
@SarahCannonDocs
Global rates of premenopausal #breastcancer are rising, making fertility preservation a critical part of care.
#scri’s Dr. Sarah Premji and Dr. @ErikaHamilton9 outline strategies and evidence supporting the safety of short‑course COS for HR+ patients.
dailynews.ascopubs.org/do/fertility-preservation-discussi… -
Sarah Cannon Docs
@SarahCannonDocs
AI is revolutionizing cancer care. Dr. @DavidRSpigel, President & CMO at #scri and @SCRIOncology
medical oncologist, shares how personalized treatments and clinical trials are evolving. Read the
@NewsChannel5
feature: www.newschannel5.com/news/let-me-help/let-me-help-can-ai-… #cancerresearch #aiinhealthcare -
Sarah Cannon Docs
@SarahCannonDocs
MorningSun trial shows SC mosunetuzumab is effective & well-tolerated for elderly or CIT-ineligible #dlbcl patients. Featuring SCRI’s Dr. Jeff Sharman: www.hmpgloballearningnetwork.com/site/onc/news/subcutaneo… #ash25 #innovationinoncology #scri
-
Sarah Cannon Docs
@SarahCannonDocs
Congrats to our @SarahCannonDocs teams for powering 100 abstracts & 50+ investigator-led presentations across hematologic diseases.
Patients remain at the center of all we do—here’s to driving impact beyond Orlando!
#scri -
Sarah Cannon Docs
@SarahCannonDocs
We’re proud to share @ErikaHamilton9's latest publication in Journal of Clinical Oncology: #her2climb05, a Phase 3 study evaluating tucatinib in combo w/trastuzumab + pertuzumab as first-line maintenance therapy for HER2+ #metastaticbreastcancer.
🔗: ascopubs.org/doi/10.1200/JCO-25-02600 -
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
A new chemo free maintenance option for patients with HR+ & HR- HER-2 + disease in the 1st line setting post induction chemo that can provide a meaningful benefit in excess of 2 years is a win for our patients!
@SABCSSanAntonio @OncBrothers @OncoAlert @SarahCannonDocs
San Antonio Breast Cancer Symposium® (SABCS®)
@SABCSSanAntonio
Adding tucatinib to standard maintenance therapy led to progression-free survival of more than two years in patients with HER2-positive metastatic breast cancer, according to results of the HER2CLIMB-05 trial presented by Dr. Erika Hamilton at #sabcs25 www.aacr.org/about-the-aacr/newsroom/news-releases/adding…
-
Sarah Cannon Docs
@SarahCannonDocs
Didn’t have a chance to meet our experts at #ash25 booth 1580? Learn from them during their presentations today!
View the schedule: scriash2025.com -
Sarah Cannon Docs
@SarahCannonDocs
Meet #scri experts at #ash25. Visit booth 1580 and view our full schedule: uberflip.scri.com/i/1541695-meet-the-experts-at-ash-2025/1?
-
Sarah Cannon Docs
@SarahCannonDocs
Dr. Burke takes the #ash25 stage to answer the question: How Can Community-Based and Academic Hematologists Foster Clinical Trial Participation as Part of Patient Care?
-
Sarah Cannon Docs
@SarahCannonDocs
Dr. Frangoul presents first results of exagamglogene autotemcel in children aged 5–11 with transfusion‑dependent β‑thalassemia or #scd with recurrent severe VOCs.
A major moment for pediatric gene‑edited therapy research. #ash25 -
Sarah Cannon Docs
@SarahCannonDocs
🔬 Featured at #ash25
Dr. Burke presented new Phase II MorningSun data on fixed‑duration subcutaneous mosunetuzumab with maintenance therapy for previously untreated high‑tumor‑burden follicular #lymphoma (HTB FL). -
Sarah Cannon Docs
@SarahCannonDocs
SCRI expert, Dr. Hans Lee serves as session chair during “#multiplemyeloma: Pharmacologic Therapies: Advances in Treatment Strategies for Relapsed/Refractory Multiple Myeloma.” #ash25
-
Sarah Cannon Docs
@SarahCannonDocs
From AGAVE‑201, Dr. Farhadfar reports that switching to axatilimab 0.6 mg/kg Q4W was safe, feasible, and showed no new signals vs 0.3 mg/kg Q2W. Patients remained on therapy long‑term (median 1.7 y), with 84% continuing—suggesting ongoing benefit. #ash25
-
Sarah Cannon Docs
@SarahCannonDocs
At #ash25, #scri expert, Dr. Sharman, presented interim MorningSun results on fixed‑duration SC mosunetuzumab.
Data show encouraging efficacy, durable responses at 12.5 months, and a manageable safety profile supporting outpatient use. -
Sarah Cannon Docs
@SarahCannonDocs
Meet the SCRI committee chairs shaping the conversation at #ash25. From leukemia and lymphoma to β-thalassemia and sickle cell disease, these leaders are driving insights that matter.
Onsite? Visit booth #1580 to connect and learn from our experts. uberflip.scri.com/i/1541695-meet-the-experts-at-ash-2025/0? -
Sarah Cannon Docs
@SarahCannonDocs
Hematology is evolving fast—and SCRI experts are leading the way. Ahead of #ash25, explore 5 trends shaping research and collaboration this year.
Read more: www.scri.com/news/sarah-cannon-research-institute-to-pres…
#scri #ash25 #hematology #oncology -
Sarah Cannon Docs
@SarahCannonDocs
Sarah Cannon Research Institute will present 100 abstracts at #ash25, marking our largest presence yet. 50+ investigators will share breakthroughs in blood cancers & disorders. Learn more: www.scri.com/news/sarah-cannon-research-institute-to-pres…
-
Sarah Cannon Docs
@SarahCannonDocs
Mike’s cancer journey shows the power of research + compassionate care. At SCRI, he found hope through clinical trials and unwavering support.
Watch his story: www.youtube.com/watch?v=29KRbgdmTZ4
#cancercare #clinicaltrials #patientstories
@McKesson | @SCRIOncology -
Sarah Cannon Docs
@SarahCannonDocs
Big news from #esmo25!
Dr. @ErikaHamilton9 discusses DESTINY-Breast11 & 05 trials showing T-DXd moves into curative settings for HER2+ breast cancer.
✅ 83% pCR rate
✅ Anthracycline-sparing approach
www.medpagetoday.com/meetingcoverage/esmovideopearls/1184…
#oncology #breastcancer #clinicaltrials -
Sarah Cannon Docs
@SarahCannonDocs
We’re expanding our collaboration with @bmsnews to accelerate cancer research and broaden access to clinical trials through SCRI’s Accelero model.
#cancerresearch www.scri.com/news/sarah-cannon-research-institute-and-bri… -
Sarah Cannon Docs
@SarahCannonDocs
November is #lungcancerawarenessmonth.
Dr. @MLJohnsonMD2 of @SCRIOncology spoke with @NC5 about how early detection and clinical trials are changing the future of lung cancer care.
From low-dose CT scans to bispecifics — hope is here.
📺 Watch: www.newschannel5.com/news/let-me-help/let-me-help-innovat…
#oncology -
Sarah Cannon Docs reposted
Vivek Subbiah, MD
@VivekSubbiah
⭐️Incredible start to the morning at the Target Cancer Foundation meeting! @targetcancer #tcf25 🎯
Dr. @AndreaCercek delivered an amazing talk on neoadjuvant tumor agnostic immunotherapy !!! 100 % response in Rectal cancer
@Dr_R_Kurzrock took us on a journey to the top of Mt. Everest & then around the solar system exploring N of 1 studies and precision medicine. Visionary work and phenomenal as always.
#cancerresearch #precisionmedicine #immunotherapy #rarecancer -
Sarah Cannon Docs
@SarahCannonDocs
New findings from the #her2climb05: Adding tucatinib to first-line maintenance therapy significantly improved PFS for patients with HER2+ metastatic #breastcancer.
Read more via @CancerNetwork: www.cancernetwork.com/view/tucatinib-regimen-improves-pfs…
Expert insight from @ErikaHamilton9 #oncology -
Sarah Cannon Docs
@SarahCannonDocs
Journalist Amy Robach opens up about discovering breast cancer after a filmed mammogram. SCRI’s Dr. @ErikaHamilton9 shares expert tips on risk and prevention on @DrewBarrymoreTV.
Watch here: www.thedrewbarrymoreshow.com/videos/journalist-who-discov…
#breastcancerawareness #scriexperts -
Sarah Cannon Docs
@SarahCannonDocs
Learn about testicular cancer diagnosis, treatment options, and shared decision-making in this @cure_today segment featuring SCRI expert Dr. @BGarmezy:
🔗 www.curetoday.com/view/stage-1-testicular-cancer-a-patien…
#testicularcancer #cancereducation #scri -
Sarah Cannon Docs
@SarahCannonDocs
PHAROS 4-year data: 50% of treatment-naïve patients with BRAF V600E–mutant NSCLC on encorafenib + binimetinib are alive at 4 years.
👏 Kudos to @MLJohnsonMD2 for driving innovation in targeted therapy!
🔗 www.ajmc.com/view/long-term-data-for-pharos-show-half-of-…
#nsclc #oncology #precisionmedicine #scri -
Sarah Cannon Docs
@SarahCannonDocs
AI, precision medicine & collaboration are transforming oncology care. At #pcoc2025, experts like Dr. @VivekSubbiah shared how these trends will drive better outcomes for patients.
Watch the video + read the article:
🔗 www.ajmc.com/view/experts-highlight-ai-innovation-and-col…
#oncology #ai #cancercare -
Sarah Cannon Docs
@SarahCannonDocs
Your breast cancer risk is personal—and understanding it is powerful.
@SarahCannonDocs's Dr. Denise Yardley shares how genetic testing is changing prevention on @NC5.
🎥 Watch: www.newschannel5.com/news/let-me-help/let-me-help-breast-…
#bcam #breastcancerawareness #earlydetection #scri -
Sarah Cannon Docs
@SarahCannonDocs
We’re celebrating Dr. Howard “Skip” Burris’s remarkable career as he prepares to retire as President & CMO of SCRI.
His legacy: 850+ first-in-human trials, countless lives impacted. 💙
Welcome new leaders and read the full update: www.scri.com/news/scri-announces-the-appointments-of-lead… -
Sarah Cannon Docs
@SarahCannonDocs
At 45, Bryan was diagnosed with advanced prostate cancer. A #brca mutation led him to a clinical trial through #scri at
@TexasOncology with @MikeLattanzi. Today, his PSA levels are undetectable—and he’s thriving. #prostatecancer #scri #usoncologynetwork #clinicaltrials -
Sarah Cannon Docs
@SarahCannonDocs
Bill, 76, joined a clinical trial at SCRI to treat stage IV #prostatecancer. His goal: dance at his daughter’s wedding. Now celebrating a grandchild & still practicing law—while seeing a 15% reduction in disease.
Hope lives here.
🔗 www.scri.com/patients/?comp=25329&name=Bill
#scri #clinicaltrials -
Sarah Cannon Docs
@SarahCannonDocs
Dr. Kathleen Moore of #scri shares the latest on PARP inhibitors in ovarian cancer care in a new @OncLive interview.
🔗 www.onclive.com/view/dr-moore-on-the-present-standing-of-…
#scri #ovariancancer #parpinhibitors #cancerresearch -
Sarah Cannon Docs
@SarahCannonDocs
🎧 SCRI’s Dr. Garmezy & Dr. Bupathi discuss how to optimize GU cancer care in community settings on Oncology Decoded Ep. 13 from #worldgu2025.
🔗 www.cancernetwork.com/view/episode-13-perspectives-on-opt…
#scri #cancerresearch #guoncology #oncologydecoded -
Sarah Cannon Docs
@SarahCannonDocs
🎧 SCRI’s Dr. Garmezy & Dr. Bupathi share expert insights on treating variant histologies in GU cancers at #worldgu2025 on Oncology Decoded.
🔗 www.cancernetwork.com/view/episode-12-variant-histology-t…
#scri #cancerresearch #guoncology #oncologydecoded -
Sarah Cannon Docs
@SarahCannonDocs
Mary is proof that hope and research go hand in hand.
She’s in a clinical trial for IV #ovariancancer at #scri at Mary Crowley—and her disease has remained stable since March.
She’s walked the Camino de Santiago, joined the Lourdes Pilgrimage, & got a tattoo to celebrate it all. -
Sarah Cannon Docs
@SarahCannonDocs
Dr. Hans Lee & Dr. Kris Patel from @SCRIoncology share how new therapies like CAR T-cell treatment are changing lives.
📺 Watch the full @NC5 segment here: www.youtube.com/watch?v=hg4_bwjNiic
#bloodcancerawareness #lymphomaawareness #cancercare #scri -
Sarah Cannon Docs
@SarahCannonDocs
Dr. Jason Henry featured on @DenverChannel discussing early data from a promising #pancreaticcancer vaccine.
“This is one of the most exciting times in pancreatic cancer research in the last 100 years.”
#scri #cancerresearch #clinicaltrials
www.denver7.com/lifestyle/health/early-data-for-new-pancr… -
Sarah Cannon Docs
@SarahCannonDocs
“Prostate cancer is often treatable—if caught early.”
Dr. @BGarmezy of @SCRIOncology shares why early screening matters and how new therapies are offering hope.
🎥 Watch the clip: youtu.be/tMnvf31VWN8
#prostatecancerawareness #menshealth #cancerresearch #scrioncology -
Sarah Cannon Docs
@SarahCannonDocs
Joseph, a physician & mountain biking coach, was diagnosed with AML in 2023. A clinical trial at SCRI helped him return to biking, coaching, and living fully. 💬 Read his story: www.scri.com/patients/?comp=25329&name=Joseph
#aml #scri #clinicaltrials #hope -
Sarah Cannon Docs
@SarahCannonDocs
New studies in @ASH’s Blood Advances show significant quality-of-life gains for patients with #sicklecell & #betathalassemia.
From hospital beds to classrooms & workplaces, read how CRISPR is giving new opportunities to pts.
#genetherapy #exacel #crispr #hematology @hfrangoul
ASH
@ASH_hematology
Gene therapy is changing lives! For patients with sickle cell disease and beta thalassemia, exa-cel means freedom from hospital visits and a renewed quality of life. New studies show these gains in wellbeing are sustained.🔗Learn more in the press release: www.hematology.org/news-and-media/press-releases/2025/gen…
-
Sarah Cannon Docs
@SarahCannonDocs
Dr. Hans Lee joins OncLive On Air to discuss FDA approval of linvoseltamab for relapsed/refractory multiple myeloma. A new option for patients with limited therapies.
🔗 www.onclive.com/view/fda-approval-insights-linvoseltamab-…
#multiplemyeloma #scri #fdaapproval -
Sarah Cannon Docs
@SarahCannonDocs
Kim’s stage 4 ovarian cancer diagnosis led her to clinical trials through SCRI.
Her journey is one of hope, advocacy, and resilience.
💬 Read more: www.scri.com/patients/?comp=25329&name=Kim
#ovariancancer #scri #clinicaltrials #cancersurvivor #patientvoices -
Sarah Cannon Docs
@SarahCannonDocs
Early data from a personalized mRNA vaccine shows promise in delaying recurrence in pancreatic cancer. Dr. Jason Henry shares why this is generating hope.
🔗 www.onclive.com/view/personalized-cancer-vaccine-leads-to…
#pancreaticcancer #cancervaccine #scri -
Sarah Cannon Docs
@SarahCannonDocs
FDA accepts NDA for vepdegestrant in ER+/HER2– metastatic breast cancer. Dr. @ErikaHamilton9 highlights the VERITAC-2 trial’s impact on this promising therapy.
🔗 www.onclive.com/view/fda-accepts-nda-for-vepdegestrant-in…
#breastcancer #veritac2 #scri #fdaapproval -
Sarah Cannon Docs
@SarahCannonDocs
In Oncology Decoded, SCRI's Drs. Bupathi and Garmezy, discuss evolving strategies for treating urothelial carcinoma beyond first-line therapy, particularly in light of recent FDA approvals.
Listen to the episode: www.cancernetwork.com/view/episode-9-advancing-beyond-fir… -
Sarah Cannon Docs
@SarahCannonDocs
Lisa was diagnosed with triple-negative breast cancer while pregnant — 20 years later, she’s thriving thanks to a clinical trial at SCRI and @TexasOncology.
Her story is a beacon of hope. 💗 www.scri.com/patients/?comp=25329&name=Lisa
#breastcancerawareness #scri #clinicaltrials #cancersurvivor -
Sarah Cannon Docs
@SarahCannonDocs
Exciting news! Dr. Sarah Premji joins #scri as Assistant Director of Breast Cancer Research. A rising leader in oncology, she’ll help advance care across our network.
📰 Read more: www.scri.com/news/sarah-cannon-research-institute-expands…
@SCRIOncology #breastcancerresearch #oncologyleadership -
Sarah Cannon Docs
@SarahCannonDocs
🧬 “AQUILA is a big trial… and there’s a trend toward improved OS.”
– SCRI expert, Dr. Burke on daratumumab for high-risk smoldering #multiplemyeloma in Targeted Therapies in Oncology.
ODAC votes 6–2 in favor. FDA decision pending.
📖 Read: www.targetedonc.com/view/dr-burke-discusses-daratumumab-i… -
Sarah Cannon Docs
@SarahCannonDocs
85% of cancer patients stay local for care.
Now, they can access clinical trials too—thanks to partnerships with SCRI.
🎥 Watch how we’re bringing hope and innovation closer to home.
www.scri.com
#cancercare #clinicaltrials #scri #oncologyresearch #hopeclosetohome -
Sarah Cannon Docs
@SarahCannonDocs
JP was diagnosed with stage IV lung cancer. He joined a clinical trial through #scri at #ohc, responded to immunotherapy, and is now in remission.
Learn about JP's empowering journey. 💙
www.scri.com/patients/?comp=25329&name=JP -
Sarah Cannon Docs
@SarahCannonDocs
How do we bring #precisionmedicine to every cancer patient? Jason Hammonds (@TheUSONetwork) spotlights insights from Dr. Eric Lander and Andrew McKenzie on simplifying workflows, integrating trials, and empowering providers in #communityoncology.
www.targetedonc.com/view/expanding-precision-medicine-s-i… -
Sarah Cannon Docs
@SarahCannonDocs
New from @CancerNetwork: @ErikaHamilton9 of @SCRIOncology shares insights on ADCs, CDK4/6 inhibitors & early breast cancer care from #ibc25.
🎧 Listen: www.cancernetwork.com/view/highlighting-breast-cancer-adv…
#breastcancer #oncology #scri -
Sarah Cannon Docs
@SarahCannonDocs
Clinical trials = access to tomorrow’s treatments, today.
Learn why they could be a powerful part of your cancer journey.
Watch now: youtu.be/UvnsfYyl4bw
#cancertrials #oncologyresearch #scri #hopeclosetohome -
Sarah Cannon Docs
@SarahCannonDocs
Thank you, #asco25!
We’re grateful to our presenters, panelists, and the entire ASCO community for an inspiring week of innovation and collaboration.
Here’s to advancing therapies for patients —together.
Until next year!
#scri #cancerresearch #oncologyleadership #thankyouasco -
Sarah Cannon Docs
@SarahCannonDocs
Tomorrow, SCRI's Dr. Yardley will join @industrydive in a State of Oncology Research Virtual Event. Join her June 5, 1PM ET.
dive.pub/43zAmrB
#cancernews #oncologyresearch #scri #breastcancernews -
Sarah Cannon Docs
@SarahCannonDocs
Dr. Meredith McKean delivers her oral presentation on Novel Targets in #melanoma Treatment at #asco2025
-
Sarah Cannon Docs
@SarahCannonDocs
Dr. @VivekSubbiah shared final ARROW trial results on a developmental therapy for RET fusion-positive solid tumors at #asco25 yesterday. Thank you Dr. Subbiah for an insightful session on efficacy and safety!
-
Sarah Cannon Docs
@SarahCannonDocs
Dr. Cloven shares her #asco25 poster on “Rinatabart sesutecan (Rina-S) for patients with advanced endometrial cancer: First disclosure from dose expansion cohort B2 of the
GTC1184-01 study.” -
Sarah Cannon Docs
@SarahCannonDocs
Happening now at #asco25! Dr. Naqash serves as chair during the Oral Abstract Session: Lung Cancer-Non-
Small Cell Local-Regional/ Small Cell/ Other Thoracic Cancers session. -
Sarah Cannon Docs
@SarahCannonDocs
New data from the AIM-HIGH trial presented by Dr. @DavidRSpigel at #asco25 shows a 78% relative reduction in recurrence or death with adjuvant chemo for high-risk early-stage #nsclc patients, identified via a 14-gene molecular assay. Watch interview here: ascopost.com/videos/2025-asco-annual-meeting/david-r-spig…
-
Sarah Cannon Docs reposted
McKesson Corporation
@McKesson
📷 from #asco2025 where @SarahCannonDocs, @TheUSONetwork and @OntadaOncology are presenting a combined 170 abstracts on their latest research and innovations — showcasing their commitment to always advancing cancer research and care. Together, #cancerdoesntstandachance.
-
Sarah Cannon Docs
@SarahCannonDocs
Come meet SCRI expert, @ErikaHamilton9 at #asco25 booth 27022, now!
-
Sarah Cannon Docs
@SarahCannonDocs
🚨 LIVE from #asco25 🚨
Dr. @ErikaHamilton9 presents first-in-human data on Emi-Le (B7-H4 ADC) in solid tumors.
🔹 ORR: 31% in B7-H4 high
🔹 ORR: 44% w/ ≤4 prior lines
🔹 ACC-I: 55.6% ORR
Promising activity + tolerability in mBC, OC, EC & ACC-I.
#scri #adc #oncology -
Sarah Cannon Docs
@SarahCannonDocs
We look forward to seeing more of you on day four of the #asco25 Annual Meeting. Stop by both #27022 to meet experts from across the network, from 9:45am-2:00pm. #cancerresearch
uberflip.scri.com/i/1535506-meet-the-experts-at-asco-2025/2 -
Sarah Cannon Docs
@SarahCannonDocs
Live from #asco25, Dr. @DavidRSpigel breaks down AIM-HIGH findings on a 14-gene assay guiding chemo decisions in early-stage #nsclc, with a nearly 80% reduction in recurrence or death for high-risk patients. Watch his interview in @OncLive here: www.onclive.com/view/dr-spigel-on-adjuvant-chemotherapy-i…
-
Sarah Cannon Docs
@SarahCannonDocs
Dr. Melissa Johnson tackled how community oncology can deliver cutting-edge lung cancer therapies:
🔹 Not all bispecifics need inpatient care
🔹 Tarlatamab = outpatient-friendly
🔹 Innovative care models = better access
#lungcancer #immunotherapy #scri #asco25 -
Sarah Cannon Docs
@SarahCannonDocs
Honoring a legacy in oncology!
Dr. @Howard A. Burris III now has a Conquer Cancer Young Investigator Award in his name, recognizing his impact on cancer research.
Congrats to inaugural recipient Dr. Allison Taylor!
🔗 www.scri.com/leadership/?comp=25030&name=Skip
#oncology #cancerresearch #asco -
Sarah Cannon Docs
@SarahCannonDocs
At #asco25, Dr. Naqash explores the promise & challenges of bispecific T-cell engagers (BiTEs) in lung cancer & beyond:
✅ Tarlatamab earns FDA nod for SCLC
⚠️ CRS & ICANS toxicity management is key
🎯 DLL3 & other targets may expand BiTE reach
#immunotherapy #lungcancer -
Sarah Cannon Docs
@SarahCannonDocs
Meet the experts from Sarah Cannon Docs at the 2025 ASCO Annual Meeting! Visit booth #27022 to connect with leaders from across our organization and discover the latest in oncology research.
uberflip.scri.com/i/1535506-meet-the-experts-at-asco-2025/1? -
Sarah Cannon Docs
@SarahCannonDocs
To all the fighters, heroes, mothers, grandmothers, friends, sons, coworkers, golf partners, sisters, bakers, neighbors and many more, happy National Cancer Survivors Day! Today, and every day we celebrate you. #nationalcancersurvivorsday www.scri.com/patients/
-
Sarah Cannon Docs
@SarahCannonDocs
At #asco25, Dr. @ErikaHamilton9 presented Phase 3 VERITAC-2 results:
🧬 Vedegestrant (first PROTAC ER degrader) showed:
✅ Significant PFS benefit vs fulvestrant (ESR1m ER+/HER2- ABC)
✅ Favorable safety (<5% AEs led to dose changes)
⏳ OS data maturing
A promising new option! -
Sarah Cannon Docs
@SarahCannonDocs
SCRI patient, Jimi, shares his first-hand experience with sickle cell disease in a powerful ASCO/AACR Joint Session.
#genetherapy #ascoaacr #scd #precisionmedicine #asco25 -
Sarah Cannon Docs
@SarahCannonDocs
Dr. @hfrangoul takes the stage in the ASCO/AACR Joint Session:
"Established Gene Therapy Options in the Clinic" 🧬
🔬 Exploring real-world gene therapy: successes, challenges & equitable access.
#genetherapy #ascoaacr #precisionmedicine #asco2025 -
Sarah Cannon Docs reposted
Rafeh Naqash, MD, FASCO
@thenasheffect
The man.. the mission @BurrisSkip Chair of @ConquerCancerFd Board. A world renowned passionate leader and innovator but more importantly an advocate for junior investigators and trainees ! Celebrating tomorrow ..Skips Endowed YIA @SarahCannonDocs @ASCO @VivekSubbiah
-
Sarah Cannon Docs
@SarahCannonDocs
Join us at #asco2025 on June 1 at 12 p.m. CDT in Arie Crown Theater, where Dr. Melissa Johnson will join fellow experts to break down real-world use of amivantamab & tarlatamab for #lungcancer, covering efficacy, toxicities & patient experience. dailynews.ascopubs.org/do/do-recent-approvals-bispecific-…
-
Sarah Cannon Docs
@SarahCannonDocs
Dr. Skip Burris, President of #scri, takes the stage to honor this year’s Top Donors—recognizing the individuals and organizations driving progress in cancer research and care.
Grateful for those fueling the future of oncology. #asco25 #cancerresearch #ascoopeningsession -
Sarah Cannon Docs
@SarahCannonDocs
Breaking new ground at #asco25! Proud to share Dr. Erika Hamilton’s latest research on vepdegestrant in #erpositive/#her2negative metastatic #breastcancer, showing promising results for patients with ESR1 mutations. Learn more here: dailynews.ascopubs.org/do/asco25-first-look-dr-erika-hami…
Erika Hamilton, MD, FASCO
@ErikaHamilton9
Today at #asco25, I’ll be presenting findings from the VERITAC-2 study on vepdegestrant in ER+/HER2- metastatic #breastcancer, the most common subtype, demonstrating a 43% risk reduction in progression/death for ESR1-mutant patients. @NEJM www.nejm.org/doi/abs/10.1056/NEJMoa2505725
-
Sarah Cannon Docs
@SarahCannonDocs
🚨 LIVE from #asco25: Dr. Dax Kurbegov shares promising results on a reflex blood-based #mced test for people with obesity.
🧬 Fills a critical screening gap
📈 Strong PPV & early-stage sensitivity
🔍 Targets cancers w/ no current screening
✅ Warrants prospective validation -
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
Join us in Hall B1 this afternoon to hear the details.
What am I particularly excited about?
Of course 5.0 vs. 2.1 months for ESR1m
But...it's the tolerability! Discontinuations and reductions <5%!
#veritac2 #vepdegestrant #protac #asco25 @SarahCannonDocs
Dr Amol Akhade
@SuyogCancer
🧬 VERITAC-2 Trial (NEJM May 2025)
📌 Oral PROTAC ER degrader vepdegestrant vs. fulvestrant in ER+/HER2– MBC post-CDK4/6i
🎯 Primary PFS Results: — ESR1-mut+ ⬆️ PFS:
5.0 vs 2.1 mo
HR 0.58 | p < 0.001
— ITT:
3.8 vs 3.6 mo
HR 0.83 | NS (p = 0.07)
📈 ORR (ESR1-mut):
18.6% vs 4.0%
💊 All-oral, well tolerated. Low GI & QTc issues.
🔍 BUT...
❌ No benefit in unselected population
❌ OS data immature
❌ No chemo-pretreated patients
❌ Cross-trial gains vs. elacestrant/imlunestrant need caution
❌ Fulvestrant underperforms in ESR1-mut — was that the bar?
🧠 Verdict: A cleaner, smarter SERD — but biomarker-driven use essential.
#breastcancer #esr1 #asco25 #oncologytrials #protac #vepdegestrant #mbc @ASCO @hoperugo @ErikaHamilton9 @stolaney1 @OncoAlert @brunolarvol -
Sarah Cannon Docs
@SarahCannonDocs
We look forward to seeing more of you on day two of the Annual #asco Meeting. Stop by both #27022 to meet our scientific leaders from 9:30am-3:30pm CDT.
uberflip.scri.com/i/1535506-meet-the-experts-at-asco-2025/0? -
Sarah Cannon Docs
@SarahCannonDocs
At #asco25 Dr. Fontana presents:
KRAS G12C: From First to Next Gen
• Early trials: safe KRAS G12C + anti-EGFR ± chemo
• No unexpected toxicities
• Promising, but not practice-changing
• FDA-approved:
– Sotorasib + panitumumab
– Adagrasib + cetuximab
#gicancer -
Sarah Cannon Docs
@SarahCannonDocs
At SCRI, we enhance clinical trial access and bring the latest cancer research to patients throughout our growing network. Connect with us at #asco2025 to learn about how we’re advancing therapies for patients.
www.scri.com/asco/
@ErikaHamilton9 -
Sarah Cannon Docs
@SarahCannonDocs
Interim data from ASC2ESCALATE—asciminib is showing promising efficacy & safety in CML-CP after one TKI. Dr. Andorsky delivered the latest in these advancements in leukemia care. #oncologyresearch #cml #scri #asco2025 Abstract #6516
-
Sarah Cannon Docs
@SarahCannonDocs
🚨 *Live from #asco25!* SCRI’s Dr. Patt just shared how ASCO is shaping AI’s role in cancer care—guiding its integration into decision support & care delivery.
This shift in #oncology is happening now. #ai -
Sarah Cannon Docs
@SarahCannonDocs
Dr. Meredith Pelster shares her insights on the meaningful results of the BREAKWATER study for colorectal pts with BRAF V600E Mutation with @endpoints endpts.com/asco25-pfizers-braftovi-combo-doubles-survival… #oncology #asco25
-
Sarah Cannon Docs
@SarahCannonDocs
At SCRI, we’re dedicated to advancing cancer research for patients. Our team accelerates progress through innovative clinical trials—because today’s research are tomorrow’s therapies. Meet us at the #asco25 and discover what’s next in oncology. www.scri.com/asco/
-
Sarah Cannon Docs
@SarahCannonDocs
We are pleased to announce that SCRI leaders will highlight our latest research insights through more than 155 accepted abstracts and presentations at the 2025 @ASCO Annual Meeting. For more information, read the press release: www.scri.com/news/sarah-cannon-research-institute-to-show…
#asco25 #cancerresearch -
Sarah Cannon Docs
@SarahCannonDocs
We’re excited to announce a strategic alliance with @AbbVie to accelerate innovative cancer therapies and enhance clinical trial delivery.
Learn more: www.scri.com/news/sarah-cannon-research-institute-announc… -
Sarah Cannon Docs
@SarahCannonDocs
May is Melanoma Awareness Month.
SCRI's Dr. @MeredithMcKean shares expert insights on uveal melanoma, a rare eye cancer.
Hear about her patient Mike’s journey: www.scri.com/patients/?comp=25329&name=Mike
#uvealmelanoma #melanomaawareness #patientstories #scri @SCRIOncologyThis media couldn't be displayed. See it on the original post. -
Sarah Cannon Docs
@SarahCannonDocs
We’re thrilled to welcome Dr. Hans Lee as Director of Myeloma Research at SCRI!
A global leader in myeloma care, Dr. Lee joins us from MD Anderson and will serve patients in Nashville starting June 1. @SCRIOncology
#myeloma #cancerresearch #oncology
🔗 www.scri.com/news/sarah-cannon-research-institute-welcome… -
Sarah Cannon Docs
@SarahCannonDocs
SCRI and @IQVIA_global are collaborating to accelerate oncology trials globally. Together, we can eliminate operational hurdles, accelerate data delivery, and expedite the availability of cutting-edge therapies. Learn more: www.scri.com/news/iqvia-and-scri-collaborate-to-accelerat…
#clinicaltrials #asco25 -
Sarah Cannon Docs
@SarahCannonDocs
This #oncologynursingmonth, we honor our incredible nurses across Sarah Cannon Research Institute. Your dedication, compassion, and expertise make a world of difference. Thank you for all you do! 💙 #thankyounurses #healthcareheroes
This media couldn't be displayed. See it on the original post. -
Sarah Cannon Docs
@SarahCannonDocs
SCRI expert, @Phase1Onc, presented promising data in the STELLA Phase 1/2a trial for ART0380 at #aacr25. Conducted by our CRO, SCRI Development Innovations, it has shown significant clinical responses in ATM-negative & ATM-low solid tumors. www.artios.com/press-release/artios-pharma-reports-differ…
@StephensonCC -
Sarah Cannon Docs reposted
Oncology News Central
@OncNewsCentral
Second-line ER+ #breastcancer treatment is evolving rapidly. @ErikaHamilton9 discusses the complexities & emerging therapies in this space with Dr Rob Figlin of @CedarsSinai. www.oncologynewscentral.com/podcast/breast-cancer/second-… #breastcancer #oncology #esr1 @SarahCannonDocs
-
Sarah Cannon Docs
@SarahCannonDocs
SCRI experts Drs. Strickland, Eghtedar, and Farhadfar, recently shared significant insights from #aacr25 - The interim results of the SENTI-202-101 clinical trial. Read about how it leverages logic-gating technology to target cancer cells www.aacr.org/about-the-aacr/newsroom/news-releases/off-th… #aml
-
Sarah Cannon Docs
@SarahCannonDocs
April is #testicularcancerawarenessmonth! Dr. @BGarmezy from @SCRIOncology stresses the importance of self-exams and shares breakthroughs in treatment. Let's spread awareness! 🔬
Read more: www.newschannel5.com/news/let-me-help/let-me-help-what-to… -
Sarah Cannon Docs
@SarahCannonDocs
Dr. @KrishPatelMD discusses CAR T-cell therapy advancements in NHL at the Annual Medical Oncology Summit. Learn about the latest trials and treatments reshaping care. Read more via @DocWireNews! #nhl #oncologyinnovation #scri
www.docwirenews.com/post/experts-discuss-new-data-on-role… -
Sarah Cannon Docs
@SarahCannonDocs
🌟 Celebrating Dr. Joyce O'Shaughnessy, a breast cancer research expert who has revolutionized treatment and inspired a new generation. Her journey is a testament to innovation and dedication. Read more via @NBCDFW ! #breastcancerresearch
www.nbcdfw.com/news/local/local-oncologist-making-medical… -
Sarah Cannon Docs
@SarahCannonDocs
🎧 Episode 3: Traversing the Complexities of Non-Clear Cell RCC! Join experts @mkbupathi and @BGarmezy as they discuss personalized treatments, new TKIs, and IO advances in the latest Oncology Decoded podcast. Listen now! #oncologydecoded #cancerresearch
www.cancernetwork.com/view/episode-3-traversing-the-compl… -
Sarah Cannon Docs
@SarahCannonDocs
Meet Ivy! After battling stage IV melanoma, she found hope at @SCRIOncology Partners. Thanks to Dr. @MeredithMcKean and a clinical trial, she's now cancer-free and enjoying life with her grandkids. A testament to resilience and expert care!
www.scri.com/patients/?comp=25329&name=Ivy -
Sarah Cannon Docs
@SarahCannonDocs
🎧 Dive into the latest Oncology Decoded podcast! Drs. @mkbupathi & @BGarmezy discuss optimizing therapy for mHSPC at the 2025 ASCO Symposium. Explore treatment strategies, imaging, and more with top experts! Listen now: #oncologydecoded #prostatecancer
www.cancernetwork.com/view/episode-2-navigating-treatment… -
Sarah Cannon Docs
@SarahCannonDocs
SCRI is transforming cancer care through groundbreaking trials at 250 locations in 24 states. Join us in advancing therapies and offering hope.
Watch how we collaborate to make a difference.
#cancerresearch #clinicaltrials #newhope #scri
scri.com -
Sarah Cannon Docs
@SarahCannonDocs
🚀 Big news from SCRI's Dr. @DavidRSpigel: The ADRIATIC study reveals Durvalumab shows a 27% reduction in death risk & a 22.5-month median survival boost in our global trial! 🎉 @TargetedOnc #clinicaltrials #scri Watch to learn more:
www.targetedonc.com/view/adriatic-study-shows-durvalumab-… -
Sarah Cannon Docs
@SarahCannonDocs
On this #nationalcaregiversday, we are celebrating those who support people facing cancer and #scri care teams! Beth, loving caretaker and fiancé of prostate cancer survivor, Jim, shared these kind words about their experience with @SCRIOncology’s Dr. @BGarmezy and team!
-
Sarah Cannon Docs
@SarahCannonDocs
SCRI's Dr. @ErikaHamilton9 joins @GMA after Katie Thurston's breast cancer diagnosis to discuss invasive ductal carcinoma. Learn about rising cancer rates in young adults and risk factors. #breastcancerawareness #cancerresearch
www.goodmorningamerica.com/culture/video/former-bachelore… -
Sarah Cannon Docs
@SarahCannonDocs
Explore the impact of remote patient monitoring duration in outpatient CART-cell therapy! Tonya Cox and #sctctn team will share their research comparing 15 vs. 30 days of monitoring across a large health system and its effects on patient outcomes. #tandem25
-
Sarah Cannon Docs
@SarahCannonDocs
Don’t miss the #edithaltrial results in today’s poster session! Dr. @hfrangoul presents on #renicel, showing successful engraftment, increased hemoglobin, and reduced transfusion dependence in #betathalassemia. 🗓️ Feb 13, 2025 🕒 6:45-7:45pm 📍 Exhibit Hall 3 #scri #genetherapy
-
Sarah Cannon Docs
@SarahCannonDocs
📢 Join SCRI at the #tandem25 Poster Session! Discover how Prophylactic Dexamethasone rescues unrestrained lymphocyte expansion in Anti-BCMA CART-cell therapy for multiple myeloma.. 🗓️ Feb 13, 2025 🕒 6:45-7:45pm 📍 Exhibit Hall 3 #scri #multiplemyeloma #cartherapy #dexamethasone
-
Sarah Cannon Docs
@SarahCannonDocs
🔬 Join SCRI expert, Dr. @hfrangoul today at #tandem25 as we explore the promising results of Reni-Cel in severe sickle cell disease from the RUBY Trial. #scri #sicklecelldisease #geneediting
-
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
On this #worldcancerday, I'm reflecting.
It's a privilege to be able to lead our Breast Cancer Research Program for @SarahCannonDocs. Advancing care for patients and bringing not only "better" but less toxic drugs to the clinic makes me happy to come to work every day!
SCRI Oncology Partners
@SCRIOncology
As a part of @SarahCannonDocs, we see firsthand how our #clinicaltrials provide groundbreaking insights to the oncology community.
This #worldcancerday, we’re proud to highlight the innovative work we’re doing to advance care. Together, we are #scriunitedbyunique. -
Sarah Cannon Docs
@SarahCannonDocs
On #worldcancerday, SCRI is "United by Unique." Each cancer journey is distinct, just like our innovative approaches and dedicated team. Let's celebrate the individuality that strengthens our fight against cancer. Together, we're united in uniqueness. #scriunitedbyunique
-
Sarah Cannon Docs
@SarahCannonDocs
🎧 Listen up! Dr. @MeredithMcKean from @SCRIOncology joins the @BBCWorld 's "The Inquiry" to discuss the future of #cancervaccines. Explore groundbreaking trials for melanoma & lung cancer. A must-hear for all in #cancerresearch!
🔗 www.bbc.co.uk/sounds/play/w3ct5xjg
#healthcareinnovation -
Sarah Cannon Docs reposted
The US Oncology Network
@TheUSONetwork
Thanks to our partnership with @SarahCannonDocs, we're able to offer practices access to the latest cancer #clinicaltrials. That means more personalized treatments for local communities.
Find out more here: usoncology.com/practice-success/clinical-innovation/clini…
#cancerresearch #healthcareinnovation -
Sarah Cannon Docs reposted
OncoDaily
@oncodaily
3 Key Insights for Patients Considering Clinical Trials - @VivekSubbiah (@SarahCannonDocs)
oncodaily.com/blog/vivek-subbiah218746
#health #medicine #cancer #oncodaily #oncology #clinicaltrials #medx -
Sarah Cannon Docs
@SarahCannonDocs
Big news! SCRI expands with the acquisition of Mary Crowley Cancer Research, enhancing clinical trial access in North Texas. With 25+ years of pioneering research, we're advancing cancer treatment together. Welcome, Mary Crowley team!
Learn more: www.scri.com/news/sarah-cannon-research-institute-grows-n… -
Sarah Cannon Docs
@SarahCannonDocs
Mike's incredible journey with ocular melanoma highlights the power of resilience. Discover how clinical trials played a role in his story of hope: Read More #cancerjourney #scri
www.scri.com/patients/?comp=25329&name=Mike -
Sarah Cannon Docs
@SarahCannonDocs
Exciting progress in cancer research! Our experts, @KrishPatelMD, @ErikaHamilton9, @VivekSubbiah, and @MeredithMcKean, share their insights on 2024's breakthroughs and 2025's predictions with @FoxNews. Let's advance the fight against cancer together! www.foxnews.com/health/year-cancer-advances-made-2024-pre…
-
Sarah Cannon Docs
@SarahCannonDocs
Congratulations to @ErikaHamilton9, MD, SCRI’s Director of Breast Cancer Research, on her election to the ASCO Nominating Committee! Please join us in congratulating Dr. Hamilton!
Erika Hamilton, MD, FASCO
@ErikaHamilton9
Thrilled to be elected to the @ASCO Nominating Committee! Excited to contribute to decisions regarding leadership over the next 3 years & grateful to serve as ASCO Scientific Chair for 2025.🙏
Thank you for your support!
#asco #leadership #cancerresearch
@SarahCannonDocs -
Sarah Cannon Docs
@SarahCannonDocs
The IDMC recommends a move-forward dose in the trial for 1L HLA-A2-Negative MUM, marking a key step forward for the darovasertib + crizotinib combo. With FDA Fast Track status, we're closer to new treatment options for MUM patients. #melanoma
www.prnewswire.com/news-releases/ideaya-announces-idmc-re… -
Sarah Cannon Docs
@SarahCannonDocs
We had a fantastic evening with @TheUSONetwork during #sabcs24 . Healthcare leaders dedicated to advancing breast cancer care gathered for inspiring discussions and shared commitment to improving patient outcomes. #breastcancerawareness #oncologyresearch
The US Oncology Network
@TheUSONetwork
Honored to join @SarahCannonDocs in hosting a dinner for our peers during the San Antonio Breast Cancer Symposium. We are proud to be part of a community working to improve patient outcomes and advance oncology research. Thank you to all who attended!
-
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
Dr. Turner presents #zest adj study of MRD in pts with HR + w/ BRCA & TNBC all comers w/ niraparib as intervention
147 had ctDNA+, only 40 randomized
Rad recurrence assoc w/ ⬆️ ctDNA level
RFI 5.4 -> 11.4 mo w/ niraparib
#sabcs24
@SABCSSanAntonio
@OncoAlert -
Sarah Cannon Docs
@SarahCannonDocs
Phase III TIGeR-PaC trial now enrolling patients with advanced pancreatic cancer at @SCRIOncology. Led by Dr. Pelster, this study explores innovative TAMP™ therapy. More info: www.globenewswire.com/news-release/2024/12/11/2995362/0/e… #oncology #clinicaltrials #cancerresearch #innovation
-
Sarah Cannon Docs
@SarahCannonDocs
After a great first day of the #ash24 yesterday, we are excited to welcome even more experts to booth 1154. If you are attending, stop by to connect with leaders from across the SCRI network.
#ash24 #oncologyresearch #scientificexperts
uberflip.scri.com/i/1530159-ash-2024-meet-the-experts -
Sarah Cannon Docs
@SarahCannonDocs
Join us at #ash2024 Booth #1154 for SCRI "Meet the Expert" Sessions! Connect with top oncologists and explore cancer research innovations. #oncology #cancerresearch
@DavidRSpigel @KrishPatelMD @hfrangoul @BldCancerDoc @DrBattiwalla
linktr.ee/scrinetwork?ltsid=e2afadec-da85-49d9-b949-2e02f… -
Sarah Cannon Docs
@SarahCannonDocs
Big News! @Cure_Today featured Dr. @ErikaHamilton9 to highlight the future of antibody-drug conjugates in #breastcancer treatment! Read on to learn about this innovative treatment and to meet Karen Boyles, whose inspiring journey with #adcs showcases resilience and hope.
Erika Hamilton, MD, FASCO
@ErikaHamilton9
Thrilled to share this feature on ADCs in breast cancer in @Cure_Today!
Learn about these innovative treatments and how they’re impacting patients like my patient, Karen.
Read about the full inspiring story.
www.curetoday.com/view/finding-hope-with-antibody-drug-co…
#cancerresearch #breastcancer #innovation -
Sarah Cannon Docs
@SarahCannonDocs
Excited for our 50+ investigators from SCRI to present abstracts on malignant/non-malignant blood cancers, blood disorders, CAR T-Cell therapy, innovative immunotherapies, and real-world outcomes at #ash24. Stay tuned for our featured presentations! www.scri.com/news/sarah-cannon-research-institute-to-show…
-
Sarah Cannon Docs
@SarahCannonDocs
Join us in welcoming Dr. Krish Patel, SCRI’s new Director of Lymphoma Research. Dr. Patel will lead our lymphoma research program and practice locally at @SCRIOncology in Nashville. Learn more about his appointment and how it will enhance patient care: www.scri.com/sarah-cannon-research-institute-appoints-dir…
-
Sarah Cannon Docs
@SarahCannonDocs
.@ErikaHamilton9 shares her insights into one of the newest cancer therapies making waves in treatment: endocrine therapy. Check out what these studies novel therapies suggest: www.targetedonc.com/view/the-present-and-future-of-endocr…
#breastcancer #endocrine #cancerinnovation
@TargetedOncology -
Sarah Cannon Docs
@SarahCannonDocs
SCRI breast cancer expert, @ErikaHamilton9 joins @PeerVoice in this comprehensive two-part #ce activity as they discuss strategies to prevent and manage antibody-drug conjugate-associated nausea and vomiting. Access the session here: peervoice.com/VCG?PromoCode=815&AudienceID=Twitter
#oncology #adcs
PeerVoice
@PeerVoice
Watch Now: www.peervoice.com/VCG?PromoCode=815&AudienceID=Twitter
Watch a new two-part #ce activity on strategies for preventing and managing antibody-drug conjugate-associated nausea and vomiting with Prof Karin Jordan and Dr Erika Hamilton.
#oncology #cinv #antiemesis #antibodydrugconjugates #adcs -
Sarah Cannon Docs
@SarahCannonDocs
Excited to announce Dr. Deepak Bhamidipati as SCRI’s new Assistant Director of Drug Development! He'll also join @SCRIOncology in Nashville starting Oct 22. Welcome, Dr. Bhamidipati! 👏 #oncology #drugdevelopment #healthcareinnovation #scri
www.scri.com/news/archive/sarah-cannon-research-institute… -
Sarah Cannon Docs
@SarahCannonDocs
Join us in celebrating Jimi as he reaches new heights! You may remember Jimi from #crispr news. After receiving treatment and becoming functionally cured of #sicklecelldisease, he summited #mountkilimanjaro, becoming the first person with SCD to reach 19,341 ft. #patientstory
-
Sarah Cannon Docs
@SarahCannonDocs
We are excited to announce our partnership with @BostonGeneCorp to integrate their #moleculartesting and informatics platforms into our network. Read more about the collaboration below.
BostonGeneCorp
@BostonGeneCorp
We are excited to collaborate with @SarahCannonDocs (SCRI) to integrate innovative molecular testing and informatics platforms into the clinical decision-making processes at SCRI's Phase 1 clinics. This collaboration also aims to validate novel biomarkers using BostonGene’s AI-powered multiomics platform in real-world cancer populations, further advancing the potential for personalized oncology care.
Read more: bostongene.com/news-and-publications/news/bostongene-and-… -
Sarah Cannon Docs
@SarahCannonDocs
1 in 8 women will have breast cancer at some point in their life. This #breastcancerawarenessmonth, Dr. @ErikaHamilton9 SCRI Breast Cancer expert is educating about common breast cancer myths and misconceptions.
Check out what you should know on @WKRN News 2. #breastcancer
Erika Hamilton, MD, FASCO
@ErikaHamilton9
Happy to talk to @WKRN with @WKRNAllieLynch @TheBlakeEason this morning during October #bcsm awareness to dispel common myths!
@SarahCannonDocs
@SCRIOncology
Breast Cancer Awareness Month: Dispelling myths about the disease www.wkrn.com/video/breast-cancer-awareness-month-dispelli… -
Sarah Cannon Docs
@SarahCannonDocs
How much do diet and exercise impact breast cancer risk? @katiecouric media interviewed @ErikaHamilton9 from @SCRIOncology:
🔹Healthy weight & exercise = lower risk
🔹 Fruit/veggie-rich diet>high-fat foods
🔹 Alcohol = higher risk katiecouric.com/health/cancer/food-diet-exercise-breast-c… -
Sarah Cannon Docs
@SarahCannonDocs
This morning SCRI breast cancer expert Dr. @ErikaHamilton9, @SCRIOncology, joined @GMA to speak about stage 1 triple-negative #breastcancer following #jennafischer's recent cancer battle. Watch the full conversation: abcnews.go.com/GMA/Culture/video/jenna-fischer-opens-canc…
-
Sarah Cannon Docs
@SarahCannonDocs
“I am very competitive, type-A personality and a fighter, but you can’t fight something that is internal by yourself.” With @BGarmezy and our team of oncology experts, Jim didn’t have to fight his battle alone. Read his full #prostatecancer story below.
www.linkedin.com/feed/update/urn:li:activity:724474454368… -
Sarah Cannon Docs
@SarahCannonDocs
Today, on #worldcancerresearchday, SCRI proudly reflects on our work to advance cancer treatment through research and innovation.
Learn more at scri.com -
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
Well isn't this a gift 🎁 for a Tuesday!
#bcsm, welcome our 2nd CDK4/6 approved in the adj setting
Remember w/ #ribociclib:
📍3 yrs vs. 2 like abema
📌includes intermediate risk pts including N0
🧷 intermittent vs. continues dosing
⬇️ 💩, ⬆️ neutropenia
@OncoAlert
Tatiana Prowell, MD
@tmprowell
📣 NEW #onctwitter 🇺🇸
Ribociclib is now FDA-approved for treatment of adults with stage 2 & 3 hormone receptor positive, HER2 negative #breastcancer at high risk of recurrence based on efficacy & safety results of the NATALEE trial.
#bcsm #regulatory #esmo24 -
Sarah Cannon Docs reposted
Vivek Subbiah, MD
@VivekSubbiah
⭐️It was a terrific to see several oral presentations & amazing talks from our @SarahCannonDocs #scri fearless leaders @MLJohnsonMD2 @DavidRSpigel @SCRIOncology #manishpatel FCS/SCRI @myESMO #esmoambassadors @OncoAlert #esmo24
-
Sarah Cannon Docs reposted
Vivek Subbiah, MD
@VivekSubbiah
⭐️It was such a great honor to talk about “Tumor-Agnostic Biomarker Driven Drug development: How & How often?” at the special joint session of @ASCO & @myESMO meeting #esmo24 #esmoambassadors !
⭐️Grateful to our beloved ASCO President @ASCOPres & amazing ESMO President @AndresC27622123 for the invite to the talk & their vision in putting this amazing session together.
Link to the @Annals_Oncology ETAC-S paper: www.annalsofoncology.org/article/S0923-7534(24)01519-9/fu…
🙏🏽@herbloong for the pictures. -
Sarah Cannon Docs
@SarahCannonDocs
The #wclc24 conference in San Diego, CA is in full swing! SCRI experts @DavidRSpigel and @MLJohnsonMD2 presented earlier today on the latest advancements in #lungcancer. Be sure to hear from more of our SCRI researchers today and tomorrow. #lcsm @IASLC
-
Sarah Cannon Docs
@SarahCannonDocs
SCRI and #floridacancerspecialistsandresearchinstitute work together to bring cutting-edge therapies to patients throughout Florida. We are excited about the opportunities this integration will have for our continued research operations with FCS.
McKesson Corporation
@McKesson
We announced a definitive agreement to acquire a controlling interest in Core Ventures, a business & administrative services organization established by Florida Cancer Specialists & Research Institute, LLC, a leading community oncology practice. Read more: investor.mckesson.com/news/financial-news/2024/McKesson-S…
-
Sarah Cannon Docs
@SarahCannonDocs
SCRI expert, @MLJohnsonMD2 joined @WKRN
News 2's #goodmorningnashville to discuss the leading cause of #lungcancer deaths in the U.S. and to shine a light on the #latesttreatment advances offering hope for this disease. #oncologyexpert
www.wkrn.com/video/lung-cancer-leading-cause-of-cancer-de… -
Sarah Cannon Docs
@SarahCannonDocs
Today, on #worldlungcancerday, we reflect on Matt's inspiring lung cancer journey which was featured in @WSJ . Matt's experience highlights the critical importance innovative treatments, and the power of clinical trials. www.wsj.com/health/healthcare/lung-cancer-treatment-death…
-
Sarah Cannon Docs
@SarahCannonDocs
Long-term survival analysis of the DESTINY-Breast03 trial reveals efficacy in HER2-positive metastatic breast cancer. Read more in @NatureMedicine :
www.nature.com/articles/s41591-024-03021-7
#asco24 #breastcancer #oncology @ErikaHamilton9 -
Sarah Cannon Docs
@SarahCannonDocs
Dr. David Spigel highlights lung cancer research findings emerging from #asco24. Read more in @FiercePharma: www.fiercepharma.com/pharma/asco-astrazenecas-tagrisso-im… #asco24 #lungcancer #oncology
-
Sarah Cannon Docs
@SarahCannonDocs
Dr. @MeredithMcKean presented research from pivotal melanoma trials at #asco24. Watch her insights on @VJOncology: www.vjoncology.com/video/wzgxzz2ygvo-melanoma-trials-at-a… #asco24 #melanoma #cancerresearch
-
Sarah Cannon Docs
@SarahCannonDocs
Dr. @ErikaHamilton9 discusses the potential of 'smart warheads' in cancer treatment. Learn more in @BeckersHR: www.beckershospitalreview.com/oncology/smart-warheads-of-… #asco24 #oncology #innovativetreatment
-
Sarah Cannon Docs
@SarahCannonDocs
SCRI's Dr. Robert Jotte presents how Adagrasib shows improvement in PFS and ORR over Docetaxel in NSCLC. Watch on @eCancer: ecancer.org/en/video/11900-adagrasib-demonstrates-improve… #asco24 #nsclc #cancerresearch
-
Sarah Cannon Docs
@SarahCannonDocs
Dr. @MeredithMcKean explores the potential of JZP898 and Pembrolizumab in advanced solid tumors. Watch on @VJOncology www.vjoncology.com/video/snb2epuyw8g-evaluating-jzp898-an… #asco24 #oncology #immunotherapy
-
Sarah Cannon Docs
@SarahCannonDocs
SCRI's Dr. @DavidRSpigel joined Dr. Narjust Florez to present results from the ADRIATIC study on limited-stage small cell lung cancer. Watch on the @ASCOPost: ascopost.com/videos/2024-asco-annual-meeting/narjust-flor… #asco24 #lungcancer #cancerresearch
-
Sarah Cannon Docs
@SarahCannonDocs
Dr. @DavidRSpigel highlights how #immunotherapy extends survival for rare lung cancer. Read the @BioPharmaDive article: www.biopharmadive.com/news/astrazeneca-imfinzi-lung-cance… #lungcancer #oncology
-
Sarah Cannon Docs
@SarahCannonDocs
. @CNBC highlights Dr. @DavidRSpigel's research on long-term results for advanced lung cancer. www.cnbc.com/2024/05/31/pfizer-lung-cancer-drug-shows-pro… #cancerresearch #oncology
-
Sarah Cannon Docs
@SarahCannonDocs
Exciting insights from Dr. @ErikaHamilton9 on ADCs and their future in cancer treatment. Learn more in @AJMC_Journal: (www.ajmc.com/view/adc-improvements-mean-more-targets-new-…) #cancerresearch #oncology
-
Sarah Cannon Docs
@SarahCannonDocs
Chief Scientific Officer for SCRI, @DavidRSpigel, MD, shares exciting #lungcancer therapy updates with @YahooNews : www.yahoo.com/news/breakthrough-pill-stops-incurable-lung…
-
Sarah Cannon Docs
@SarahCannonDocs
The ADRAITIC trial's results were detailed by SCRI expert, Dr. @DavidRSpigel, discover how this research is impacting people facing #lungcancer (www.youtube.com/watch?v=n4x772p6ECA) #oncology #asco24
-
Sarah Cannon Docs
@SarahCannonDocs
Proud of Dr. Yardley’s findings from the NATALEE trial, showing reduced recurrence in early breast cancer. A notable step forward for patients in this at-risk subgroup! #breastcancer (www.pharmacytimes.com/view/natalee-data-shows-ribociclib-…) #cancerresearch #asco24
-
Sarah Cannon Docs
@SarahCannonDocs
Lung cancer treatment is evolving! Dr. @DavidRSpigel shares the latest from ASCO 2024, showcasing significant progress in drug trials. [#lungcancer](www.iaslc.org/iaslc-news/lung-cancer-considered/asco-2024…) #oncology #asco24 @IASLC
-
Sarah Cannon Docs
@SarahCannonDocs
Dr. @ErikaHamilton9 presents at #asco24 on H3B-6545 for ER+, HER2- breast cancer. Watch the @VJOncology interview: www.vjoncology.com/video/ifagkgezmfy-h3b-6545-in-women-wi… #breastcancer #oncology
-
Sarah Cannon Docs
@SarahCannonDocs
Dr. McKean's latest on PD-1–refractory advanced melanoma at @eCancer highlights new treatments for this challenging condition. [#melanoma](ecancer.org/en/video/11928-pd-1-refractory-advanced-melan…) #cancerresearch #asco24
-
Sarah Cannon Docs
@SarahCannonDocs
Excited to share Dr. @ErikaHamilton9’s insights on the future of antibody-drug conjugates (ADCs) from ASCO 2024. Learn what these advancements could mean for #breastcancer treatment! #cancerresearch (www.vjoncology.com/video/xln150llvm8-the-abcs-of-adcs-wha…) #oncology #asco24
-
Sarah Cannon Docs
@SarahCannonDocs
“It's just kind of blown everyone away that the results are just so outstanding,” Dr. @DavidRSpigel commented on the major #lungcancerresearch CROWN, LAURA, and ADRIATIC studies for @PatientPower. #asco24 Why Lung Cancer Research Earned Big Applause (patientpower.info)
-
Sarah Cannon Docs
@SarahCannonDocs
During her discussion with @VJOncology, Dr. @ErikaHamilton9 of SCRI shares the recently updated survival data comparing T-DXd and T-DM1 in HER2+ metastatic breast cancer from the DESTINY-Breast03 trial. #asco24 #breastcancerresearch
www.vjoncology.com/video/rm6bedjywfy-updated-survival-res… -
Sarah Cannon Docs reposted
OncoAlert
@OncoAlert
The #oncoalerttoptweet 🚨Day 4 #asco24 by
@ErikaHamilton9
Black are underrepresented in clinical trials and have some genomic differences
#oncoalertaf
@nataliagandur
@acampsmalea
@MartaPerachino
@heinrich_kat
@BiagioRicciutMD
@DenizCanGuven1
@yekeduz_emre
@HHorinouchi
@FadiHaddad_MD
@Dr_Ivanoncologo
@Abdallah81MD
@FernandoOnco
@ElisaAgostinett
@dr_yakupergun
@to_be_elizabeth
@anmwongNZ
@lungoncdoc
Erika Hamilton, MD, FASCO
@ErikaHamilton9
Black 👩🏾 are underrepresented on trials & have some genomic differences.
Therefore, our drugs developed may not be drugs that are better for them.
I firmly believe we need better awareness & education around clinical trials BEFORE people are diagnosed with cancer.
#asco24 -
Sarah Cannon Docs reposted
Vivek Subbiah, MD
@VivekSubbiah
🚨Sarah Cannon Research Institute @SarahCannonDocs Presents Latest Cancer Research Insights at 2024 ASCO® Annual Meeting -
✅> 145 presentations @ASCO #asco24
✅Over 100 investigators from across SCRI’s network are co-authors on clinical trial updates #scri
✅Data presented from more than 65 early-phase clinical trials @BurrisSkip @DavidRSpigel
www.businesswire.com/news/home/20240530232039/en/Sarah-Ca… -
Sarah Cannon Docs reposted
Vivek Subbiah, MD
@VivekSubbiah
⭐️Such an incredible honor to discuss the latest in tumor-agnostic drug development at the ASCO @ASCO panel discussion with amazing colleagues. The energy and insights shared were electric!
jumbotron was an added bonus #asco #tumoragnostic #cuttingedge @oncodaily -
Sarah Cannon Docs
@SarahCannonDocs
Dr. Cesar Perez presenting at the educational session on Head and neck cancers at ASCO 2024 #asco24
-
Sarah Cannon Docs
@SarahCannonDocs
We are proud to participate in #asco24 to help accelerate progress for the next generation of cancer therapies. Learn more about our research and network of experts at www.scri.com/ASCO/
-
Sarah Cannon Docs
@SarahCannonDocs
SCRI expert, @IshwariaMD delivered findings from the “5-year multicenter analysis of clinical trial participation and total cost of
care for older adults with cancer” study earlier today at #asco24. -
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
A-BRAVE: adjuvant aveulmab after definitive treatment for high risk TNBC
❌DFS not significantly improved~5% numerically diff
✅ OS 8.5 months better!
✅ DDFS 7.5% better, HR 0.70
#asco24
#bcsm -
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
PEARLY
AC->T vs. AC -> Tcarbo among TNBC LN+ or 2cm
🔹7.2% ⬆️ in EFS w/ addition of carbo
🧐OS already very close to significant with 3.7% diff, p0.058
☑️Very compelling data that pCR translates to outcome in TNBC
#asco24
#bcsm -
Sarah Cannon Docs reposted
David R. Spigel, MD, FASCO
@DavidRSpigel
@VivekSubbiah and Dr. Andy McKenzie providing expert insights and perspectives in: ‘Beyond Tumor Types: Advancing Tumor-Agnostic Drug Development and the Role of the Tumor Microenvironment’ in Dev Ther Session w/ Dr. Aparna Raj Parikh & @MarkLadanyi at #asco24 @SarahCannonDocs
-
Sarah Cannon Docs reposted
Thomas Hutson, DO, PharmD, PhD FACP
@DrTHut
Busy ASCO for @DrTHut. Great science with greater colleagues on the search for the CURE. #asco24 @TTUHSC @SarahCannonDocs @BGarmezy @MarkTFlemingMD1 @VivekSubbiah @MikeLattanzi @DavidRSpigel
-
Sarah Cannon Docs reposted
Vivek Subbiah, MD
@VivekSubbiah
⭐️Today !!! Don’t miss the “Tumor-Agnostic session” @ASCO #asco24 @aparna1024 @MLadanyi @OncoAlert !
CA: A Cancer Journal for Clinicians
@CACancerJournal
For the #asco24 3pm session today on "Beyond Tumor Types: Advancing Tumor-Agnostic Drug Development & the Role of the Tumor Microenvironment" featuring @VivekSubbiah, read his new #tissueagnostic therapies in #precisionmedicine review in CA.
acsjournals.onlinelibrary.wiley.com/doi/10.3322/caac.21844
@OncoAlert -
Sarah Cannon Docs reposted
Lilly Oncology Medical
@LillyOncMed
HR+, HER2- #metastaticbreastcancer (#mbc) is a heterogeneous disease w/ distinctive subtypes and varied clinical outcomes. The current 1L SOC treatment includes CDK4/6i + ET.
To see the full video on disease heterogeneity, click here: e.lilly/3Ww4PVP
#bcsm #breastcancer -
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
Bria-IMT off the shelf cancer vaccine 💉 for #bcsm + checkpoint inhibitor
⏺️Activity across tumor subtypes -CBR 55%.
⏺️100% CBR and 50% responses in HER-2
⏺️No diff in when CPI was started
🔉no d/c to tox
#asco24 -
Sarah Cannon Docs reposted
Vivek Subbiah, MD
@VivekSubbiah
🚨Live now 👉🏼Ishwaria Subbiah, MD, MS, FASCO, @IshwariaMD is sharing the latest data on a 5-year multicencer analysis of clinical trial participation & total cost for older adults with cancer @SarahCannonDocs @TheUSONetwork @ASCO #asco24 @OncoAlert
www.scri.com/asco/ -
Sarah Cannon Docs reposted
CA: A Cancer Journal for Clinicians
@CACancerJournal
For the #asco24 3pm session today on "Beyond Tumor Types: Advancing Tumor-Agnostic Drug Development & the Role of the Tumor Microenvironment" featuring @VivekSubbiah, read his new #tissueagnostic therapies in #precisionmedicine review in CA.
acsjournals.onlinelibrary.wiley.com/doi/10.3322/caac.21844
@OncoAlert -
Sarah Cannon Docs
@SarahCannonDocs
SCRI expert, @IshwariaMD will share the latest on a 5-year multicencer analysis of clinical trial participation and total cost for older adults with cancer. Learn more during her oral presentation today at 1:30PM in S102 #asco24
www.scri.com/asco/ -
Sarah Cannon Docs reposted
Shankar Siva
@_ShankarSiva
📢🚨#asco24 plenary @DavidRSpigel - pivotal ADRIATIC ph III trial; adjuvant durvalumab arm after chemoradiotherapy (cCRT) ± PCI in small cell #lungcancer; ⬆️ OS (HR 0.73), median OS 55.9 vs 33.4 for placebo. Grade 3/4 AEs in 24.3% vs 24.2%. 💥Practice changing!!! #radonc #lcsm
-
Sarah Cannon Docs
@SarahCannonDocs
SCRI’s @DavidRSpigel presented important updates from the ADRIATIC study for limited stage small cell lung cancer.
An exciting day in #lungcancer with results from LAURA study as well as ADRIATIC study, proving again that Today’s Clinical Trials are Tomorrow’s Therapies #asco24 -
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
So proud of @DavidRSpigel for an excellent presentation of transforming results with consolidation durvalumab in small cell #lcsm 🫁
Big win for patients!
@SarahCannonDocs -
Sarah Cannon Docs
@SarahCannonDocs
Congratulations to @VivekSubbiah and @BurrisSkip on their recent publication on the evolving landscape of tissue‐agnostic therapies in
precision oncology in the @CACancerJournal!
CA: A Cancer Journal for Clinicians
@CACancerJournal
In advance of the Genomics101 workshop at #asco24, read how #genomictests can lead to better outcomes in cancer care by informing cancer risk, prognosis, and therapeutic selection.
acsjournals.onlinelibrary.wiley.com/doi/full/10.3322/caac…
@Raffa_Casolino @VivekSubbiah @BenWestphalen @OncoAlert -
Sarah Cannon Docs
@SarahCannonDocs
Our CSO, Dr. @DavidRSpigel, will present the latest in LS-SCLC research at this afternoon's plenary session in Hall B1 at 3PM #asco24. #cancerresearch www.scri.com/ASCO/
-
Sarah Cannon Docs
@SarahCannonDocs
Want to learn more about collaborations with SCRI? Learn more about our CRO, SMO, Personalized Medicine and Access programs at www.scri.com/partners/
-
Sarah Cannon Docs reposted
Vivek Subbiah, MD
@VivekSubbiah
⭐️@ASCO #asco24 Sunday morning! Starting the day with @BurrisSkip @ConquerCancerFd & @DavidRSpigel
Big day for small cell lung cancer 👍🏼.
👉🏼Our amazing CSO @SarahCannonDocs Dr. Spigel will be presenting at the big plenary!
✅#lba5 ADRIATIC: Durva after CRT in LS-SCLC
✅Primary OS&PFS
✅NCT03703297
🙌🏼#scri - Today’s trials tomorrow’s therapies 🏆
#lcsm @OncoAlert @ASCO
meetings.asco.org/abstracts-presentations/239063 @ErikaHamilton9 @IshwariaMD @TheUSONetwork -
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
#conquercancer continues to fund more research for #cancer moving forward year over year, inspiring to be here tonight.
#asco24 -
Sarah Cannon Docs reposted
Ishwaria Mohan Subbiah, MD MS FASCO
@IshwariaMD
Together we go far! Celebrating the launch of @ASCO and ACS @AmericanCancer Society’s expanded collaboration — two most trusted #cancer organizations uniting to bring the highest quality #cancercare information is such a meaningful win for our entire #healthcare community and our patients, families, and society at large! Can’t wait to guide our patients to the invaluable resources they co-create! 👏👏 to @AmerCancerCEO @arifkamalmd @CliffordHudis @jrgralow and teams! #asco24
American Cancer Society
@AmericanCancer
Announcing our expanded collaboration with @ASCO to help patients better find cancer information online, creating one of the largest and most comprehensive online resources available for FREE to the public on cancer.org. More: pressroom.cancer.org/releases?item=1334
-
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
My favorite picture so far at #asco24. Have to love @BurrisSkip our President of @SarahCannonDocs and previous #asco president!
This guy has been the best mentor and champion for me that I ever could have wished for! -
Sarah Cannon Docs
@SarahCannonDocs
This morning, Dr. @ErikaHamilton9 served as chair and delivered the ABCs of ADCs in the “Next-Generation Antibody-Drug Conjugates: The Revolution Continues” #asco24 session.
-
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
Presented this morning 📈 and the paper is simultaneously published in @Nature 📖
Survival in DB-03, 2nd line TDXd for HER-2 positive #bcsm, 10 months improved survival 👏 🎉!
#asco24
@JavierCortesMD
@curijoey
@SarahCannonDocs
www.nature.com/articles/s41591-024-03021-7 -
Sarah Cannon Docs
@SarahCannonDocs
To all the fighters, heroes, mothers, grandfathers, friends, sons, coworkers, surfers, and sisters, bakers, neighbors and many more, happy National Cancer Survivors Day! Today, and every day we celebrate you. #nationalcancersurvivorsday
-
Sarah Cannon Docs
@SarahCannonDocs
Cancer-fighting antibodies inject chemo directly into tumor cells, upping effectiveness. @ErikaHamilton9 weighs in on the latest advancements in ADCs. @NBCNews #breastcancer #clinicaltrials www.nbcnews.com/health/health-news/cancer-fighting-antibo…
-
Sarah Cannon Docs
@SarahCannonDocs
We look forward to seeing more of you on day three of the Annual #asco24 Meeting. Stop by both #11058 to meet @VivekSubbiah, @MeredithMcKean, @BldCancerDoc and #andrewmckenzie PhD, from 11am-2:30pm.
#asco24 -
Sarah Cannon Docs
@SarahCannonDocs
In today’s #asco24 Opening Session, @BurrisSkip’s message was clear: Research Conquers Cancer. We echo his gratitude towards our oncology researchers’ unwavering commitment to patients everywhere. 👏👏👏 #oncologyresearch
-
Sarah Cannon Docs
@SarahCannonDocs
Join us to hear the latest progress in next-generation anti-drug conjugates with Dr. @ErikaHamilton9 tomorrow at 9:45 in #asco24 Hall D1. And be sure to attend her oral presentation on Monday. Get all of the details on where you can learn from here: www.scri.com/ASCO/
-
Sarah Cannon Docs
@SarahCannonDocs
SCRI experts Drs @bgarmezyz, #markflemming and #lancecowey are at booth #11058! Come discuss what you are excited to see today at #asco24. #oncology #clinicaltrials #cancerreserch
-
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
Mammaprint HR+:
High-2 pts do inferior with TC vs. AC-T
Conversely, high-1 pts do just as well w/ TC alone
More data about how to #personalize #bcsm tx? This seems likely to be predictive of benefit for "bigger" chemo more than clinical characteristics alone
#asco24
#bcsm -
Sarah Cannon Docs
@SarahCannonDocs
We look forward to seeing you at this year's Annual ASCO Meeting and our experts do too! Stop by both #11058 to meet leaders from across our network.
uberflip.scri.com/i/1521061-meet-the-experts/0?
#asco24 #oncology #cancer Research -
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
@YardleyDenise presents updated #natalee ribo data from node neg pts
Benefit in the included node neg pts (IIa with other risks factors, IIb and III everyone) at 3 yrs is 2.6%
📌 Very eager to see more follow-up and if this benefit increases
#asco24
#bcsm
@SarahCannonDocs -
Sarah Cannon Docs reposted
CA: A Cancer Journal for Clinicians
@CACancerJournal
In advance of the Genomics101 workshop at #asco24, read how #genomictests can lead to better outcomes in cancer care by informing cancer risk, prognosis, and therapeutic selection.
acsjournals.onlinelibrary.wiley.com/doi/full/10.3322/caac…
@Raffa_Casolino @VivekSubbiah @BenWestphalen @OncoAlert -
Sarah Cannon Docs reposted
Vivek Subbiah, MD
@VivekSubbiah
⭐️Ready, set, go @ASCO #asco24 Day 1.
Looking forward to groundbreaking #precisionmedicine treatments, visionary insights, & state-of-the-art research at the 2024 ASCO Annual Meeting. Most importantly meeting with all amazing oncology colleagues from everywhere.
@SarahCannonDocs @OncoAlert -
Sarah Cannon Docs
@SarahCannonDocs
SCRI’s Dr. @MeredithMcKean takes the #asco24 stage in the “PD-1-Refractory
Advanced Melanoma: How Do We Get to the Finish Line?” session as a discussant covering key #melanoma takeaways. -
Sarah Cannon Docs
@SarahCannonDocs
Want to hear more about our network, learn about ongoing clinical research, or just say hi to our team? Stop by our booth #11058 tomorrow in the #asco24 exhibit hall.
-
Sarah Cannon Docs
@SarahCannonDocs
Excited for the @ASCO Annual Meeting in Chicago this weekend! We'll be showcasing our latest insights in #cancerresearch from across our network. Looking forward to connecting with you at the meeting! #asco24 www.scri.com/ASCO/
@BurrisSkip -
Sarah Cannon Docs reposted
McKesson Corporation
@McKesson
@SarahCannonDocs brings cutting-edge cancer research closer to home, providing access to advanced therapies through community-based clinical trials. Ahead of the @ASCO Annual Meeting, learn how SCRI is transforming the standard of care: www.mckesson.com/our-stories/revolutionizing-cancer-care/
-
Sarah Cannon Docs
@SarahCannonDocs
Check out this recently published abstract co-authored by SCRI experts @VivekSubbiah and @BurrisSkip #scientificexperts #precisionmedicine #oncologyresearch
CA: A Cancer Journal for Clinicians
@CACancerJournal
🎯 Just in time for #asco24! Tumor-agnostic therapies represent a paradigm shift in oncology. This review by @VivekSubbiah @Dr_R_Kurzrock et al delves into the expansive landscape of tissue-agnostic targets and drugs. #precisionmedicine
acsjournals.onlinelibrary.wiley.com/doi/10.3322/caac.21844 @OncoAlert -
Sarah Cannon Docs
@SarahCannonDocs
Personalized medicine, immunotherapy, and targeted therapies are just few topics our oncology experts will cover in 145+ presentations at this year's Annual @ASCO Meeting. www.scri.com/news/archive/sarah-cannon-research-institute…
#cancerresearch #medicaladvancements #clinicaltrials #asco24 -
Sarah Cannon Docs reposted
Vivek Subbiah, MD
@VivekSubbiah
⭐️It’s the Wednesday before @ASCO #asco24 & we have another FDA approval for a RET inhibitor 👉🏼 I knew this baby would graduate 👨🏽🎓 right from the 1st patient dosed. Now this baby has graduated in “real babies” - a #precisionmedicine Pediatric approval 👉🏼FDA grants accelerated approval to selpercatinib for pediatric patients two years and older with RET-altered metastatic thyroid cancer or solid tumors #precisionmedicine 🧬🎯🏆 @OncoAlert www.fda.gov/drugs/resources-information-approved-drugs/fd…
-
Sarah Cannon Docs reposted
Vivek Subbiah, MD
@VivekSubbiah
⭐️It’s Wednesday before @ASCO #asco24 👉🏼Zanidatamab Granted Priority Review for HER2-Positive Metastatic Biliary Tract Cancer | Jazz Pharmaceuticals plc #her2 #precisionmedicine investor.jazzpharma.com/news-releases/news-release-detail…
-
Sarah Cannon Docs
@SarahCannonDocs
SCRI's Dr. @MeredithMcKean discusses exciting advances in melanoma research and the critical importance of #clinicaltrials to advance therapies for people facing #melanoma.
www.linkedin.com/pulse/developments-melanoma-research-loo… -
Sarah Cannon Docs reposted
The US Oncology Network
@TheUSONetwork
On #clinicaltrialsday, we celebrate the hope they bring to patients. Alongside @SarahCannonDocs, we deliver cutting-edge trials to patients' communities, bringing tomorrow's therapies into today's clinics and opening new doors with the latest advancements. @OHC_CancerCare
-
Sarah Cannon Docs
@SarahCannonDocs
Hear from our Chief Scientific Officer, Dr. @DavidRSpigel, as he reflects on the vital role of clinical research in cancer care on this Clinical Trials Day. #ctd2024
www.linkedin.com/pulse/reflecting-vital-role-research-can… -
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
Prof. Loibl presents f/u from GeparX looking at denosumab 🦴 with nab-paclitaxel
No significant improvement in iDFS with denosumab
For non-pCR patients, tx with weekly nab-paclitaxel seemed to be better (🔼10%)
#esmobreast2024
#bcsm
#esmoambassadors -
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
Emulated target trial looking at #statins in early #bcsm
Those that received statins had ⬆️ survival.
🎯 Question is what other healthy behaviors are associated with statin use?
Hard to conclude much with study design, MASTER randomized will help.
#esmobreast24
@myESMO -
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
#esmobreast24 already buzzing and the conference doesn't start for 20 minutes.
Join us in Berlin Hall at 1pm for the opening lecture!
@myESMO
#bcsm
@SarahCannonDocs -
Sarah Cannon Docs reposted
Stephanie Graff, MD, FACP, FASCO
@DrSGraff
Chairs kick off #esmobreast24
By the numbers:
#️⃣3381 Participants
#️⃣ 2700 onsite in Berlin
#️⃣ 620 submitted abstracts
#️⃣6 Proffered Papers
#️⃣17 Mini Oral presentations
#️⃣256 Posters
#️⃣1 Amazing Conference
@OncoAlert @myESMO -
Sarah Cannon Docs
@SarahCannonDocs
SCRI expert, @ErikaHamilton9 discusses the newly announced #uspstf recommendation for breast cancer screening. Watch as she speaks with @WKRN Good Morning Nashville.
www.wkrn.com/news/local-news/nashville/national-health-pa…
#mammogram #breastcancerscreening #bcsm @SCRIOncology -
Sarah Cannon Docs reposted
Vivek Subbiah, MD
@VivekSubbiah
Nivolumab + Ipilimumab as Immunotherapeutic Boost in Metastatic Urothelial Carcinoma
A Nonrandomized Clinical Trial
Second-/third-line nivolumab plus high-dose ipilimumab may benefit patients with metastatic urothelial carcinoma @JAMA_current @JAMAOnc
jamanetwork.com/journals/jamaoncology/article-abstract/28… -
Sarah Cannon Docs
@SarahCannonDocs
Tune in with us to hear the latest from SCRI oncology expert, @ErikaHamilton9 throughout the @myESMO Breast Cancer Annual Congress. #esmoambassadors #esmobreast24 #oncologyexpert #clinicalresearch
Erika Hamilton, MD, FASCO
@ErikaHamilton9
#esmobreast24 is starting Wednesday. I love this meeting - all breast, smaller digestible size, international faculty, and plenty of conversation and collaboration.
Follow us for meeting updates!
@myESMO
@SarahCannonDocs
#bcsm
@oncoalert -
Sarah Cannon Docs
@SarahCannonDocs
Watch SCRI breast cancer expert, @ErikaHamilton9, MD discuss the updated #uspstf breast cancer screening recommendations with @NicholeBerlie on @NewsNation
www.newsnationnow.com/health/breast-cancer-screening-40-e…
#bcsm #cancerresearch #newsnationnow -
Sarah Cannon Docs
@SarahCannonDocs
…but that’s not all! Dr. @hfrangoul also contributed to research published today in The New England Journal of Medicine showing the encouraging results of CRISPR/Cas9 gene-editing therapy for the treatment of Transfusion-Dependent Beta Thalassemia.
www.nejm.org/doi/full/10.1056/NEJMoa2309673
Sarah Cannon Docs
@SarahCannonDocs
SCRI Research Leader @hfrangoul helped pioneer exciting research published today in @NEJM showing results of CRISPR/Cas9 gene-editing therapy for the treatment of #sicklecelldisease. Read more:
www.nejm.org/doi/full/10.1056/NEJMoa2309676 @TriStarHealth -
Sarah Cannon Docs
@SarahCannonDocs
SCRI Research Leader @hfrangoul helped pioneer exciting research published today in @NEJM showing results of CRISPR/Cas9 gene-editing therapy for the treatment of #sicklecelldisease. Read more:
www.nejm.org/doi/full/10.1056/NEJMoa2309676 @TriStarHealth -
Sarah Cannon Docs
@SarahCannonDocs
Join us in celebrating Laboratory Professionals Week! Thank you to those who work tirelessly behind the scenes, making invaluable contributions to cancer research. #thefutreislab #cancerresearchheroes
-
Sarah Cannon Docs
@SarahCannonDocs
Don't miss the plenary session chaired by SCRI leader, @VivekSubbiah, MD, today. "AI at the Interface: Accelerating Evidence Generation, Advancing Disparities Research, and Improving Trial Design" is set to be an enlightening discussion. #aiinoncology #aacr24
-
Sarah Cannon Docs
@SarahCannonDocs
Join Andrew McKenzie, PhD, as he shares his insights on precision oncology in the panel discussion, "Putting the Precision Back in Precision Oncology". Don't miss it! #precisiononcology #aacr24
-
Sarah Cannon Docs
@SarahCannonDocs
Attention NSCLC researchers! Today Dr. Alex Spira presents his poster, "FURVENT: A Phase 3 Trial Comparing Furmonertinib vs Chemotherapy in Advanced NSCLC with EGFR Exon 20 Insertions". Who else is joining to discover the latest treatment options? #nsclc #aacr2024
-
Sarah Cannon Docs
@SarahCannonDocs
Dr. @MeredithMcKean has exciting news for BRAF-mutant cancers and will discuss the Phase 1 trial of PF-07799933 (ARRY-440), a next-generation BRAF inhibitor, today. Stay tuned for more insights. #brafmutation #aacr24
-
Sarah Cannon Docs
@SarahCannonDocs
Calling all breast cancer researchers! @ErikaHamilton9 presents her poster, "ELECTRA: A Study of Elacestrant in Combination with Abemaciclib in Patients with Brain Metastasis" today at #aacr24. Stop by the session to learn about the latest advancements. #breastcancer
-
Sarah Cannon Docs
@SarahCannonDocs
Exciting news! SCRI experts will be presenting innovative research at the AACR meeting from April 5-10 in San Diego, CA. Stay tuned for updates on their abstracts, posters, and presentations. #aacr24 #oncologyresearch #scientificadvancements
www.abstractsonline.com/pp8/ -
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
Fantastic work looking at #tucatinib activity post #tdxd for #her-2+ #bcsm. These real world looks at a drug's activity when sequencing is altered/new drugs are approved is important!
jamanetwork.com/journals/jamanetworkopen/fullarticle/2817003 -
Sarah Cannon Docs reposted
Vivek Subbiah, MD
@VivekSubbiah
⭐️Who is ready for @AACR #aacr24 ? Such a delight to Chair an amazing futuristic Plenary session on AI at the interface @OncoAlert @oncodaily @AACRFoundation
AACR
@AACR
Some of the most important and compelling topics in cancer research will be explored during plenary sessions each day at #aacr24. Learn more in AACR Annual Meeting News: www.aacrmeetingnews.org/daily-plenary-sessions-to-explore…
-
Sarah Cannon Docs
@SarahCannonDocs
We can't wait to attend this session at #aacr24. Who else plans to sit in on this Plenary Session on April 10?
Vivek Subbiah, MD
@VivekSubbiah
📍🚨Honored & thrilled to Chair the Plenary session at @AACR #aacr24
📍SAVE THE DATE
✅When: Wed, April 10, 2024
✅Plenary: AI at the Interface: Accelerating Evidence Generation, Advancing Disparities Research, & Improving Trial Design
✅If you're at #aacr24 , don't miss it.
👉A rockstar panel of speakers will unveil the latest in AI & Oncology. See you there! 🌟 #cancerresearch #ai
@anantm @TClozel @ElizSMcKenna @oncodaily
@OncoAlert @AACRPres @AACR_CEO @CD_AACR
@CCR_AACR @Aiims1742 @Rick__Buck @SarahCannonDocs @BldCancerDoc
Link: www.abstractsonline.com/pp8/ -
Sarah Cannon Docs
@SarahCannonDocs
They’re SCRI physicians, of course we’re going to celebrate them on Doctors’ Day, tomorrow!
#nationaldoctorsday #oncologyexperts -
Sarah Cannon Docs
@SarahCannonDocs
Exciting news! The @NEJM recently published a study on ribociclib's impact on breast cancer survival rates. Read more about the study, contributed to by SCRI’s Dr. Denise Yardley. #cancerresearch www.nejm.org/doi/full/10.1056/NEJMoa2305488
-
Sarah Cannon Docs reposted
Vivek Subbiah, MD
@VivekSubbiah
⭐️100 months on a phase 1 trial 🙌🏼
#precisiononcology in action 👉🏼Delivering the right medicine to the right patient at the right time
👉🏼Several years ago, Theresa noticed a knot in her right breast, but at the time, she was caring for her mother and delayed visiting her doctor. Following her mother’s passing, Theresa noticed a new lump growing on the crown of her head and scheduled a biopsy with a dermatologist, which revealed a malignant growth. This ultimately led to her being diagnosed with stage 4 metastatic #breastcancer
Following further testing, Theresa’s primary doctor explained that she was a candidate for a clinical trial in @SarahCannonDocs Nashville, Tenn., where she met @ErikaHamilton9 & began her clinical trial treatment journey using a hormone blocker in combination with a PI3 kinase inhibitor.
Theresa continues the trial with no visible disease on scans & has maintained a thriving & full life in her retirement. In fact, Theresa recently celebrated 100 months on her phase 1 clinical trial, @BurrisSkip & the care team at SCRI in Nashville surprised her with a cake to honor this incredible moment 🙌🏼 @OncoAlert @oncodaily
Sarah Cannon Docs
@SarahCannonDocs
Join us in celebrating Theresa’s 100th month on her phase 1 clinical trial. The care team at SCRI in Nashville surprised her with a cake to honor this incredible moment.
-
Sarah Cannon Docs
@SarahCannonDocs
Join us in celebrating Theresa’s 100th month on her phase 1 clinical trial. The care team at SCRI in Nashville surprised her with a cake to honor this incredible moment.
-
Sarah Cannon Docs
@SarahCannonDocs
Today, we're shining the spotlight on SCRI women who are driving cutting-edge advancements in oncology research. We asked them why they believe it's crucial to have more women in STEM, read their inspiring responses. #internationalwomensday www.linkedin.com/feed/update/urn:li:activity:717188246193…
-
Sarah Cannon Docs
@SarahCannonDocs
We are collaborating with @AstraZeneca to implement modern solutions that accelerate clinical trial delivery. Learn how we are advancing cancer research through technology enhancements and in our new coordinating CRO model
www.scri.com/News/SCRI-Announces-Collaboration-AstraZenec… -
Sarah Cannon Docs
@SarahCannonDocs
We look forward to sharing key insights and developments around CAR T-Cell therapy, data management, gene-therapy, real-world outcomes and much more during the Tandem Annual Meetings. #tandem24
image.sf-marketing.scri.com/lib/fe3011747364047e731675/m/… -
Sarah Cannon Docs
@SarahCannonDocs
Tune in to hear @DavidRSpigel on @iHeartRadio as he sheds light this National Cancer Prevention Month! Discover actionable steps to take charge of your health, from cancer prevention, to screenings, and the latest advancements in treatment and research.
www.iheart.com/podcast/960-iheartradio-communities-282412… -
Sarah Cannon Docs reposted
HCA Healthcare
@HCAhealthcare
#sicklecell disease (SCD) occurs in approx. 1 out of every 365 African-American births (@CDCgov). This #blackhistorymonth, HCA Healthcare SCD patients share the positive impact the CRISPR therapy, led by @SarahCannonDocs and @TriStarHealth, has made. www.goodmorningamerica.com/video/107255640
Good Morning America
@GMA
“My life has been completely transformed.”
A breakthrough treatment for sickle cell anemia is offering a new hope for people living with the painful disease, many of whom are Black. @robinroberts has more on the cutting edge gene therapy.This media couldn't be displayed. See it on the original post. -
Sarah Cannon Docs
@SarahCannonDocs
In need of some uplifting news this morning? Watch #sicklecelldisease warriors Jimi and Victoria share how they’re battling the disease with a new cutting-edge #crispr therapy and how it has impacted their lives. @GoodMorningAmerica www.goodmorningamerica.com/wellness/video/breakthrough-tr…
-
Sarah Cannon Docs
@SarahCannonDocs
Colleagues from across the network shared how they contribute to this year’s #worldcancerday theme. From expanding access to advanced treatments, to reducing barriers to care, to focusing on our patients through each moment of their cancer journey, we work to #closingthecaregap.
-
Sarah Cannon Docs
@SarahCannonDocs
SCRI breast cancer expert, Dr. @ErikaHamilton9, joins @scrippsnews to discuss #breastcancerawareness and screening following CNN’s anchor Sara Sidner’s recent announcement about undergoing treatment for stage 3 #breastcancer.
youtu.be/85F6veh3GTg -
Sarah Cannon Docs
@SarahCannonDocs
In a VuMedi interview, SCRI expert, Dr. @ErikaHamilton9 shares, "The Future of Oral SERDs in Breast Cancer." Watch the full interview today.
www.vumedi.com/video/sabcs-2023-insights-the-future-of-or…
#sabcs23 -
Sarah Cannon Docs
@SarahCannonDocs
We are thrilled to announce SCRI Oncology Partners! With this expansion of the SCRI network, we build upon our capabilities and will undertake new groundbreaking studies that will continue our mission to advance cancer care.
usoncology.com/news/the-us-oncology-network-further-expan… -
Sarah Cannon Docs
@SarahCannonDocs
Earlier today, @hfrangoul's oral presentation titled, "Exagamglogene Autotemcel for Severe Sickle Cell Disease,” was selected as a #bestofash at the @ASH_hematology annual meeting! We are so proud of this important work.
www.hematology.org/meetings/annual-meeting/programs/gener… -
Sarah Cannon Docs
@SarahCannonDocs
Today is your last chance to stop by our booth to meet SCRI experts. Dr. Jeffery Sharman, Dr. Jeffery Matous and Dr. Navneet Majhail are all eager to discuss the latest research presented at the ASH Annual Meeting and Exposition. #ash23 #meettheexperts
-
Sarah Cannon Docs reposted
Vivek Subbiah, MD
@VivekSubbiah
⭐️Great discussions on the latest & greatest in acute leukemias/MDS/MPN with our amazing Leukemia clinical trial strategy leader @SAStricklandMD @SarahCannonDocs @ASH_hematology @ASHClinicalNews #ash23
-
Sarah Cannon Docs
@SarahCannonDocs
Our experts are back at booth #2104, ready to engage and answer all of your questions about #ash23! Stop by now to chat with @DrBattiwalla or throughout the day to see @VivekSubbiah, Dr. Strickland and Dr. Burke!
-
Sarah Cannon Docs reposted
Vivek Subbiah, MD
@VivekSubbiah
Pleased to meet with Dr. Aravind Ramakrishnan @SarahCannonDocs Blood cancer network & catch up @TapKadia @MDAndersonNews ! Such incredible clinical researchers in heme malignancies moving the cancer needle. #ash23 bringing friends together @ASH_hematology
-
Sarah Cannon Docs reposted
Vivek Subbiah, MD
@VivekSubbiah
⭐️So excited to partner with the one & only @BldCancerDoc guru of transplants @ASHClinicalNews @ASH_hematology #ash23 ! This weekend, we're celebrating remarkable achievements in cancer care, sickle cell disease & immune effector cell therapy. Our dedicated physicians & researchers across our research network are presenting groundbreaking research and innovations that are transforming the lives of our patients. @BldCancerDoc is hiring @SarahCannonDocs !!! 👇🏼
-
Sarah Cannon Docs
@SarahCannonDocs
Attending ASH today? Stop by Booth 2104 between 11-3 to meet our esteemed experts. Learn from and connect with our brilliant physicians @hfrangoul, @viveksubbiah, Dr. Aravind Ramakrishnan, and Dr. Mitul Gandhi.
#oncologyexperts #ash23 #clinicaltrials #cancerreserch -
Sarah Cannon Docs
@SarahCannonDocs
"The heroes of the story are not the physicians or the basic scientists that discovered this. They are the patients." @hfrangoul said it best. The patients were the heroes in today's historic #fdaapproval of the first #crispr gene-editing therapy for #sicklecelldisease
ABC News
@ABC
The FDA has approved Casgevy and Lyfgenia, gene therapies that represent two "milestone" treatments for sickle cell disease, according to the announcement. abcnews.com/Health/fda-approves-new-gene-therapies-sickle…
-
Sarah Cannon Docs reposted
Haydar Frangoul
@hfrangoul
So proud of our team at SCRI and TriStar Children Hospital to be part of this transformational therapy for people with SCD
www.fda.gov/news-events/press-announcements/fda-approves-… -
Sarah Cannon Docs
@SarahCannonDocs
The 2023 American Society of Hematology (ASH) annual meeting in San Diego kicks off tomorrow! Our experts are preparing to present latest in #cancerresearch from SCRI's network. If you'll be there too, stop by booth #2104! #ash23
-
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
❓Should we be dissecting axilla in pts with residual ITCs after neoadjuvant chemo?
▪️Additional LN found in 30% of cases 😳
👏 Despite this, no diff at 5 years among that had axillary dissection or not.
#sabcs23 @SABCSSanAntonio #bcsm -
Sarah Cannon Docs
@SarahCannonDocs
With the 65th ASH Annual Meeting and Exposition almost here, we cannot for 65+ investigators from across our network to share recent advancements in sickle cell disease treatment, immune effector cell therapy, and more. #ash23 @ASH_hematology
www.scri.com/News/Sarah-Cannon-Research-Institute-to-Pres… -
Sarah Cannon Docs reposted
OncLive.com
@OncLive
Letomemingeal disease is a high unmet need.
These pts are often excluded from trials- with increasing evidence our drugs w/ 🧠 activity also work for LMD, who thinks they should be included in trials where the agents are thought to have 🧠 activity?
@itsnot_pink #sabcs23
Erika Hamilton, MD, FASCO
@ErikaHamilton9
#debbrah cohort 5 of TDXd tx for pts with leptomeningeal disease
7 pts: 4 HER-2 low, 3 HER-2 +
OS = 13.3 months
mPFS =8.9 months
CBR 74%
IMO....very encouraging data in a small sample!
#sabcs23 @SABCSSanAntonio #bcsm -
Sarah Cannon Docs reposted
OncLive.com
@OncLive
Good morning everyone. Welcome to Thursday at @SABCSSanAntonio #sabcs23!
I'm @ErikaHamilton9 from @SarahCannonDocs and will be tweeting from this account today!
🎉 🤠🌟 -
Sarah Cannon Docs
@SarahCannonDocs
Breast cancer expert, @ErikaHamilton9, recently joined the @ASCO Post for a conversation on early-stage hormone receptor–positive/HER2-negative #breastcancer.
ascopost.com/video-roundtable/updates-in-early-stage-brea… -
Sarah Cannon Docs
@SarahCannonDocs
We are profoundly thankful for our dedicated colleagues who provide world class care and clinical research access to people facing cancer.
-
Sarah Cannon Docs reposted
OncLive.com
@OncLive
As ADCs continue to emerge as invaluable therapeutics for patients with lung cancer, efforts have been made to improve the benefit derived from this drug class. @mljohnsonmd2 @DanaFarber @SarahCannonDocs @TriStarHealth @harvardmed @iaslc #wclc23 #lcsm www.onclive.com/view/investigators-deliver-updates-on-evo…
-
Sarah Cannon Docs reposted
OncLive.com
@OncLive
Melissa L. Johnson, MD, Terufumi Kato, MD, and Pasi A. Jänne, MD, PhD, present updates from the @iaslc 2023 World Conference on Lung Cancer. @mljohnsonmd2 @DanaFarber @SarahCannonDocs @TriStarHealth @harvardmed #wclc23 #lcsm www.onclive.com/view/investigators-deliver-updates-on-evo…
-
Sarah Cannon Docs reposted
Ishwaria Mohan Subbiah, MD MS FASCO
@IshwariaMD
🔸This is #equityinaction!👏Congrats, @BldCancerDoc @BillupsRocky and the entire @SarahCannonDocs Transplant & #cellulartherapy team on the National Marrow Donor Program @bethematch "Lives Award" celebrating their work in increasing access to unrelated bone marrow donor transplants!
🔸2022 was a busy year for our @SarahCannonDocs blood cancer team — they cared for 1,350 transplant and 250 cellular therapy recipients! 🔸This team increased access to blood and marrow transplants nationwide through superb clinical care and cutting-edge research! #sarahcannonproud
📷 bit.ly/40PB1Ui
NMDP
@nmdp_org
We're celebrating @SarahCannonDocs at The #oneforum with the Lives Award! As a large integrated network that cares for transplant, #celltherapy and #leukemia patients, their team provides enhanced access to patients who need treatment. Cheers to their invaluable work! 👏
-
Sarah Cannon Docs reposted
Vivek Subbiah, MD
@VivekSubbiah
😥Such a delight to arrive in Boston to deliver the Scientific Keynote
“Future-Proofing Healthcare: A Vision of Patient-Centric Tissue-Agnostic Precision Medicine” At the TargetCancer Foundation Think Tank on Advancing #precisionmedicine in Rare cancers spearheaded by the amazing Jim Palma @targetcancer & @Dr_R_Kurzrock
👉🏼The Think Tank on Advancing Precision Medicine in Rare Cancers is a highly interactive, one-day meeting uniting clinicians, researchers, industry, FDA, patient advocates and patients in a unique format to promote collaboration, information sharing, and idea generation.
👉🏼The diverse perspectives of speakers and attendees allows for a comprehensive discussion of challenges, goals, opportunities and best practices in addressing the needs of patients facing rare cancers.
👉🏼The Think Tank on Advancing Precision Medicine in Rare Cancers leverages the successful “think tank” model that TargetCancer Foundation has established through over a decade of meetings on other topics, such as gastroesophageal cancers.
👉🏼This meeting also builds on the progress being made through TargetCancer Foundation’s TCF-001 TRACK study, a nationwide, decentralized, patient-driven clinical trial studying precision medicine in rare cancers @OncoAlert @jacobadashek @SarahCannonDocs -
Sarah Cannon Docs reposted
Vivek Subbiah, MD
@VivekSubbiah
⭐️A pleasure to be in Washington,DC to deliver the keynote address on “Next Generation Evidence-based Medicine” at the RARE Diseases Clinical Research Network @NIH #rdcrn @ncats_nih_gov #ncats
⭐️Even better when I get to travel with @IshwariaMD who’s in DC to meet with key stakeholders to advance #clinicianwellbeing and equitable access to #clinicaltrials across the US and world! @OncoAlert @SarahCannonDocs @theNCI @TheUSONetwork
www.nature.com/articles/s41591-022-02160-z -
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
Happy to join @DrNeilLove on Tuesday December 5th to talk about #er+ #bcsm.
Joining @jhaveri_komal, @VKaklamani, and @hoperugo in what promises to be fast paced and filled with all the latest updates.
Join us! Link below!
#sabcs23
@SABCSSanAntonio
@SarahCannonDocs
Research To Practice
@DrNeilLove
Join us in December for three presentations by clinical investigators on the management of breast cancer. Register for this event at the link below.
researchtopractice.com/Meetings/SA2023 -
Sarah Cannon Docs reposted
Ishwaria Mohan Subbiah, MD MS FASCO
@IshwariaMD
Not only is our @SarahCannonDocs @MLJohnsonMD2 a global scientific powerhouse in #lungcancer research, she’s also the leading voice for Tennesseans on how legislators and health systems can collaborate to close the disparity gap in biomarker testing across the state! Grateful to @ACSCANTennessee for hosting this platform for us all to advance #cancercare #equity in Tennessee and beyond!🙌
ACSCANTennessee
@ACSCANTennessee
Register here: act.fightcancer.org/a/2023-tennessee-future-cancer-care-p…
-
Sarah Cannon Docs reposted
Ishwaria Mohan Subbiah, MD MS FASCO
@IshwariaMD
On this 1-yr anniversary of our SCRI-US Oncology research partnership, a story👇on our Why!
I’ll never forget meeting Michael Davis.
Him: Doc, wanna hear my #sarahcannon story?
Me: Of course!
Him: I had sickle cell.
Me: Had?
(He broke out a smile, not an everyday one — this smile was something more. I knew I was about to hear something special. Enter the anticipatory chills and goosebumps.)
Him: So, I’m living in Mississippi, with sickle cell. And it’s not going good.
Him: My mom kept calling place after place near us, trying to find a #clinicaltrial that’ll take me.
But there was nothing.
Him: One day, I’m in a waiting room…. I look around and see an @NPR magazine out the corner of my eye.
Him: I picked it up, flipped it open and landed on a page. “Sarah Cannon Research Institute,” I remember thinking. “I wonder if they have a trial for me….”
“Naaah.” I set the magazine right back down.
Him: But, a minute later, my head was turning, looking back at it. And, Doc, for some reason, I picked it back up. “Maybe Sarah Cannon *does* have a trial for me.”
So, my mom called. She told them about me, gave them the info they needed.
Three months later, I got the call — *the* call — that I’m in! #scri had a spot for me on their #sicklecell #crispr trial.
Him: Doc, that moment! When that call came. The way my mom and I felt… I can’t even begin to describe it to you.
Him: Now, here I am, two years later.
Doc…… I’m cured.
(Chills all over, again)
Him (still smiling): I’m cured.
And I owe it to this place.
After something like that, you know I’m like ‘I gotta work here!’
👏👏👏💯💯💯
Meet Mr. Michael Davis — our @SarahCannonDocs IT support guru, my new friend, and the embodiment of our #scri/#uson mission. He is why we do what we do!
Happy 1st anniversary to the SCRI-@TheUSONetwork Research partnership!
Sarah Cannon Docs
@SarahCannonDocs
Today, we celebrate the anniversary of our joint venture between SCRI & US Oncology Research. We are so proud of what we have accomplished so far and cannot wait to continue to advance therapies and provide greater access to cutting-edge research in the years to come. @McKesson
Sarah Cannon Docs
@SarahCannonDocs
The science of collaboration begins with us. SCRI and USOR have officially combined to form a joint venture that will advance the next generation of cancer care through clinical research in the community.
-
Sarah Cannon Docs
@SarahCannonDocs
Exciting Milestone: Advisors discuss next steps for groundbreaking gene-editing treatment which combats sickle cell disease. Learn more!
#sicklecelldisease #medicaladvancements
www.npr.org/sections/health-shots/2023/10/31/1208041252/a… -
Sarah Cannon Docs
@SarahCannonDocs
Today, we celebrate the anniversary of our joint venture between SCRI & US Oncology Research. We are so proud of what we have accomplished so far and cannot wait to continue to advance therapies and provide greater access to cutting-edge research in the years to come. @McKesson
Sarah Cannon Docs
@SarahCannonDocs
The science of collaboration begins with us. SCRI and USOR have officially combined to form a joint venture that will advance the next generation of cancer care through clinical research in the community.
-
Sarah Cannon Docs reposted
Ishwaria Mohan Subbiah, MD MS FASCO
@IshwariaMD
💫Thrilled to co-host @ASCO 3-part Series for #womeninoncology Navigating Mid-Career Success!
💫Join my co-host Dr. @SuzanneColeMD as we kickoff Session 1 TODAY 10/24 4p ET Zoom with panelists Drs. @SoniSmithMD @AMarshallMD @AshleySumrallMD and @NathalieMckenz3 as we explore “opportunities within your current sphere of influence.”
💫It’s not too late to register: asco1.zoom.us/meeting/register/tJwqd-iorz8vGdF8nNVH1GSpWN…!
Dr. Estela Rodriguez
@Latinamd
Don’t miss tonight!
@ASCO Panel for #womeninoncology Navigating Mid-Career Success — don't miss the first session on Tues. 10/24!
@HemOncWomenDocs @LatinasInMed
@LatinxOncology
👇🏽👇🏽👇🏽👇🏽
Register here: asco1.zoom.us/meeting/register/tJwqd-iorz8vGdF8nNVH1GSpWN… -
Sarah Cannon Docs
@SarahCannonDocs
We are proud to partner with @HCAhealthcare and @GrailBio to advance science and transform care through multi-cancer early detection screening. Learn more in the full press release.
HCA Healthcare
@HCAhealthcare
Today, we are proud to announce a strategic collaboration with Sarah Cannon Cancer Institute and @GrailBio to advance comprehensive #cancer care through early detection. Learn about this cutting-edge innovation: hcahealthcaretoday.com/2023/10/17/hca-healthcare-and-grai…. #improvemorelives
-
Sarah Cannon Docs reposted
Vivek Subbiah, MD
@VivekSubbiah
💥🚨Excited to invite you to join me this Friday @myESMO for #esmo23!
Let's dive into the cutting-edge world of #precisionmedicine.
🌟 Don't miss our TED styled symposia: "Delivering on the Promise of Precision Oncology: From the Big Bang to Tangible Impact on Patients’ Lives" alongside some fantastic colleagues, patient advocates & many more. See you there! 👩⚕️👨🔬 @javihl75 @DrJNaidoo @danieltanmd @dramoore1 @OncoAlert @SarahCannonDocs @BayerOncMed @alitimumab @OncBrothers
Link: cslide.ctimeetingtech.com/esmo2023/attendee/confcal/show/… -
Sarah Cannon Docs
@SarahCannonDocs
Prevention, detection, unmet needs, and “smart bombs” Dr. @ErikaHamilton9 recaps the latest advancements that will have breast cancer spooked this October and beyond. #breastcancerawarenessmonth.
www.linkedin.com/pulse/breast-cancer-where-we-heading-sar… -
Sarah Cannon Docs reposted
Ishwaria Mohan Subbiah, MD MS FASCO
@IshwariaMD
📍It’s been 10 years since the IoM consensus report on Delivering High-Quality #cancercare!📍Honored to serve on the planning committee for the 2023 edition!
📍JOIN US for our @theNAMedicine @ASCO NCPF Workshop on “Assessing and Advancing Progress in the Delivery of High-Quality #cancer Care.”
📍Looking forward to moderating the Patient-Centered Care session and speaking at the #clinicianwellbeing session!
📍Agenda and Link to Register below:
🔗 www.nationalacademies.org/event/39827_10-2023_assessing-a… -
Sarah Cannon Docs
@SarahCannonDocs
On this World Cancer Research Day, SCRI’s @VivekSubbiah emphasizes how, “clinical trials hold great promise for patients with cancer by providing tailored treatments.” Learn about more key insights for patients considering a clinical trial
www.linkedin.com/pulse/3-key-insights-patients-considerin… -
Sarah Cannon Docs
@SarahCannonDocs
“There is growing hope for delivering targeted therapies through the use of ADCs," says SCRI's @BurrisSkip , M.D. Learn how we are collaborating with @VincerxPharma in a Phase 1 dose escalation study. www.globenewswire.com/news-release/2023/09/14/2743128/0/e…
-
Sarah Cannon Docs
@SarahCannonDocs
Today, we remember all those impacted by 9/11 and honor the incredible sacrifice of first responders, service men and women, and volunteers. #neverforget
-
Sarah Cannon Docs
@SarahCannonDocs
SCRI expert, Dr. Noelle Cloven recaps recent research advancing gynecologic cancer therapies. Read as she shares her insights in this LinkedIn article.
www.linkedin.com/pulse/biggest-advancements-gynecologic-c… -
Sarah Cannon Docs
@SarahCannonDocs
Jason Henry, MD shares recent updates in early onset colorectal cancer with @OncLive. Learn "What We Know and Where to Go" from our SCRI expert in this feature:
www.onclive.com/view/recent-updates-in-early-onset-colore… -
Sarah Cannon Docs
@SarahCannonDocs
SCRI expert, @IshwariaMD joined @CBSNews to discuss a recently published cancer screening study. She weighs in on how these results should be interpreted and the importance of early detection.
www.cbsnews.com/live/video/20230901172210-most-cancer-scr… -
Sarah Cannon Docs reposted
HCA Healthcare
@HCAhealthcare
HCA Healthcare patient Jimi is giving hope to those living with #sicklecelldisease by participating in an innovative clinical trial with @SarahCannonDocs exploring the use of #crispr gene editing. Learn about its potential impact in @washingtonpost: www.washingtonpost.com/science/2023/04/28/sickle-cell-dis….
-
Sarah Cannon Docs
@SarahCannonDocs
If you are in Nashville, TN, do not miss your opportunity to learn from our experts at tonight's @OncLiveSOSS event. Register now:
event.onclive.com/event/42d74c85-f5a4-461d-8a31-20a2447b5… -
Sarah Cannon Docs
@SarahCannonDocs
SCRI expert, Dr. @hfrangoul shares how patients facing sickle cell disease are finding hope with the help of CRISPR gene editing in this Washington Post story. Hear first-hand from Dr. Frangoul and patient, Jimi.
www.washingtonpost.com/science/2023/04/28/sickle-cell-dis… -
Sarah Cannon Docs
@SarahCannonDocs
Want to learn from and network with SCRI experts, Dr. @ErikaHamilton9, Dr. @BurrisSkip, Dr. Denise Yardley, and Andrew McKenzie, PhD? Register for @OncLiveSOSS happening in Nashville, TN on July 17. For more details visit: event.onclive.com/QWxo41?RefId=grid
-
Sarah Cannon Docs reposted
VJ Oncology
@VJOncology
🎥@ErikaHamilton9 from @SarahCannonDocs discusses age-related results in adjuvant abemaciclib + endocrine therapy for high-risk early #breastcancer. Patients ≥65 had similar survival, safety, and dose reduction possibilities:
➡️www.vjoncology.com/video/eggth-hexfq-age-stratified-findi…⬅️
#bcsm #asco23 @ASCO -
Sarah Cannon Docs
@SarahCannonDocs
Happy Juneteenth! Here's to celebrating freedom today and every day!
-
Sarah Cannon Docs
@SarahCannonDocs
SCRI expert, Dr. @ErikaHamilton9 sat down with @Forbes to share breast cancer insights and an in-depth look into what you need to know about diagnosis and treatment. Learn from our Director of Breast Cancer: www.forbes.com/health/body/breast-cancer/
-
Sarah Cannon Docs reposted
Vivek Subbiah, MD
@VivekSubbiah
⭐️A big thank you to the amazing audience who stayed for the last day sessions at ASCO @ASCO #asco23 ! Your commitment to ending cancer is truly inspiring. Let's continue to work together towards a brighter future. #genomics #precisionmedicine 🎯🧬 @SarahCannonDocs #asco2023 #endcancer 💪🙏🎗️@OncoAlert @ONCOassist @OncBrothers looking forward for the discussion @CharuAggarwalMD
Rebecca Previs
@BeccaPrevisMD
@VivekSubbiah presenting at #asco2023 that prior single gene testing limits the performance of CGP and negatively impacts CGP turn around time and the identification of therapeutically relevant genomic variants in #nsclc. Performing tissue based CGP is standard of care. @Labcorp
-
Sarah Cannon Docs reposted
Vivek Subbiah, MD
@VivekSubbiah
⭐️Taking #precisionmedicine to the next level @SarahCannonDocs ! Looking forward to the future with Andy McKenzie & team in harnessing the power of molecular data to improve patient outcomes #precsionmedicine for the win @SarahCannonDocs @OncoAlert @ErikaHamilton9 @MLJohnsonMD2
-
Sarah Cannon Docs
@SarahCannonDocs
Another inspiring @ASCO Annual Meeting, sharing new research and collaborating on innovative ways to deliver cancer care closer to home. See the latest SCRI research abstracts and presentations from #asco23: www.scri.com/ASCO/ #clinicaltrials
-
Sarah Cannon Docs
@SarahCannonDocs
Leaders from across our network played integral roles at this year's #asco23 over the weekend. SCRI expert, Dr. Cesar Perez from #floridacancerspecialists & Research Institute did a wonderful job chairing the Head and Neck session on Monday.
-
Sarah Cannon Docs
@SarahCannonDocs
Increasing access to cancer treatments in our communities is the foundation of SCRI. We are proud to participate in #asco23 to help progress development of new cancer therapies for patients in need. Learn more about what we do: www.scri.com/ASCO/
-
Sarah Cannon Docs
@SarahCannonDocs
Dr. Danso moderated this afternoon’s #asco23 metastatic breast cancer session where @ErikaHamilton9 delivered exciting data on a phase 2 HER3-Dxd study @DaiichiSankyo #virginiaoncologyassociates
-
Sarah Cannon Docs
@SarahCannonDocs
Great follow up analysis from Dr. Hutson in today’s genitourinary session #asco23
David R. Spigel, MD, FASCO
@DavidRSpigel
Dr. Tom Hutson delivering perfect presentation of 4-yr OS results (HR 0.79 (0.63-0.99)) from the CLEAR Study (Lenvatinib/pembro v sunitinib in adv RCC) in GU oral session #asco23 @SarahCannonDocs
-
Sarah Cannon Docs reposted
Skip Burris, MD
@BurrisSkip
Proud and excited to have @IshwariaMD @VivekSubbiah join our @SarahCannonDocs team ! Already making an impact @ASCO
-
Sarah Cannon Docs reposted
ASCO
@ASCO
#asco23: New ADAURA data reinforce adjuvant osimertinib as the standard of care for patients with resected EGFR-mutated stage IB to IIIA #nsclc: dailynews.ascopubs.org/do/final-adaura-os-analysis-reinfo… #ascodailynews @DrRoyHerbstYale @YaleCancer @bensolomon1 #lcsm
-
Sarah Cannon Docs reposted
OncoAlert
@OncoAlert
The #oncoalerttoptweet 🚨
DAY3⃣of #asco23 🌐
Tweet by our @OncoAlert Faculty @NiuSanford 🇺🇸
Need to carefully consider toxicity trade-offs in PROSPECT. Rates of pre-operative Gr3 & 4 toxicity were 2x and 3x higher in FOLFOX group vs. chemoRT.
Best,
@weoncologists
Dr. Nina Niu Sanford
@NiuSanford
Need to carefully consider toxicity trade-offs in PROSPECT.
Rates of pre-operative Gr3 & 4 toxicity were 2x and 3x higher in FOLFOX group vs. chemoRT.
www.nejm.org/doi/full/10.1056/NEJMoa2303269
#asco23 -
Sarah Cannon Docs reposted
OncoAlert
@OncoAlert
The #oncoalerttoptweet 🚨
DAY3⃣of #asco23 🌐
Tweet by our @OncoAlert Faculty @neerajaiims 🇺🇸
PEACE-1 trial by Dr. Bossi👉Significant delay in disease progression and delay of serious GU obstructive events by radiation therapy in mCSPC (no OS benefit): results confirm the role of radiation in low volume denovo mCSPC
Best,
@weoncologists
Neeraj Agarwal, MD, FASCO
@neerajaiims
#asco23 @asco PEACE-1 trial by Dr. Bossi👉Significant delay in disease progression and delay of serious GU obstructive events by radiation therapy in mCSPC (no OS benefit): results confirm the role of radiation in low volume denovo mCSPC @OncoAlert @urotoday @PCFnews
-
Sarah Cannon Docs
@SarahCannonDocs
#asco23 has been inspiring and informing. Stop by our booth #13033 located by the Poster Hall to celebrate with us by sharing your favorite @ASCO story and learn more about our expansive network and ongoing clinical research across oncology.
-
Sarah Cannon Docs reposted
Vivek Subbiah, MD
@VivekSubbiah
⭐️Excited to meet with Jake Van Naarden, EVP Eli Lilly & President @LoxoLillyOnc & @DHymanMD CMO, @LoxoLillyOnc two of my most treasured partners & trusted friends in drug development.
👉🏼Looking forward to the future to continue our winning collaboration for thoughtful, nimble, & rapid approaches to #precisionmedicine 🎯🧬therapies in our continued efforts to advance cancer care & research @SarahCannonDocs @BurrisSkip @OncoAlert #precisionmedicine #drugdevelopment #cancerresearch -
Sarah Cannon Docs reposted
Mike Lattanzi
@MikeLattanzi
Great to catch up with @SarahCannonDocs near and far! #asco23 @khud23 @TexasOncology @mkbupathi
-
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
Repeating pertuzumab doesn't get us much in terms of PFS.
Strange improvement in OS, seems most patients post repeat pertuzumab got eribulin or TDXd...confounder!
#bcsm #her2 -
Sarah Cannon Docs
@SarahCannonDocs
Earlier this evening Dr. @ErikaHamilton9 took on the #asco23’s next frontier! Thank you for sharing your resistance to ADCs and combination strategies.
-
Sarah Cannon Docs
@SarahCannonDocs
“Using dose reductions or lowering the amount somebody may take per day to help them feel better day to day, really doesn't impact their outcome,” @ErikaHamilton9 shared with @cure_today. Hear more updates from the monarchE trial: www.curetoday.com/view/verzenio-dose-reductions-don-t-wor…
-
Sarah Cannon Docs reposted
-
Sarah Cannon Docs reposted
-
Sarah Cannon Docs reposted
-
Sarah Cannon Docs reposted
-
Sarah Cannon Docs reposted
-
Sarah Cannon Docs reposted
Melissa L. Johnson
@MLJohnsonMD2
Great resource!! Taking home to my DDU.
Santhosh Ambika
@RenoHemonc
All oncologists should learn to manage low grade CRS 😀 - ain’t too hard
-
Sarah Cannon Docs reposted
Melissa L. Johnson
@MLJohnsonMD2
Hopeful and optimistic! Positive discussion of SCLC abstracts by Alberto Chiappori @MoffittNews .
-
Sarah Cannon Docs reposted
-
Sarah Cannon Docs reposted
OncLive.com
@OncLive
Excellent break down by mutation. We need more data presented like this so we can truly provide precision and personalized care. Signal in CDK12 in addition to BRCA. - @BGarmezy @SarahCannonDocs #asco2023
-
Sarah Cannon Docs reposted
OncLive.com
@OncLive
We are starting Day 3 of @ASCO coverage with a bang! Today we have @KristenCiombor, of @VUMC_Cancer, and @BGarmezy, of @SarahCannonDocs, sharing their respective highlights from the GI and GU sessions LIVE on site! Tune in to follow along! #asco2023 #oncology #medtwitter
-
Sarah Cannon Docs reposted
Vivek Subbiah, MD
@VivekSubbiah
🚨Late breaking at #asco23: In the PROSPECT trial comparing preoperative chemoradiotherapy and FOLFOX in patients with rectal cancer undergoing sphincter-sparing surgery, 5-year disease-free survival was 80.8% with FOLFOX and 78.6% with chemoradiotherapy. www.nejm.org/doi/full/10.1056/NEJMoa2303269 @OncoAlert
Vivek Subbiah, MD
@VivekSubbiah
🚨🚨🚨 @ASCO #asco23 #latebreaking 👉🏼👉🏼👉🏼Preoperative Treatment of Locally Advanced Rectal Cancer @NEJM @OncoAlert www.nejm.org/doi/full/10.1056/NEJMoa2303269
-
Sarah Cannon Docs reposted
Vivek Subbiah, MD
@VivekSubbiah
🚨🚨🚨 @ASCO #asco23 #latebreaking 👉🏼👉🏼👉🏼Preoperative Treatment of Locally Advanced Rectal Cancer @NEJM @OncoAlert www.nejm.org/doi/full/10.1056/NEJMoa2303269
-
Sarah Cannon Docs reposted
Skip Burris, MD
@BurrisSkip
Throughout my career, I have had the privilege to work with thousands of patients facing cancer. Every #nationalcancersurvivorsday I reflect on the vital role they play in advancing therapies. Join me in thanking them for their courage and contributions to research.
Sarah Cannon Docs
@SarahCannonDocs
This #nationalcancersurvivorsday, we honor our patients’ strength, celebrate their perseverance and thank them for their trust in us. Learn more about what our patients mean to us. www.scri.com/patients/
-
Sarah Cannon Docs reposted
OncLive.com
@OncLive
Mirvetuximab Soravtansine Positioned as New Standard in Frα+ Platinum-Resistant Ovarian Cancer @StephensonCC @@OUCollegeofMed @ASCO #asco23 #asco2023 #gyncsm www.onclive.com/view/mirvetuximab-soravtansine-positioned…
-
Sarah Cannon Docs reposted
OncLive.com
@OncLive
Getting ready for the GU oral session. Happy to be taking over @OncLive Twitter to share exciting new data to better help our patients! -@BGarmezy with @SarahCannonDocs and @TNOncology
-
Sarah Cannon Docs reposted
OncLive.com
@OncLive
In low volume metastatic prostate cancer, addition of XRT to standard of care fails to reach overall survival benefit but does have some benefits in other endpoints. Presentation of peace1 data by Dr Bossi @BGarmezy @SarahCannonDocs
-
Sarah Cannon Docs
@SarahCannonDocs
This #nationalcancersurvivorsday, we honor our patients’ strength, celebrate their perseverance and thank them for their trust in us. Learn more about what our patients mean to us. www.scri.com/patients/
-
Sarah Cannon Docs reposted
David R. Spigel, MD, FASCO
@DavidRSpigel
@BGarmezy delivering perfect talk in the GU Poster Discussion - incl a breakdown of Q-TWiST mathematics with IO in urothelial ca!! @SarahCannonDocs #asco23
-
Sarah Cannon Docs
@SarahCannonDocs
SCRI’s @ErikaHamilton9 sat down with the @OncLearnNetwork to share her expertise on #asco23 breast cancer findings. Stay tuned for the full video coming soon.
-
Sarah Cannon Docs reposted
David R. Spigel, MD, FASCO
@DavidRSpigel
@MLJohnsonMD2 w excellent presentation of ARC-7: RP2 of Domvanalimab (antiTIGIT) Zimberelimab (antiPD1) v Zim in 1L PDL1H NSCLC in ASCO Plenary Rapid Updates. PFS - HR
0.67 (0.4, 1.13) @SarahCannonDocs #asco23 #lcsm -
Sarah Cannon Docs reposted
OncoAlert
@OncoAlert
Dear Colleagues at #asco23
An honor to introduce Our @OncoAlert 🚨 faculty @ErikaHamilton9 of @SarahCannonDocs 🇺🇸presenting subgroup analysis of #monarche 🦋: Adjuvant abemaciclib efficacy & safety by age.
Best,
@weoncologistsThis media couldn't be displayed. See it on the original post. -
Sarah Cannon Docs
@SarahCannonDocs
Plenary chair and SCRI expert, @Melissajohnsonmd2 addresses #asco23 attendees with the latest findings from the ARC-7 trial. #nsclc
-
Sarah Cannon Docs reposted
OncLive.com
@OncLive
🫶 @ASCO education book paper 👉Partnering With All Patients: Ensuring Shared Decision Making and Evidence-Based Management for Underrepresented Groups With Multiple #myeloma @bldcancerdoc ascopubs.org/doi/10.1200/EDBK_390202
-
Sarah Cannon Docs reposted
OncLive.com
@OncLive
🚨Sharing some 😎 heme abstracts from #asco23 🚨
@BldCancerDoc @SarahCannonDocs -
Sarah Cannon Docs reposted
OncLive.com
@OncLive
Stop by booth #13033 to learn about @SarahCannonDocs and 😎 things our teams are doing in #cancerresearch + impact we are making on patients through clinical trials (and don’t forget to pick up #scri mints - important accessory for #asco23) @BldCancerDoc
-
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
Hallway crossing alert 🚨 @BldCancerDoc
@SarahCannonDocs are showing up strong to #asco23- solid AND heme! -
Sarah Cannon Docs reposted
Ishwaria Mohan Subbiah, MD MS FASCO
@IshwariaMD
🔔#oncology #clinicianwellbeing is now an @ASCO Strategic Goal!👏👏
“Drive healthy clinical and research work environments that lead to fulfillment for oncology professionals”
▪️Participating in the @ASCO board retreat where we began crafting this Professional #wellness Strategic Goal was incredibly impactful on me — bc it demonstrated @ASCO’s unequivocal commitment to the professional wellbeing of our #oncology community! #asco23 #inthistogether -
Sarah Cannon Docs reposted
OncLive.com
@OncLive
BMT doc @BldCancerDoc trying to find #bloodcancer at #asco23 - finding more and more as I ⛏️ in! 🙏 fellow transplant/leukemia/lymphoma/myeloma and @doctorpemm (one and only #bpdcn doc) help me here by sharing info 🙏
-
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
Want to know how our organization is led?
Enter @Dee_Anna_Smith (@SarahCannonDocs CEO) as well as @BurrisSkip (@SarahCannonDocs President) attending #bcsm oral yesterday to support me.
Despite their busy schedules, they show up for us.
#leadbyexample #walkthewalk 👫 -
Sarah Cannon Docs reposted
OncLive.com
@OncLive
#asco23 #genetherapy comes to #myeloma! @BerdejaJesus @sarahcannondocs highlights ongoing trial of CRISPR-genome edited allo anti-BCMA #cartcell trial (+ 🫡 to whoever came up with “CAMMOUFLAGE trial”) @BldCancerDoc meetings.asco.org/abstracts-presentations/226019
-
Sarah Cannon Docs reposted
Ishwaria Mohan Subbiah, MD MS FASCO
@IshwariaMD
Successful #cancerresearch collaborations begin with great people! 👏Pausing to celebrate our wonderful @SarahCannonDocs physicians and clinical &
research team members and to recognize their #asco23 presentations from across the #scri network. 🔗 scri.com/ASCO/
Dee Anna Smith
@Dee_Anna_Smith
This is a record ASCO for SCRI, with 135+ presentations, 64 early-phase study updates and 82 authors across the network late-phase study findings. #asco23
-
Sarah Cannon Docs
@SarahCannonDocs
Hear about the latest in lung cancer drug research from expert, Melissa Johnson, @MLJohnsonMD2, Director Lung Cancer Research at SCRI. meetings.asco.org/abstracts-presentations/217315?0=n&1=u&…
-
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
Agree. This was my #1 take way too. We can be doing a better job helping people stay on drug and tolerate better- intertwine to see the discontinuations in NATALEE as well. No reason to discontinue without trying dose reductions!
#monarche #cdk #bcsm
Stephanie Graff, MD, FACP, FASCO
@DrSGraff
Embedded in @ErikaHamilton9 presentation is this critical pearl ➡️ adjuvant Abemaciclib benefit is maintained for ALL patients when dose modification is utilized💥
🔑dose modification for AE management is KEY!
#asco23 @OncoAlert @OncBrothers -
Sarah Cannon Docs reposted
OncLive.com
@OncLive
Day 2 of LIVE @ASCO coverage begins with more timely updates straight from the experts! Tune in to hear from @BldCancerDoc, of @SarahCannonDocs, who will be taking over the OncLive Twitter account to share his commentary on hematologic updates! #asco2023 #oncology #medtwitter
-
Sarah Cannon Docs
@SarahCannonDocs
Our SCRI experts, like Dr. @DavidRSpigel, are excited to present the latest in immunotherapy research at #asco23. #cancerresearch www.scri.com/ASCO/
-
Sarah Cannon Docs reposted
OncLive.com
@OncLive
Efficacy and Safety of Abemaciclib Plus ET Is Maintained Older Patients with HR+, HER2–, Early Breast Cancer @ErikaHamilton9 @SarahCannonDocs @ASCO #asco23 #asco2023 #bcsm www.onclive.com/view/efficacy-and-safety-of-abemaciclib-p…
-
Sarah Cannon Docs reposted
David R. Spigel, MD, FASCO
@DavidRSpigel
@ErikaHamilton9 delivering fantastic talk on efficacy/safety from monarchE-adjuvant abemacilib in ER+/HER2 High Risk Early BC - in Local/Reg/Adj Breast Session. Benefit and Safety data across age groups - Great to see data on older patients! @SarahCannonDocs #asco23
-
Sarah Cannon Docs
@SarahCannonDocs
Dr. @ErikaHamilton9 takes the #asco23 stage to present data from adjuvant monarchE trial.
-
Sarah Cannon Docs
@SarahCannonDocs
Dr. @ErikaHamilton9 takes the #asco23 stage to present data from adjuvant monarchE trial.
-
Sarah Cannon Docs reposted
Vivek Subbiah, MD
@VivekSubbiah
⭐️Great start to @ASCO #asco23 & wonderful evening @OncLive Giants In Cancer Care Awards ceremony celebrating with our amazing @CharlesSwanton @TheCrick & all the 2023 inductees
@GiantsofCC @OncoAlert @OncBrothers @MJHLifeSciences @DrChoueiri -
Sarah Cannon Docs reposted
Vivek Subbiah, MD
@VivekSubbiah
🚨 Today 👉🏼 Now 👉🏼Super thrilled to talk in the Session on New Drugs in Oncology: Incorporation Into Practice Session Type: Education Session
Date: Friday, June 2, 2023 Time: 2:45 PM - 4:15 PM Location: E450
Primary Track: Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology @OncoAlert @ASCO #asco23 #precisionmedicine 🧬🎯 -
Sarah Cannon Docs
@SarahCannonDocs
Want to hear more about our expansive network, learn about ongoing clinical research, or just say hi to our team? Stop by our booth #13033, located near the Poster Hall. #asco23
-
Sarah Cannon Docs reposted
Dee Anna Smith
@Dee_Anna_Smith
This is a record ASCO for SCRI, with 135+ presentations, 64 early-phase study updates and 82 authors across the network late-phase study findings. #asco23
-
Sarah Cannon Docs reposted
Vivek Subbiah, MD
@VivekSubbiah
Thrilled to share our article in the ASCO educational handbook @ASCOPost
@ASCO #asco23! Don't miss the session today 📚 "Expanding the Benefit: Dabrafenib/Trametinib as Tissue-Agnostic Therapy for BRAF V600E–Positive Adult and Pediatric Solid Tumors" -->This practical guide builds on the ROAR basket paper @NatureMedicine
go.nature.com/3I4YyYS, offering invaluable insights for oncologists and clinicians. Together, we're advancing #precisionmedicine to transform cancer care! #braf --> #cancerresearch
@OncoAlert
Link: ascopubs.org/doi/full/10.1200/EDBK_404770 -
Sarah Cannon Docs reposted
Vivek Subbiah, MD
@VivekSubbiah
🚨So honored to share today 👉🏼 Presenting to the 🌎👉🏼A new drug for patients with #chondrosarcoma
⭐️Hot off the press for @ASCO #asco23 👉🏼@CCR_AACR @AACR
🔺Preclinical Characterization and Phase 1 Trial Results of INBRX-109, a Third-Generation, Recombinant, Humanized, Death Receptor 5 Agonist Antibody, in Chondrosarcoma
🔺Started working with 1st gen DR5 targeting Rx in 2012 --> Now we have a 3rd gen DR5 drug with activity in chondrosarcoma ! Thankful to all patients, caregivers & all co-investigators @weoncologists
@OncoAlert @OncBrothers @bvantine1 rb.gy/1m23s -
Sarah Cannon Docs
@SarahCannonDocs
Join us to hear the latest data in endocrine therapy for high-risk early breast cancer from Dr. @ErikaHamilton9 today at #asco23. Don’t miss her presentation at 2:45 in Hall D1. meetings.asco.org/abstracts-presentations/218406
-
Sarah Cannon Docs reposted
Skip Burris, MD
@BurrisSkip
Excited to be in Chicago this weekend for ASCO 2023, hope to see you there!
Sarah Cannon Docs
@SarahCannonDocs
We’re gearing up to attend the @ASCO annual meeting in Chicago this week where we will share the latest #cancerresearch findings from across SCRI’s network. Hope to see you there! www.scri.com/ASCO/ #asco23
-
Sarah Cannon Docs reposted
Vivek Subbiah, MD
@VivekSubbiah
⭐️Great start to @ASCO #asco23 meeting all day with @rschilsky discussing all things #precisiononcology! His in-depth knowledge & wisdom in the field of oncology is truly inspiring, & I'm grateful for his leadership in spearheading the TAPUR basket trial. Thank you for always motivating me ! Excited for new beginnings @SarahCannonDocs @BurrisSkip #oncology #cancerresearch
Richard Schilsky
@rschilsky
Ready for my 44th consecutive @ASCO meeting! See you there!
-
Sarah Cannon Docs
@SarahCannonDocs
We’re thrilled to share our progress in personalized medicine, immunotherapy, and targeted therapy research to be presented at @ASCO’s annual meeting. Learn more: sarahcannon.com/about/newsroom/scri-to-present-latest-onc… #asco23
-
Sarah Cannon Docs reposted
Ovarcome
@ovarcome
Dr. @rcoledude, Chief Medical Officer, @SarahCannonDocs answers all your questions related to diagnosis, treatment, remission, survivorship and OVARCOMING Ovarian Cancer in this most recent episode of OC360 LIVE! Learn and Share! #oc360live
WATCH: youtu.be/HWoRZ38FQic -
Sarah Cannon Docs
@SarahCannonDocs
We’re gearing up to attend the @ASCO annual meeting in Chicago this week where we will share the latest #cancerresearch findings from across SCRI’s network. Hope to see you there! www.scri.com/ASCO/ #asco23
-
Sarah Cannon Docs
@SarahCannonDocs
Today, we pause to remember and honor those who have served our country. #memorialday2023
-
Sarah Cannon Docs
@SarahCannonDocs
For 30 years, we’ve expanded access to cutting-edge therapies and have conducted 700+ first-in-human trials. We could not have done this without our expert physicians, talented clinical teams, and everyone behind the scenes who live our mission to serve patients every day.
-
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
So all- it's official- we are excited to welcome @VivekSubbiah and @IshwariaMD to @SarahCannonDocs and Nashvegas! 🤠
Ishwaria Subbiah, MD Joins SCRI as Executive Director for Cancer Care Equity and Professional Wellness www.businesswire.com/news/home/20230515005267/en/Ishwaria… -
Sarah Cannon Docs
@SarahCannonDocs
We are pleased to welcome Dr. Ishwaria Subbiah to the SCRI network where she will lead two critical programs to further advance our mission for both our patients and research care teams. Learn more about her new role:
sarahcannon.com/about/newsroom/ishwaria-subbiah-md-joins-… -
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
Yes! 100% true, going to be talking about this later this morning at #esmobreast23 in regards to #protacs
Dr. Kelly Shanahan
@stage4kelly
Fulvestrant can be effective in the presence of an ESR1 mutation - depending on which particular mutant allele. Fulvestrant doesn’t work with all ESR1 mutations! #esmobreast23
-
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
Benefit regardless of ER expression for T-DXd.
Not surprising, but exciting to see. 👏
#esmobreast23
Federica Miglietta
@FedeMiglietta
#esmobreast23 Prof Cameron showing DB04 data of TDXd efficacy according to ER levels.
Finally the lights are now on ER-low #breastcancer -
Sarah Cannon Docs reposted
Vivek Subbiah, MD
@VivekSubbiah
1/2 📣IT’S OFFICIAL📣
Honored to join the @SarahCannonDocs #scri as the Chief, Early Phase Drug Development. The next generation of #personalizedmedicine is here and now more than ever, we call for rapid & efficient access to #precisiononcology #clinicaltrials for our patients and families!
The mission and vision —
🔸To envision a world without cancer
🔸To bring cutting-edge #cancertreatments to persons with #cancer where they are, in their hometowns, across our country and world @BurrisSkip @deehubie @DavidRSpigel @TheUSONetwork @BldCancerDoc @IshwariaMD
Skip Burris, MD
@BurrisSkip
Excited to announce that Vivek Subbiah, MD, has joined SCRI to advance early-phase clinical research | Sarah Cannon @SarahCannonDocs @VivekSubbiah sarahcannon.com/about/newsroom/vivek-subbiah-md-joins-scr…
-
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
No doubt that ctDNA predicts poor prognosis for me...the question now is...what do we do about it?
Does additional therapy convert bad to good prognosis? Can we change the natural history? Or do we just waste other therapies with no change in outcome?
#esmobreast2023
Karla Centelles
@KCentelles
Dr. Gupta presenting very interesting evidence on ctDNA status as a potential biomarker for TNBC patients on adjuvant capecitabine.
-
Sarah Cannon Docs reposted
Vivek Subbiah, MD
@VivekSubbiah
Excited to announce the publication of our article in the ASCO educational handbook @ASCOPost @ASCO #asco23! 📚
📢 "Expanding the Benefit: Dabrafenib/Trametinib as Tissue-Agnostic Therapy for BRAF V600E–Positive Adult and Pediatric Solid Tumors" 🩺💥
This practical guide builds on the ROAR basket paper @NatureMedicine go.nature.com/3I4YyYS, offering invaluable insights for oncologists and clinicians.
Together, we're advancing #precisionmedicine to transform cancer care! #braf🚀💪 #precisionmedicine #cancerresearch @OncoAlert
Link: ascopubs.org/doi/full/10.1200/EDBK_404770 -
Sarah Cannon Docs
@SarahCannonDocs
Today, we are pleased to announce Dr. @VivekSubbiah, a globally recognized key opinion leader in precision medicine and early-phase research, will be joining the SCRI team. Learn more about his new role and contributions to drug development:
geo-blocked-site.azurewebsites.net -
Sarah Cannon Docs
@SarahCannonDocs
Within each of our 250, you will find talented, dedicated nurses living out our mission. Although this work continues all year round, each May we get to celebrate the tremendous contributions they make in the lives of our patients and everyone touched by cancer. THANK YOU NURSES!
-
Sarah Cannon Docs reposted
Krishna Komanduri, MD, FASTCT
@drkomanduri
Thanks to Rachel Cook @OHSUKnight, @BldCancerDoc @SarahCannonDocs and @DiannaSHoward @WakeForest for superb leadership for the @ASTCT Leadership Training Course!
-
Sarah Cannon Docs
@SarahCannonDocs
SCRI expert, Dr. Meredith Pelster, shared insights on the latest research and treatment in head and neck cancer. Read the full update:
www.linkedin.com/pulse/latest-advances-head-neck-cancer-t… -
Sarah Cannon Docs reposted
-
Sarah Cannon Docs
@SarahCannonDocs
More of our experts share the latest in lung cancer research at this year's @TLCconference. This afternoon hear from Dr. Nadler, Dr. Patt and Dr. Paulson!
-
Sarah Cannon Docs
@SarahCannonDocs
.@MLJohnsonMD2 shares, "Advantages of Chemo-Immunotherapy for NSCLC," in a @TLCconference presentation. Head to the Immunotherapy for Advanced NSCLC session now!
-
Sarah Cannon Docs
@SarahCannonDocs
This morning at the Texas Lung Cancer Conference, our experts @DavidRSpigel and Dr. Nadler are presenting in the NSCLC session. Be sure to take in their insights today!
-
Sarah Cannon Docs
@SarahCannonDocs
This National Doctors’ Day, our physicians are expressing their gratitude for patients, mentors, and support staff who inspire them daily. Thank you to all of our doctors who have dedicated their lives to advancing therapies & caring for patients. youtu.be/0oJl_tS5YGU
-
Sarah Cannon Docs
@SarahCannonDocs
Chief Medical Officer, @rcoledude, shared thoughts and illuminated opportunities in gynecologic malignancies with @OncLiveSOSS
www.onclive.com/view/coleman-illuminates-opportunities-in… -
Sarah Cannon Docs
@SarahCannonDocs
In celebration of International Women’s Day, physician and operational leaders from across our network are sharing how they strive to “Embrace Equity” every day. How do you plan to Embrace Equity for women this year?
This media couldn't be displayed. See it on the original post. -
Sarah Cannon Docs
@SarahCannonDocs
Breakout Session #2 was packed with the latest in lung cancer, myeloma, and genitourinary cancer.
-
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
Final day of @SarahCannonDocs Annual Scientific Meeting.
Fantastic opportunity for us to hang out with our tribe dedicated to advancing care for our patients through #clinicaltrails! -
Sarah Cannon Docs
@SarahCannonDocs
Day two of the SCRI Scientific Meeting has kicked off! Attendees are breaking out to hear about the latest in breast cancer, melanoma, and lymphoma & leukemia/MDS research
-
Sarah Cannon Docs
@SarahCannonDocs
The future of research is happening HERE at SCRI. Scientific leaders, @davidRspigel, @BldCancerDoc from Sarah Cannon, and Dr. Andrew McKenzie lead attendees through the latest highlights in early and late phase research, blood cancer research, personalized medicine and beyond.
-
Sarah Cannon Docs
@SarahCannonDocs
Thank you Dr. Peter Marks, Director of the Center for Biologics Evaluations & Research at the FDA, for sharing insights from the FDA’s Efforts to Advance Clinical Development with attendees at SCRI’s scientific meeting.
-
Sarah Cannon Docs
@SarahCannonDocs
AstraZeneca’s Global Head of Oncology, Dr. Sunil Verma joined our annual meeting to discuss, “Developing Next Generation Treatments, Together” in a Q&A.
-
Sarah Cannon Docs
@SarahCannonDocs
.@deehubie @BurrisSkip @rcoledude and @DavidRSpigel kick off our annual meeting’s General Session and introduce this year’s theme, “Bench to Bedside: Bringing Innovative Therapies to the Community.”
-
Sarah Cannon Docs
@SarahCannonDocs
We are excited to host our 26th Annual Scientific Meeting which brings together experts from across our newly combined, expansive network. Follow along for updates from this year's meeting.
-
Sarah Cannon Docs reposted
Daiichi Sankyo US
@DaiichiSankyoUS
.@SarahCannonDocs is at the forefront of understanding the needs of patients with cancer. Our partnership with SCRI brings new opportunities as we work together to accelerate the development of new medicines that can improve patient’s lives. Read more: daiichisankyo.us/our-stories/creating-a-dream-team-to-acc…
-
Sarah Cannon Docs
@SarahCannonDocs
At 3:35pm, Dr. Spira from SCRI at Virginia Cancer Specialists will present, "G12C Inhibitors + Other Combinations" in the #ttlc23 Targeted Therapies session. Don't miss the latest from our lung cancer experts🧬🔬🫁.
-
Sarah Cannon Docs
@SarahCannonDocs
Tonight, @DavidRSpigel presents, "Non University Based Models," at this year's Targeted Therapies of Lung Cancer Meeting. Join this Early Careers Session for Fellows at 7:45pm. #ttlc23
-
Sarah Cannon Docs
@SarahCannonDocs
.@BerdejaJesus, presents “Idecabtagene Vicleucel Versus Standard Regimens in Patients with Triple-Class-Exposed Relapsed and Refractory Multiple Myeloma: Karmma-3 a Phase 3 Randomized Controlled Trial”@ 4:30pm. You won't want to miss this late breaking abstract session #tandem23
-
Sarah Cannon Docs
@SarahCannonDocs
In addition to #ascogu23, we are also presenting at #tandem23 this weekend. Check out where you can find our experts' presentations sarahcannon.uberflip.com/i/1492123-tandem-2023-calendar/3
-
Sarah Cannon Docs
@SarahCannonDocs
Don't miss Dr. @BGarmezy's #ascogu23 poster, “First in human phase 1/1b study evaluating KIN-3248, a next-generation, irreversible pan-FGFR inhibitor, in patients with advanced urothelial carcinoma and other solid tumors harboring FGFR2 and/or FGFR3 gene alterations" today @ 2:30
-
Sarah Cannon Docs
@SarahCannonDocs
Today at #ascogu23, Jeff Yorio, MD, SCRI at @TexasOncology, is the first author on poster titled, “Estimated cost of adverse event management for patients with metastatic renal cell carcinoma treated with a VEGFR TKI.” Be sure to catch it tonight before 7:45PM!
-
Sarah Cannon Docs
@SarahCannonDocs
On this World Cancer Day we asked our colleagues to reflect on this year’s theme, #closethecaregap. With collaboration, innovation and expanded access, we will help close the gap by always putting our patients first.
-
Sarah Cannon Docs
@SarahCannonDocs
Our Women Physicians across SCRI are integral to advancing research for people facing cancer. Join us in celebrating them this National Women Physicians Day!
-
Sarah Cannon Docs
@SarahCannonDocs
.@reuterseventshealthc #valuebasedcare23's whitepaper on ‘Multi-cancer early detection for health systems: Four Adoption Models’ authored by @DaxKurbegov – showcases our collective work with @HCAhealthcare & @GRAIL to advance cancer screening. 1.reutersevents.com/LP=34271
-
Sarah Cannon Docs
@SarahCannonDocs
Today we’re celebrating 30 years of bringing cutting-edge therapies to people facing cancer in their communities. Watch founders, Dr. Greco and Dr. Hainsworth, talk about how SCRI got its start.
youtu.be/QeJTzrzvtiY -
Sarah Cannon Docs reposted
Harbinger Health
@HarbingerHlth
For these 2 CEOs, actions speak louder than words. Life-long cancer advocates, @Stephen_M_Hahn
& Dee Anna Smith @deehubie of
@SarahCannonDocs donated blood for our clinical study to further develop our platform for early cancer detection. Study details: www.clinicaltrials.gov/study/NCT05435066 -
Sarah Cannon Docs
@SarahCannonDocs
This inspiring story is getting us in the spirit of giving and gratitude. If you missed @ABCGMA3's recent story featuring our patient, Brady, watch it now & let it uplift you! @TriStarHealth
www.youtube.com/watch?v=6_d2Io-NpKs -
Sarah Cannon Docs
@SarahCannonDocs
Dr. @ErikaHamilton9, director of breast cancer and gynecologic cancer research at the Sarah Cannon Research Institute at @TNOncology is sharing insight on how diet and exercise levels can impact your chances of getting breast cancer. Read more below:
katiecouric.com/health/cancer/food-diet-exercise-breast-c… -
Sarah Cannon Docs
@SarahCannonDocs
Andrew McKenzie, PhD, Vice President of Personalized Medicine at Sarah Cannon Research Institute and Scientific Director at Genospace, discusses the variety of molecular testing modalities in patients with metastatic non–small cell lung cancer (NSCLC).
www.onclive.com/view/dr-mckenzie-on-navigating-the-landsc… -
Sarah Cannon Docs
@SarahCannonDocs
Dr. @MLJohnsonMD2, a medical oncologist with @TNOncology and Director of Lung Cancer Research at Sarah Cannon Research Institute in Nashville, discusses the CodeBreaK 200 trial presented at the European Society for Medical Oncology (ESMO) Congress 2022. www.obroncology.com/video/what-to-make-of-pfs-and-os-resu…
-
Sarah Cannon Docs
@SarahCannonDocs
Dr. @ErikaHamilton9, director of breast cancer & gynecologic cancer research at the Sarah Cannon Research Institute at @TNOncology discusses what excites her most regarding advancements in breast cancer treatment: katiecouric.com/health/cancer/new-breast-cancer-treatments/
-
Sarah Cannon Docs reposted
OncLive.com
@OncLive
WATCH: Andrew McKenzie, PhD, of @SarahCannonDocs, discusses the variety of molecular testing modalities in patients with metastatic non–small cell lung cancer. #lcsm www.onclive.com/view/dr-mckenzie-on-navigating-the-landsc…
-
Sarah Cannon Docs reposted
Expert Perspectives in Medicine
@ExpertsMedicine
John C. Byrd, MD of @UCincyMedicine, Ian W. Flinn, MD, PhD of @SarahCannonDocs & @TNOncology, & @jeff_sharman, MD of @TheUSONetwork & @WVCancer discuss unmet needs in chronic lymphocytic #leukemia.
www.expertperspectives.com/Oncology/CLL/unmet-needs-in-ch…
#twittermed #medtwitter #onctwitter #meded #mednews #cll -
Sarah Cannon Docs reposted
Targeted Onc
@TargetedOnc
Lauren Welch, MSN, NP-C, AOCNP, describes how she approaches management of patients with #nsclc and known high PD-L1 expression while she waits for pending biomarker testing results. #lcsm | @SarahCannonDocs @TNOncology
www.targetedonc.com/view/a-commentary-on-high-pd-l1-expre… -
Sarah Cannon Docs
@SarahCannonDocs
Exciting news! The FDA approved a treatment combination based on the POSEIDON Phase III Trial results. Read more about this #nsclc treatment and @MLJohnsonMD2’s response in the press release.
AstraZenecaUS
@AstraZenecaUS
Today, the @US_FDA approved our treatment combination for adults with Stage IV non-small cell lung cancer (#nsclc), the most advanced form of lung cancer. Learn more about how this approval may impact the #lungcancer community: www.astrazeneca-us.com/media/press-releases/2022/imfinzi-…
-
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
Happy to talk to @katiecouric Media again re: #bcsm and how we have gotten smarter 💡🧠in terms of personalized medicine and "right sizing" treatment necessary.
@SarahCannonDocs @OncoAlert
How Breast Cancer Treatment Is Becoming More Customized katiecouric.com/health/cancer/new-breast-cancer-treatments/ #kcm -
Sarah Cannon Docs
@SarahCannonDocs
Watch as Dr. @ErikaHamilton9 and Dr. Komal Jhaveri review novel endocrine agents. www.medscape.com/viewarticle/978314?faf=1
-
Sarah Cannon Docs reposted
McKesson Corporation
@McKesson
We’ve completed the transaction with HCA Healthcare to establish an oncology research joint venture. The new organization, Sarah Cannon Research Institute (SCRI), will serve to enhance cancer care while increasing access to oncology research. Read more: www.mckesson.com/About-McKesson/Newsroom/Press-Releases/2…
-
Sarah Cannon Docs
@SarahCannonDocs
The science of collaboration begins with us. SCRI and USOR have officially combined to form a joint venture that will advance the next generation of cancer care through clinical research in the community.
-
Sarah Cannon Docs
@SarahCannonDocs
We are thrilled to announce Stephen A. Strickland, Jr, MD, MSCI, has been named the Director of Leukemia Research for the Transplant & Cellular Therapy Network. Read more about this role here: ascopost.com/issues/october-10-2022/stephen-a-strickland-….
-
Sarah Cannon Docs
@SarahCannonDocs
.@MLJohnsonMD2 discusses the CodeBreaK 200 trial presented at the European Society for Medical Oncology (ESMO) Congress 2022.
www.obroncology.com/video/what-to-make-of-pfs-and-os-resu… -
Sarah Cannon Docs
@SarahCannonDocs
Today @Phase1Onc presents "A Phase 1 study of the anti-tissue factor antibody-drug conjugate XB002 in patients with advanced solid tumors (JEWEL-101): initial results from the dose-escalation stage," in a poster presentation. Be sure to stop by poster 224 at 10am!
-
Sarah Cannon Docs
@SarahCannonDocs
Janux Therapeutics announces first patient dosed with JANX007 in First-in-Human Phase 1 Clinical Trial in patients with prostate cancer.
pharmaceuticaldaily.com/janux-therapeutics-announces-firs… -
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
Another ER+ press release. These drugs are coming - I remain confident we will have new endocrine backbones for our patients.
And please consider a clinical trial...TODAY!
#bcsm #ceran #endocrine @SarahCannonDocs
ir.olema.com/news-releases/news-release-details/olema-onc… -
Sarah Cannon Docs reposted
VJ Oncology
@VJOncology
🎥 @ErikaHamilton9 of @SarahCannonDocs discusses therapeutic strategies to maximize sensitivity to endocrine therapy in breast cancer
Watch: 👉www.vjoncology.com/video/8l1w1hlxscu-therapeutic-strategi…👈
@myESMO #esmo22 #bcsm #breastcancer -
Sarah Cannon Docs reposted
OncLive SOSS
@OncLiveSOSS
Melissa L. Johnson, MD, of @SarahCannonDocs, discusses new drug approvals for EGFR exon 20 insertion mutation–positive non–small cell lung cancer #lcsm www.onclive.com/view/dr-johnson-on-new-drug-approvals-for…
-
Sarah Cannon Docs reposted
OncLive.com
@OncLive
Durvalumab, Tremelimumab, and Chemotherapy Elicit Promising Long-Term OS Rates in NSCLC @MLJohnsonMD2 @SarahCannonDocs #lcsm #esmo22 @myESMO www.onclive.com/view/durvalumab-tremelimumab-and-chemothe…
-
Sarah Cannon Docs reposted
OncLive SOSS
@OncLiveSOSS
David Spigel, MD, of @SarahCannonDocs, discusses the focus of each presentation, which centered on immunotherapy vs chemoimmunotherapy in the frontline metastatic setting and the surgical perspective of treatment in early-stage NSCLC #lcsm www.onclive.com/view/immunotherapy-continues-to-touch-all…
-
Sarah Cannon Docs reposted
Patient Power
@PatientPower
The @US_FDA granted the approval of two new treatment options for HER2-positive breast cancer.
@ErikaHamilton9 from @SarahCannonDocs describes patient response and response duration in those with HER2 #metastatic disease and brain metastases. www.patientpower.info/breast-cancer/treatments/how-are-br…
#bcsm #bcam -
Sarah Cannon Docs
@SarahCannonDocs
When participating in a clinical trial, there is a clinical trials staff who is closely monitoring you. They adhere to protocols making sure labs, imaging, and medications are all done exactly right. Learn more: geo-blocked-site.azurewebsites.net.
-
Sarah Cannon Docs
@SarahCannonDocs
This Blood Cancer Awareness Month, know the blood cancer symptoms to look out for. Visit our Sarah Cannon Expert Blog to learn more: sarahcannon.com/Blog.
-
Sarah Cannon Docs
@SarahCannonDocs
It’s almost here! Dr. Melissa Johnson’s OncLive SOSS on lung cancer will begin tonight at 6PM. Register to learn from her and Andrew McKenzie, PhD, and Dr. Gilmore in this virtual event.
event.onclive.com/event/5239edbc-f90c-4de9-9f4e-be7c0d5eb… -
Sarah Cannon Docs
@SarahCannonDocs
With many different types of gynecologic cancers, it's important to know the signs, symptoms, and screening options available. Check out our recommendations and guidelines starting at age 21: geo-blocked-site.azurewebsites.net.
-
Sarah Cannon Docs
@SarahCannonDocs
Ways we do this is by connecting patients with mental health providers who help with trauma and post-traumatic stress disorder and rehabilitation resources, such as physical therapy, to improve limb function and assist with activities of daily living. geo-blocked-site.azurewebsites.net
-
Sarah Cannon Docs
@SarahCannonDocs
If you have questions about cancer, we can help! Nurses are standing by to answer your questions and get you connected with the right resources. Call now: (844)482-4812. #asksarah #cancerresources
-
Sarah Cannon Docs
@SarahCannonDocs
If you’ve been diagnosed with a form of blood cancer, your hematologist/oncologist will help you determine the right treatment approach based on the disease, your overall health and other factors. Learn more below. sarahcannon.com/blog/entry/understanding-blood-cancer-tre…
-
Sarah Cannon Docs
@SarahCannonDocs
One major advancement in bone sarcoma treatment is the focus on quality of life and sensitivity to the patient, including their mental health, not just the oncologic problem we need to treat. Learn more here: geo-blocked-site.azurewebsites.net.
-
Sarah Cannon Docs
@SarahCannonDocs
When it comes to the fight against cancer, it’s not just the physicians and researchers in labs creating new treatments – it’s the patients who participate. Joining a clinical trial makes scientific breakthroughs possible. Science needs you. #worldcancerresearchday
-
Sarah Cannon Docs
@SarahCannonDocs
.@NFL Hall of Famer, @ShannonSharpe was diagnosed with prostate cancer in 2016 and is now sharing his story to encourage men to get screened. Yesterday, @NBCLX had our very own Dr. Benjamin Garmezy on the show to educate them on prostate cancer. Watch now.
This media couldn't be displayed. See it on the original post. -
Sarah Cannon Docs
@SarahCannonDocs
Do you have questions about cancer? Call askSARAH, our helpline where specially-trained nurses are ready to help you with your questions. Call now: (844)482-4812.
#asksarah #cancerresources -
Sarah Cannon Docs
@SarahCannonDocs
Explore seven reasons why clinical trial participation might be right for you over on our Sarah Cannon Expert Blog. geo-blocked-site.azurewebsites.net
-
Sarah Cannon Docs
@SarahCannonDocs
Learn from our experts @MelissaJohnsonMD2 @DavidRSpigel, and Andrew McKenzie, PhD on September 29 in an in person @OncLive State of the Summit networking event. Register NOW
event.onclive.com/event/0546bd7f-b039-4312-9677-e21b0030a… -
Sarah Cannon Docs
@SarahCannonDocs
If you have questions about cancer, we can help! Nurses are standing by to answer your questions and get you connected with the right resources. Call now: (844)482-4812.
#asksarah #cancerresources -
Sarah Cannon Docs
@SarahCannonDocs
Daniel Lerman, MD, an orthopedic oncologist with the Institute for Limb Preservation at Presbyterian/St. Luke's Medical Center, shares promising new advances in bone sarcoma treatment. sarahcannon.com/blog/entry/the-latest-advancements-in-bon…
-
Sarah Cannon Docs
@SarahCannonDocs
Today is National Day of Encouragement! Let's encourage Cancer Warriors near and dear to us. 💙 #nationaldayofencouragement #cancerwarriors
-
Sarah Cannon Docs
@SarahCannonDocs
SCRI expert, @ErikaHamilton9 delivered an oral presentation on, “Therapeutic strategies to maximize ET sensitivity and confront resistance in MBC” at an AZ #esmo22 symposium.
-
Sarah Cannon Docs
@SarahCannonDocs
The extended follow-up data from a phase 1/2 trial of DS-7300 is here! Read about the results and how this impacts patients facing lung, esophageal, and prostate cancers in the release: bwnews.pr/3qvnYpA
-
Sarah Cannon Docs
@SarahCannonDocs
Today, we take time to reflect on how grateful we are to the first responders, service men and women, and volunteers who dedicated their efforts to save lives and help rebuild. #neverforget #911anniversary
-
Sarah Cannon Docs
@SarahCannonDocs
"These results support the addition of a limited course of tremelimumab to durvalumab plus chemotherapy as a potential new treatment option for patients with these harder-to-treat forms of lung cancer,” @MLJohnsonMD2 shares. Read POSEIDON trial updates www.astrazeneca.com/media-centre/press-releases/2022/imfi…!
-
Sarah Cannon Docs
@SarahCannonDocs
Bonjour! We are excited to join globally recognized scientific leaders at #esmo22. Do not miss our experts, @MLJohnsonMD2 @ErikaHamilton9 @DavidRSpigel + more, as they present a their e-poster presentations on September 10 from Paris, France. image.news.sarahcannon.com/lib/fe5d15707c62007d7d12/m/2/c…
-
Sarah Cannon Docs
@SarahCannonDocs
This is an uplifting story you will not want to miss! #fightingcancertogether
HCA Healthcare
@HCAhealthcare
With 18 million views, a moving video has gone viral featuring a young @SarahCannonDocs patient beating the odds. #watch as caregivers at HCA Healthcare’s @PresStLukesDenv stood by his side as he married his fiancé while fighting Stage 4 cancer. #carelikefamily
-
Sarah Cannon Docs
@SarahCannonDocs
It is so important to listen to your body and pay attention to changes. Today, cervical cancer is the only gynecologic cancer for which there is a screening exam. Learn more about what to look for here: geo-blocked-site.azurewebsites.net.
-
Sarah Cannon Docs
@SarahCannonDocs
This week's wellness tip...R & R! To combat fatigue, get seven or eight hours of sleep each night and maintain consistent sleep-wake times. ✨ #cancerwarrior #wellnesstips
-
Sarah Cannon Docs
@SarahCannonDocs
Do you have questions about cancer? Call askSARAH, our helpline where specially-trained nurses are ready to help you with your questions. Call now: (844)482-4812. #asksarah #cancerresources
-
Sarah Cannon Docs
@SarahCannonDocs
The cancer journey can be very emotional, and both patients and their loved ones may experience grief. This blog discusses what people should know about coping with grief throughout the cancer journey. sarahcannon.com/blog/entry/understanding-the-grief-response
-
Sarah Cannon Docs
@SarahCannonDocs
Tag a healthcare hero you know in the comments and say THANK YOU! #laborday
-
Sarah Cannon Docs
@SarahCannonDocs
September is a time to raise awareness for many cancer types. Visit our Sarah Cannon Expert Blog to learn more about the signs, symptoms, screening recommendations, etc. relating to these cancer types. geo-blocked-site.azurewebsites.net
-
Sarah Cannon Docs
@SarahCannonDocs
Navigators are at the patient's side, literally and figuratively, to provide encouraging words, a listening ear, and a caring hand to hold. They celebrate the big and small milestones with patients and lift them up when they experience disappointment. 💙🫶
-
Sarah Cannon Docs
@SarahCannonDocs
If you have questions about cancer, we can help! Nurses are standing by to answer your questions and get you connected with the right resources. Call now: (844)482-4812.
#asksarah #cancerresources -
Sarah Cannon Docs
@SarahCannonDocs
Protecting yourself from skin conditions caused by sun damage doesn't mean you have to hide inside during all daylight hours. But what it does mean is you should seek shade, wear UV-protective clothing, and apply sunscreen every time you go outside. ☀️
-
Sarah Cannon Docs reposted
Targeted Onc
@TargetedOnc
An expert provides his perspective on the first- and second-line treatment approaches in the patient case and comments on the patient’s likely prognosis. #lymsm #dlbcl @SarahCannonDocs @TNOncology
www.targetedonc.com/view/second-line-treatment-approaches… -
Sarah Cannon Docs
@SarahCannonDocs
To combat common skin conditions like the below, we recommend avoiding sun exposure, particularly between 10 a.m. and 2 p.m., when the sun's rays are strongest. You can do this through a combination of staying indoors, seeking shade & applying sunscreen every time you go outside.
-
Sarah Cannon Docs
@SarahCannonDocs
Join us in welcoming Dr. Stephen Strickland, our newly named Director of Leukemia Research for the Sarah Cannon Transplant & Cellular Therapy Network. Learn more about Dr. Strickland’s expertise and role.
sarahcannon.com/about/newsroom/stephen-a-strickland-jr-jo… -
Sarah Cannon Docs
@SarahCannonDocs
A little goes a long way when it comes to physical activity while undergoing chemotherapy treatment! Start with three 10-minute walks a day and go from there. 🏃♀️🏃♂️
#cancerwarrior #nationalwellnessmonth #wellnesstips -
Sarah Cannon Docs
@SarahCannonDocs
Do you have questions about cancer? Call askSARAH, our helpline where specially-trained nurses are ready to help you with your questions. Call now: (844)482-4812. #asksarah #cancerresources
-
Sarah Cannon Docs
@SarahCannonDocs
Sarah Cannon Research Institute (SCRI) has joined the Strata Precision Indications for Approved THerapies (Strata PATH™) trial. Researchers will enroll patients at 8 SCRI-affiliated sites. www.prnewswire.com/news-releases/strata-oncology-expands-…
-
Sarah Cannon Docs
@SarahCannonDocs
Visit our Sarah Cannon Expert Blog to learn how to protect yourself against the sun and have a fun-filled and safe rest of your summer! geo-blocked-site.azurewebsites.net 😎
-
Sarah Cannon Docs
@SarahCannonDocs
A new treatment option for breast cancer may alter the treatment landscape for patients with HER2-positive metastatic breast cancer. Read more + hear from Sarah Cannon expert Dr. @ErikaHamilton9 below. reachmd.com/programs/project-oncology/evaluating-a-treatm…
-
Sarah Cannon Docs
@SarahCannonDocs
If you are going through chemotherapy treatment, do your best to avoid GERMS! Wash your hands, stay out of crowds, eat fresh foods...the list goes on. 😷💙 #cancerwarrior #nationalwellnessmonth #wellnesstips
-
Sarah Cannon Docs
@SarahCannonDocs
It is recommended that sunscreen should be reapplied every two hours while you're outside, and more often when you're swimming or sweating. ⛱
-
Sarah Cannon Docs
@SarahCannonDocs
Misty is cancer free from glioblastoma, one of the most aggressive types of brain tumors. Dr. Tsvankin performed an awake craniotomy which allowed him to remove the tumor while preserving the areas of the brain that control Misty’s speech & other functions. Read her full journey:
-
Sarah Cannon Docs
@SarahCannonDocs
In part one of this four part @ASCO series "Updates in HER2-Positive Breast Cancer," Dr. @ErikaHamilton9 joins other experts to discuss the management of metastatic HER2-positive breast cancer. Learn more here: ascopost.com/video-roundtable/updates-in-her2-positive-br….
-
Sarah Cannon Docs
@SarahCannonDocs
If you have questions about cancer, we can help! Nurses are standing by to answer your questions and get you connected with the right resources. Call now: (844)482-4812.
#asksarah #cancerresources -
Sarah Cannon Docs
@SarahCannonDocs
Navigators educate patients about many topics such as treatments, side effects, and ways to identify and prevent problems. They provide educational materials and resource links for reference and further learning. 🗺
-
Sarah Cannon Docs reposted
Strata Oncology
@StrataOncology
We are excited to share that the Strata PATH Trial has expanded to eight Sarah Cannon Research Institute sites. @SarahCannonDocs
Read more: strataoncology.com/081622
#oncology #cancerresearch -
Sarah Cannon Docs
@SarahCannonDocs
We are honored to see so many Sarah Cannon experts on @NashLifestyles Top Doctors List. Take a look below: nashvillelifestyles.com/people/top-doctors/doctors in nas…
-
Sarah Cannon Docs
@SarahCannonDocs
If you remember one thing this National Wellness Month, remember how important it is to keep your mind and body STRONG during chemotherapy treatment. Tips on how to do this can be found here: geo-blocked-site.azurewebsites.net.
-
Sarah Cannon Docs
@SarahCannonDocs
After being told she had five years to live, Sandy is now in remission from Stage IV lung Cancer! Read her full journey from diagnosis to survivorship here: geo-blocked-site.azurewebsites.net. @MLJohnsonMD2
-
Sarah Cannon Docs
@SarahCannonDocs
We are saddened by the news of beloved singer, actress, and activist @OliviaNJ’s passing after her extensive battle with breast cancer. Following this news, @NBCLX brought our very own Dr. @ErikaHamilton9 on to provide her expertise on breast cancer.
This media couldn't be displayed. See it on the original post. -
Sarah Cannon Docs
@SarahCannonDocs
Staying hydrated should always be a priority, especially if you are undergoing chemotherapy treatment. Have you had your daily intake of water today?! 💧
#stayhydrated #cancerwarrior #nationalwellnessmonth #wellnesstips -
Sarah Cannon Docs
@SarahCannonDocs
Get up to date on key topics in the management of patients with HER2-positive breast cancer. Several resources are available below, as well as expert commentaries from @ErikaHamilton9. Learn more here: www.deceraclinical.com/education/oncology/programs/2022/b….
-
Sarah Cannon Docs
@SarahCannonDocs
"Two academic research leaders, Dr. Anthony Greco and Dr. John Hainsworth, had a solution: start a research program in the community, where more people could access more trial options. In 1993, they formed Sarah Cannon Research Institute." Learn more:
cancerhistoryproject.com/people/sarah-cannon-research-ins… -
Sarah Cannon Docs
@SarahCannonDocs
Do you have questions about cancer? Call askSARAH, our helpline where specially-trained nurses are ready to help you with your questions. Call now: (844)482-4812. #asksarah #cancerresources
-
Sarah Cannon Docs
@SarahCannonDocs
Working or playing outside on a sunny day is one of the joys of summer, but you could be putting yourself at risk if you don't take steps to protect your skin. Grab your sunscreen and let's learn about the 6 skin conditions caused by sun damage. ☀️⬇️ sarahcannon.com/blog/entry/6-skin-conditions-caused-by-su…
-
Sarah Cannon Docs
@SarahCannonDocs
Do you know how important it is to be proactive about keeping your body and mind strong during cancer treatment? One way to do this is by boosting your nutrition and maintaining a healthy diet. 🚀🌳 #cancerwarrior #nationalwellnessmonth #wellnesstips
-
Sarah Cannon Docs
@SarahCannonDocs
Our navigation staff plays a vital role in cancer care, managing what patients go through on a day to day basis. Patients routinely tell us what a difference our staff make as they go through one of the most challenging times of their lives! geo-blocked-site.azurewebsites.net💙🗺
-
Sarah Cannon Docs
@SarahCannonDocs
Do you know how important it is to be proactive about keeping your body and mind strong during chemotherapy treatment? Here are six tips to help you. sarahcannon.com/blog/entry/six-ways-to-stay-strong-during…
-
Sarah Cannon Docs
@SarahCannonDocs
If you have questions about cancer, we can help! Nurses are standing by to answer your questions and get you connected with the right resources. Call now: (844)482-4812.
#asksarah #cancerresources -
Sarah Cannon Docs
@SarahCannonDocs
What does wellness mean to you? 🌿 This National Wellness Month, we will be sharing tips to help you in your wellness journey. Stay tuned or visit the Sarah Cannon Expert Blog to learn more. sarahcannon.com
#nationalwellnessmonth -
Sarah Cannon Docs
@SarahCannonDocs
This Sarcoma Cancer Awareness Month, learn more about how to understand and face a sarcoma diagnosis on the Sarah Cannon Expert Blog. geo-blocked-site.azurewebsites.net
-
Sarah Cannon Docs
@SarahCannonDocs
"In the DESTINY-Breast03 primary analysis, [trastuzumab deruxtecan] showed superiority over [trastuzumab emtansine] in patients with [with HER2–positive metastatic breast cancer]" - Dr. @ErikaHamilton9
Read more about her findings below.
www.hmpgloballearningnetwork.com/site/onc/trastuzumab-der… -
Sarah Cannon Docs
@SarahCannonDocs
We're sharing ways to identify skin cancer, as well as treatment options on the Sarah Cannon Expert Blog. Stay prepared this UV Safety Month and learn more here: geo-blocked-site.azurewebsites.net #uvsafetymonth #skincancer
-
Sarah Cannon Docs
@SarahCannonDocs
Do you have questions about cancer? Call askSARAH, our helpline where specially-trained nurses are ready to help you with your questions. Call now: (844)482-4812. #asksarah #cancerresources
-
Sarah Cannon Docs
@SarahCannonDocs
Gaining knowledge and understanding can help people facing cancer feel more secure and in control of their decisions. This Sarcoma Cancer Awareness Month, learn more about this cancer type here: geo-blocked-site.azurewebsites.net.
-
Sarah Cannon Docs
@SarahCannonDocs
Sarah Cannon nurse navigators guide patients along their entire cancer journey, making it smoother by filling in some of the cracks in the often disconnected healthcare system. Navigators are a consistent point of contact for patients and families. 💙 #carelikefamily
-
Sarah Cannon Docs
@SarahCannonDocs
Dr. @ErikaHamilton9 shares a safety follow-up of the randomized, phase 3 study DESTINY-Breast03. Read her findings in @eCancer below. ecancer.org/en/video/10373-safety-follow-up-of-the-random…
-
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
Fun to have discussed #her2+ #bcsm with @CareyAnders1 and Sara Hurvitz @UCLAnewsroom for @ASCOPost
@SarahCannonDocs
Metastatic HER2-Positive Breast Cancer - The ASCO Post ascopost.com/video-roundtable/updates-in-her2-positive-br… -
Sarah Cannon Docs
@SarahCannonDocs
Less than a year after her breast cancer diagnosis, Neida has rung the bell, is cancer-free & well on her way to a complete recovery. “My fears are gone,” she says. “Most of all, I feel blessed knowing that I have so much love around me … and so much life ahead of me.”
-
Sarah Cannon Docs
@SarahCannonDocs
If you or a loved one has received a sarcoma diagnosis, we put together an overview resource to help bring clarity and comfort along the journey. Prepare yourselves with our blog, "How to understand and face a sarcoma diagnosis". geo-blocked-site.azurewebsites.net
-
Sarah Cannon Docs
@SarahCannonDocs
We're answering common questions about sarcoma on the Sarah Cannon Expert Blog below. ⬇️ sarahcannon.com/blog/entry/how-to-understand-and-face-a-s…
-
Sarah Cannon Docs
@SarahCannonDocs
If you have questions about cancer, we can help! Nurses are standing by to answer your questions and get you connected with the right resources. Call now: (844)482-4812.
#asksarah #cancerresources -
Sarah Cannon Docs
@SarahCannonDocs
Dr. @MLJohnsonMD2 discusses the mechanism of action of the novel immuno-cytokine, modakafusp alfa.
www.youtube.com/watch?v=wr8W9IEbLqU -
Sarah Cannon Docs
@SarahCannonDocs
The phase 3 HER2CLIMB-05 trial will investigate tucatinib plus standard of care maintenance in the first-line setting for patients with HER2-positive metastatic breast cancer. Learn more about this study led by Dr. @ErikaHamilton9. www.cancernetwork.com/view/tucatinib-to-be-examined-as-ad…
-
Sarah Cannon Docs
@SarahCannonDocs
Read about the safety follow-up analysis of the randomized phase 3 DESTINY-Breast03 study conducted by Dr. @ErikaHamilton9.
www.targetedonc.com/view/destiny-breast03-update-reinforc… -
Sarah Cannon Docs
@SarahCannonDocs
Learn more about the three common types of skin cancer - basal cell carcinoma, squamous cell carcinoma, and melanoma - how to identify them, and common treatment types on the Sarah Canon Expert Blog. geo-blocked-site.azurewebsites.net #melanoma #uvsafetymonth #skincancer
-
Sarah Cannon Docs reposted
VJ Oncology
@VJOncology
🎥 @MLJohnsonMD2 of @SarahCannonDocs discusses CITYSCAPE: tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected NSCLC
Watch: 👉www.vjoncology.com/video/b7e2l8k9kow-cityscape-1l-tiragol…👈
@ASCO #asco22 #lcsm -
Sarah Cannon Docs
@SarahCannonDocs
If you or a loved one has received a sarcoma diagnosis, we put together this overview to serve as a resource that brings clarity and comfort. Read more below. sarahcannon.com/blog/entry/how-to-understand-and-face-a-s…
-
Sarah Cannon Docs
@SarahCannonDocs
“Everyone is interested in what will be the next generation of immunotherapy agents, and there are a lot of pathways to pursue. TIM-3 is one of those, and it looks promising.”—Dr. Gerald S. Falchook
dailynews.ascopubs.org/do/10.1200/ADN.22.201043/full/ -
Sarah Cannon Docs
@SarahCannonDocs
Do you have questions about cancer? Call askSARAH, our helpline where specially-trained nurses are ready to help you with your questions. Call now: (844)482-4812. #asksarah #cancerresources
-
Sarah Cannon Docs
@SarahCannonDocs
Summer, with all of its outdoor activities, is a great time to learn more about skin cancer, a common and often preventable form of cancer. #skincancer #uvsafetymonth sarahcannon.com/blog/entry/skin-cancer-types-and-screenin…
-
Sarah Cannon Docs
@SarahCannonDocs
It's Sarcoma Cancer Awareness Month. If you recently received a sarcoma diagnosis or are experiencing symptoms, call askSARAH at 844-482-4812 to speak with a nurse 24/7 or visit askSARAH online. geo-blocked-site.azurewebsites.net #sarcoma #sarcomacancerawareness
-
Sarah Cannon Docs
@SarahCannonDocs
Read Dr. @ErikaHamilton9's study on safety follow-up of the randomized, phase 3 study DESTINY-Breast03, published in @JCO_ASCO.
ascopubs.org/doi/abs/10.1200/JCO.2022.40.16_suppl.1000?se… -
Sarah Cannon Docs
@SarahCannonDocs
The past year has been an active and exciting time for research and treatment options for patients with melanoma. Meredith McKean, MD, MPH, Director of Melanoma and Skin Cancer Research for Sarah Cannon shares exciting developments. #uvsafetymonth sarahcannon.com/blog/entry/melanoma-advances-in-research-…
-
Sarah Cannon Docs
@SarahCannonDocs
If you have questions about cancer, we can help! Nurses are standing by to answer your questions and get you connected with the right resources. Call now: (844)482-4812. #asksarah #cancerresources
-
Sarah Cannon Docs
@SarahCannonDocs
July is UV Safety Month! One very important outside tip is to protect your skin from burning by applying sunscreen and/or wearing protective clothing + keep in mind, some medications, cancer treatments, and loss of/thinning hair can make you more prone to burning. #uvsafetymonth
-
Sarah Cannon Docs
@SarahCannonDocs
Dr. @MLJohnsonMD2 describes the interim results of an ongoing phase I/IIa study (NCT04471727) of HPN328, a tri-specific, DLL3-targeting T-cell engager, in patients with small cell lung cancer (SCLC) and other neuroendocrine cancers. www.vjoncology.com/video/pe3c342j-fw-hpn328-a-tri-specifi…
-
Sarah Cannon Docs
@SarahCannonDocs
Dr. @ErikaHamilton9 presented findings on metastatic breast cancer including a safety follow-up for DESTINY-Breast03 at this year's ASCO Annual Meeting.
www.ajmc.com/view/asco-returns-to-chicago-with-health-equ… -
Sarah Cannon Docs
@SarahCannonDocs
.@DavidRSpigel, MD, joins other panelists to have an open conversation on complexity and expense in clinical trial development. Read more below. dailynews.ascopubs.org/do/10.1200/ADN.22.200962/full/
-
Sarah Cannon Docs
@SarahCannonDocs
Summer, with all of its outdoor activities, is a great time to learn more about this common and often preventable form of cancer. Learn more about identifying skin cancer, treatment options, and screening recommendations below. #uvsafetymonth sarahcannon.com/blog/entry/skin-cancer-types-and-screenin…
-
Sarah Cannon Docs
@SarahCannonDocs
Read about this study, led by Dr. @ErikaHamilton9, on Tucatinib plus first-line standard-of-care maintenance therapy with trastuzumab and pertuzumab.
www.onclive.com/view/tucatinib-plus-first-line-maintenanc… -
Sarah Cannon Docs
@SarahCannonDocs
.@DavidRSpigel, MD, discusses immunotherapy vs chemoimmunotherapy for patients with advanced lung cancer.
www.onclive.com/view/immunotherapy-continues-to-touch-all… -
Sarah Cannon Docs
@SarahCannonDocs
The endurance, strength and perseverance Cancer Warriors demonstrate through the treatment journey will be helpful to adjust to a new normal following cancer. Learn about cancer survivorship here: geo-blocked-site.azurewebsites.net
-
Sarah Cannon Docs
@SarahCannonDocs
Dehydration is a common side effect for people going through cancer treatment. Make sure to stay hydrated and drink plenty of water all summer long!💧
-
Sarah Cannon Docs
@SarahCannonDocs
If you have questions about cancer, we can help! Nurses are standing by to answer your questions and get you connected with the right resources. Call now: (844)482-4812. #asksarah #cancerresources
-
Sarah Cannon Docs
@SarahCannonDocs
“If you’re living the next day, you’re a survivor. You’re surviving," says Regina Clark. Regina is a registered nurse with the chemotherapy infusion center at the Sarah Cannon Cancer Institute at Lewisgale Hospital Pulaski + is a Cancer Warrior. Read more: www.wsls.com/news/local/2022/06/03/pulaski-nurse-battling…
-
Sarah Cannon Docs reposted
The Kelly Clarkson Show
@KellyClarksonTV
Like father, like son! Dr. David Randolph Sr. and his son Dr. David Randolph II both treat cancer patients as radiation oncologists at Johnson Willis Hospital in Richmond, Virginia. Hear their heartwarming daily tradition!
This media couldn't be displayed. See it on the original post. -
Sarah Cannon Docs
@SarahCannonDocs
Happy Father's Day! Whether you are a survivor, caregiver, supporter, or friend, we are wishing you a day surrounded by those you love. #fathersday
-
Sarah Cannon Docs reposted
OncLive.com
@OncLive
Participate in the @OncLiveSOSS Genitourinary Cancer in-person education and networking event with @BGarmezy of @SarahCannonDocs Expert faculty @katy_beckermann @PBarataMD and @PavlosMsaouel #soss
Register Today: event.onclive.com/event/dcc65808-af63-4b9b-bb6a-d320cd869… -
Sarah Cannon Docs
@SarahCannonDocs
Do you have questions about cancer? Call askSARAH, our helpline where specially-trained nurses are ready to help you with your questions. Call now: (844)482-4812. #asksarah #cancerresources
-
Sarah Cannon Docs
@SarahCannonDocs
Understand the importance of follow-up care after prostate cancer treatment by reading below. #menshealthweek sarahcannon.com/blog/entry/understanding-prostate-cancer-…
-
Sarah Cannon Docs
@SarahCannonDocs
During Men's Health Week, it is important to educate yourself and the men in your life on the proactive steps you can take to keeping your body healthy. Learn about screening guidelines and more here: geo-blocked-site.azurewebsites.net.
#menshealth #menshealthweek #cancerscreening -
Sarah Cannon Docs
@SarahCannonDocs
Recently, there was an exciting new FDA approval of CAR T-Cell Therapy for certain populations of lymphoma patients. We've broken down how this innovative therapy works so you can be in the know.
-
Sarah Cannon Docs
@SarahCannonDocs
Any fun plans this summer?! Make sure you are prepared! Summer can be a challenging time for someone going through cancer treatment, so we've compiled a few tips to help navigate. Read more here: geo-blocked-site.azurewebsites.net. ☀️
-
Sarah Cannon Docs reposted
OncLive.com
@OncLive
Registration is open! Join @BGarmezy of @SarahCannonDocs as he chairs an @OncLiveSOSS Genitourinary Cancer in-person education and networking event on 6/23 at 5:30pm! #soss
Register Today: event.onclive.com/event/dcc65808-af63-4b9b-bb6a-d320cd869… -
Sarah Cannon Docs reposted
OncLive.com
@OncLive
Tucatinib Plus First-Line Maintenance Under Exploration in Metastatic HER2+ Breast Cancer @ErikaHamilton9 @SarahCannonDocs @ASCO #asco22 #bcsm www.onclive.com/view/tucatinib-plus-first-line-maintenanc…
-
Sarah Cannon Docs reposted
OncLive SOSS
@OncLiveSOSS
David Spigel, MD, of @SarahCannonDocs, discusses immunotherapy vs chemoimmunotherapy in the frontline metastatic setting, plus the surgical perspective of treatment in early-stage NSCLC #lcsm www.onclive.com/view/immunotherapy-continues-to-touch-all…
-
Sarah Cannon Docs
@SarahCannonDocs
Sarah Cannon nurse navigators will equip you with a survivorship care plan to help you navigate life after treatment. Here are some things to remember about breast cancer follow-up care: sarahcannon.com/blog/entry/what-you-need-to-know-about-br…
-
Sarah Cannon Docs
@SarahCannonDocs
Follow-up care after completing cancer treatment is very important. Here are some things to remember. ⬇️ #cancersurvivor
-
Sarah Cannon Docs
@SarahCannonDocs
If you have questions about cancer, we can help! Nurses are standing by to answer your questions and get you connected with the right resources. Call now: (844)482-4812.
#asksarah #cancerresources -
Sarah Cannon Docs
@SarahCannonDocs
This year we are celebrating our 10 year anniversary of the Sarah Cannon Transplant and Cellular Therapy Network. Over the last decade, we’ve sought to advance science and transform care for patients facing blood cancer and beyond.
-
Sarah Cannon Docs
@SarahCannonDocs
Every day, we watch patients courageously face cancer head on. That resilience in the face of adversity makes us stronger. We are proud of our patients, our medical teams, and our communities for their determination - you inspire us to face our challenges with grit and grace.
-
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
Come see me at poster 484b- TIP of ph III of tucatinib or placebo with tras/pertuz in 1st line maintenance for #her2 #bcsm.
@SeagenGlobal @SarahCannonDocs @OncoAlert -
Sarah Cannon Docs
@SarahCannonDocs
Facing adversity, our incredible patients find strength. In uncertainty, they show us their unprecedented determination. We are amazed by the resilience patients facing cancer demonstrate along their journey. Survivors are our heroes. #nationalcancersurvivorsday
-
Sarah Cannon Docs reposted
Melissa L. Johnson
@MLJohnsonMD2
Remembering #virtualplenary in ASCO2020 fondly. Congratulations to @eevokes @SoniSmithMD @JhanelleGray for an unparalleled #plenarysession in person @Asco2022. @BurrisSkip @SarahCannonDocs @tmprowell
-
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
Dr. Modi presents groundbreaking DB-04 - #tdxd vs. chemo in #her2low #bcsm
PFS
- All: 5.1 mo chemo vs. 9.9 mo TDXd
-HR+: 5.4 vs. 10.1 mo
OS
-All: 16.8 to 23.4 mo
-HR+: 17.5 to 23.9 mo
TNBC:
-PFS 2.9 to 8.5 mo,
-OS 8.3 to 18.2 mo
ALL significant!
#asco22 @OncoAlert -
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
Thoughts:
1) ⬆️⬆️ pts w/ HER2 low than HER-2 high = actionable for MANY
2) to 👀 10 mo OS advantage for "TNBC" who don't even have high expression of a target 🎯 is phenomenal
3) what will we see with dato-DXD, HER3DXd etc....does target even matter? What about zeros?
#asco22 -
Sarah Cannon Docs reposted
OncoAlert
@OncoAlert
A pleasure to Bring you The #asco22 RoundUp for DAY2⃣of the Congress @LGerratana @DavidRSpigel @GeorgeSledge51 @OncBrothers @JCO_ASCO @TotalHealthConf @SarahCannonDocs @SWOG @EuropeanCancer @ESOncology @CancerCareMASCC @ESGO_society @ecancer
-
Sarah Cannon Docs
@SarahCannonDocs
We believe no one should fight cancer alone. Patients and survivors find strength, determination and resilience with the help of the support system around them. Survivors and loved ones, on National Cancer Survivors Day, we celebrate and honor you! 💙 #nationalcancersurvivorsday
-
Sarah Cannon Docs
@SarahCannonDocs
Sarah Cannon has been a clinical trial leader in the majority of approved cancer therapies over the last 10 years. Our recognized physician leadership is at the forefront of shaping new standards of cancer care based upon the latest research. geo-blocked-site.azurewebsites.net.
#asco22 -
Sarah Cannon Docs reposted
Denise Zusack
@dzusack
#asco2022 Exhibit Hall opens at 9 am tomorrow. Stop by booth #5036 and discuss new business partnership possibilities &/or employment opportunities! COME GROW WITH US! ♥️✌🏻👊🏻 @SarahCannonDocs @CesarAPerezMD
-
Sarah Cannon Docs reposted
OncLive.com
@OncLive
Trastuzumab Deruxtecan Remains Safe and Effective Option for Metastatic Breast Cancer @ErikaHamilton9 @SarahCannonDocs @ASCO #asco22 #bcsm www.onclive.com/view/trastuzumab-deruxtecan-remains-safe-…
-
Sarah Cannon Docs reposted
Melissa L. Johnson
@MLJohnsonMD2
2019…and 2022. Seeing Jerry Azzoli at #asco will always be a highlight of my meeting. @SarahCannonDocs
-
Sarah Cannon Docs reposted
Rafeh Naqash, MD, FASCO
@thenasheffect
Presenting like a pro .. as always @MLJohnsonMD2 @SarahCannonDocs on INFa2b !! Front row view @ASCO #asco22 @BurrisSkip @EladSharonMD
-
Sarah Cannon Docs
@SarahCannonDocs
Before presenting the @ConquerCancerFd Awards and the Fellows of the American Society
of Clinical Oncology (FASCO), our SMO, @BurrisSkip was recognized in the opening session for his 2020 @ASCO leadership while serving as President and as Conquer Cancer Chair. -
Sarah Cannon Docs
@SarahCannonDocs
Today, Sarah Cannon Research Institute at @HealthONEsystem Dr. Gerald Falchook will present in the #asco22 Developmental Therapeutics- Immunotherapy Session. Before attending his oral presentation, get to know our leader and scientific expert geo-blocked-site.azurewebsites.net
-
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
This is such an important topic to make sure healthcare and cancer care is equal for ALL. #languagematters #askingmatters #screeningforall
As a #bcsm doc, mammograms can be neglected in this population and shouldn't be!
@SarahCannonDocs @OncoAlert @ASCO #asco22
Ivy Elkins
@ivybelkins
Very important presentation at #asco22 by Dr Matthew Schabath on why it is important to identify #lgbtqia patients with cancer and the right questions to ask! At least 7 cancer types disproportionately affect these populations, including #lung! #lcsm #disparities #sogi @OncoAlert
-
Sarah Cannon Docs reposted
Melissa L. Johnson
@MLJohnsonMD2
Excited for Turning up the Heat: Immunotherapy and Cellular Therapies in Lung Cancer!! All star line up! Shirish Gadgeel, @RachelSanbornMD and Suresh Senan speaking. Let's figure out how to move the field of #lungcancer forward @SarahCannonDocs @WomeninOnc
-
Sarah Cannon Docs
@SarahCannonDocs
Remember what works for other people may not work for you, when it comes to managing your fears of recurrence. Once you find an activity that makes you feel at ease, be sure to include it in your schedule, and take time for yourself. #cancersurvivor #nationalcancersurvivorsmonth
-
Sarah Cannon Docs
@SarahCannonDocs
Want to learn more about our CRO and working with us for on an early phase oncology trial? Contact us today and we discuss our extensive experience or visit us at #asco22 booth 5036.
geo-blocked-site.azurewebsites.net -
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
Thanks to @ASCO for the opportunity to participate in the #ldp program this year. Amazing to get to know each other, learn, and present to the board yesterday.
#asco22 @SarahCannonDocs @BurrisSkip @KlempnerSam @cancerassassin1 @LarissaAMeyerMD @kmdillmon @michaltibbits -
Sarah Cannon Docs
@SarahCannonDocs
Clouds offer little protection when it comes to the sun's harmful rays! Be sure to continue caring for your skin and wear sunscreen rain or shine if you plan to be outdoors. 🌥
-
Sarah Cannon Docs
@SarahCannonDocs
We are excited to share our latest cancer research insights through more than 140 abstracts and presentations at #asco22. Read about where you can find our scientific experts at this year’s annual meeting. sarahcannon.com/about/newsroom/sarah-cannon-to-present-la…
-
Sarah Cannon Docs
@SarahCannonDocs
Meredith McKean, MD, MPH, Director, Melanoma and Skin Cancer Research, Sarah Cannon Research Institute, shares what you should know about melanoma, including ways to help lower your risk and the advancements in the treatment of melanoma. sarahcannon.com/blog/entry/melanoma-what-you-should-know
-
Sarah Cannon Docs
@SarahCannonDocs
Do you have questions about cancer? Call askSARAH, our helpline where specially-trained nurses are ready to help you with your questions. Call now: (844)482-4812.
#asksarah #cancerresources -
Sarah Cannon Docs
@SarahCannonDocs
The dedication of our oncology nurses is invaluable! Dana and Melissa are fully committed to the patients' needs, as well as the ongoing growth of our program and our oncology nurses' education.
-
Sarah Cannon Docs
@SarahCannonDocs
Today, we remember and honor those who have served our country. #memorialday
-
Sarah Cannon Docs reposted
OncLive SOSS
@OncLiveSOSS
Melissa L. Johnson, MD, of @SarahCannonDocs, discusses new drug approvals for EGFR exon 20 insertion mutation–positive non–small cell lung cancer #lcsm www.onclive.com/view/dr-johnson-on-new-drug-approvals-for…
-
Sarah Cannon Docs
@SarahCannonDocs
Do young breast cancer patients need to be opting for mastectomies over lumpectomies? A recent study indicated, no. Let's break it down. ⬇️
-
Sarah Cannon Docs
@SarahCannonDocs
Summer is almost here! This means more time outdoors. Be sure to take care of your skin and apply sunscreen regularly. ☀️
-
Sarah Cannon Docs
@SarahCannonDocs
Today is #clinicaltrialsday! Every cancer treatment available today started out as a clinical trial. That’s why we are committed to making sure more people can have access to options closer to home. Search for oncology clinical trials near you.
sarahcannon.com/clinical-trials/ -
Sarah Cannon Docs
@SarahCannonDocs
Meet Kim Long! Kim is a Neuro Oncology Nurse Navigator for Sarah Cannon in @HCAFLHealthcare who always goes the extra mile for her patients. #carelikefamily #oncologynursingmonth
-
Sarah Cannon Docs
@SarahCannonDocs
Clinical Trials Day is tomorrow! Clinical trials are a crucial component to developing new therapies both to benefit our current patients and our patients in the future, and allow us to take the next step in the fight against cancer. Learn more below. sarahcannon.com/blog/entry/clinical-trials-101-everything…
-
Sarah Cannon Docs
@SarahCannonDocs
If you have questions about cancer, we can help! Nurses are standing by to answer your questions and get you connected with the right resources. Call now: (844)482-4812. #asksarah #cancerresources
-
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
#asco22 is only 2 weeks away! Below are my Top 10 abstracts I'm looking forward to in #bcsm across early & metastatic settings.
I've also attached the "why" - what is intriguing me about these particular abstracts or why they are important IMO.
@SarahCannonDocs @OncoAlert -
Sarah Cannon Docs
@SarahCannonDocs
On 5/24, Dr. Ian Flinn is chairing "Institutional Perspectives in Cancer: Multiple Myeloma & Leukemia/Lymphoma" webinar and Live Q&A with @OncLive. You will not want to miss this virtual event! Register below:
event.onclive.com/event/cd04ff94-2944-4ac0-b426-0fa73ee42…
OncLive.com
@OncLive
Join Ian Flinn, MD, PhD of @SarahCannonDocs as he chairs a Multiple Myeloma & Leukemia/Lymphoma virtual event with Live Q&A on 5/24 at 6:30 PM CT! @OncLiveSOSS @OncLiveSOSS
Register: event.onclive.com/event/cd04ff94-2944-4ac0-b426-0fa73ee42… -
Sarah Cannon Docs
@SarahCannonDocs
This Oncology Nursing Month, we're highlighting some incredible Sarah Cannon Nurses. Today we are celebrating Kellie Brown, Director of Cancer Treatment at @OgdenRegional. Former patient, Amie, describes having a natural connection and comfort with Kellie from the very beginning.
-
Sarah Cannon Docs
@SarahCannonDocs
Did you know?! The sun's rays can go through clouds, and for that matter, water as well. If you're outdoors, protect yourself by wearing sunscreen and protective clothing. ☀️
-
Sarah Cannon Docs
@SarahCannonDocs
Who are these cancer experts and how do they help you? Great question! We're sharing more information on your cancer care team over on the Sarah Cannon Expert Blog here: geo-blocked-site.azurewebsites.net.
-
Sarah Cannon Docs
@SarahCannonDocs
Something to keep in mind this summer. It's important to take care of your skin - it's the only one you get! Apply sunscreen about 15 to 30 minutes ahead of exposure to the sun. ☀️
-
Sarah Cannon Docs
@SarahCannonDocs
Early detection is key for skin cancer. Starting at age 20, in addition to performing regular full-body skin self-exams, your doctor should perform a skin exam annually. Here is what you can expect: sarahcannon.com/blog/entry/full-body-skin-exam-what-to-ex…
-
Sarah Cannon Docs
@SarahCannonDocs
Do you have questions about cancer? Call askSARAH, our helpline where specially-trained nurses are ready to help you with your questions. Call now: (844)482-4812.
#asksarah #cancerresources -
Sarah Cannon Docs
@SarahCannonDocs
Friendly reminder to keep your skin HEALTHY! Tips for taking preventative measures against skin cancer can be found on our Sarah Cannon Expert Blog here: geo-blocked-site.azurewebsites.net. ☀️🌿
-
Sarah Cannon Docs
@SarahCannonDocs
We are wishing a Happy Mother's Day to all of the mothers today! Whether you are a survivor, caregiver, supporter, or friend, we hope you are enjoying a day of rest and celebrating with those you love. 💐 #mothersday
-
Sarah Cannon Docs
@SarahCannonDocs
Did you know, on average, a patient can see up to eight cancer experts during the cancer journey from diagnosis through survivorship? Find out who these cancer experts are and how they help you below.
sarahcannon.com/blog/entry/about-your-cancer-care-team -
Sarah Cannon Docs
@SarahCannonDocs
If you have questions about cancer, we can help! Nurses are standing by to answer your questions and get you connected with the right resources. Call now: (844)482-4812.
#asksarah #cancerresources -
Sarah Cannon Docs
@SarahCannonDocs
This month is a time to recognize and raise awareness for skin, brain, & bladder cancer. Visit the Sarah Cannon Expert Blog to read more about risk factors, symptoms, treatment and more! sarahcannon.com/blog
-
Sarah Cannon Docs
@SarahCannonDocs
Powerful words shared by Breast Cancer Hero, Carol, who is being treated at @TriStarHealth. Read Carol's journey, as well as other Sarah Cannon patient stories here: geo-blocked-site.azurewebsites.net. 💙
-
Sarah Cannon Docs
@SarahCannonDocs
Do you have questions about cancer? Call askSARAH, our helpline where specially-trained nurses are ready to help you with your questions. Call now: (844)482-4812. #asksarah #cancerresources
-
Sarah Cannon Docs
@SarahCannonDocs
If you notice that something isn't right, always consult your physician. Read more about risk factors, signs, and symptoms of esophageal cancer on our Sarah Cannon Expert Blog here: geo-blocked-site.azurewebsites.net.
#esophagealcancer -
Sarah Cannon Docs
@SarahCannonDocs
We are sharing five things to know about testicular cancer on our Sarah Cannon Expert Blog. Read more here: geo-blocked-site.azurewebsites.net.
#testicularcancer #testicularcancerawareness -
Sarah Cannon Docs
@SarahCannonDocs
Physician-in-Chief of Blood Cancers @BldCancerDoc wraps up #tandem22 by recognizing the people who make the Sarah Cannon team so strong. Who is one person you are grateful to work alongside?
-
Sarah Cannon Docs
@SarahCannonDocs
We have phenomenal presenters closing out #tandem22 today. Betsy Blunk, BSN, RN, CHTC, BMTCN, and Jesse Jawanda, MPH, MBA, will join a panel discussion at 10:55 am CT and Jesús Berdeja, MD will present at 12:00 pm. You won’t want to miss this exciting research!
-
Sarah Cannon Docs
@SarahCannonDocs
The extensive work that our lab professionals conduct is a key component to advancing science and transforming care for patients everywhere. Thank you to lab professionals everywhere! #ascplabweek22
-
Sarah Cannon Docs
@SarahCannonDocs
Want to learn more from our experts at #tandem22? Find their abstracts in this evening's poster sessions:
image.news.sarahcannon.com/lib/fe5d15707c62007d7d12/m/2/9… -
Sarah Cannon Docs
@SarahCannonDocs
Join us today with Sarah Cannon Transplant and Cellular Therapy team members Sara Meadors, MBA, RN, @TracyD60048569, BA MBA, RN, CPHQ, FNAHQ and Sarah Hatley, RN, as they take the stage to present at #tandem22.
-
Sarah Cannon Docs
@SarahCannonDocs
Congratulations to Tonya Cox, this year’s recipient of the ASTCT 2022 Nursing Clinical Excellence Award. She is also celebrating her 9 year anniversary with Sarah Cannon during this years #tandem22. Thank you for your inspiring leadership and dedication to our patients!
-
Sarah Cannon Docs reposted
Sharyn Foster
@SharynMFoster
High-dose chemotherapy & ASCT vs CAR-T? case discussion @TCTConference by Paul Shaugnhessy and Luciano Costa. If you missed it @gotoPER for the full presentation @End_myeloma @PaulS1594 @SarahCannonDocs @ONealCancerUAB
-
Sarah Cannon Docs reposted
OncLive.com
@OncLive
WATCH: Experts use an illustrative clinical case to highlight best practices in sequencing therapy for MCL and discuss novel combination strategies under investigation. @MDAndersonNews @ClevelandClinic @DanaFarber @SarahCannonDocs @MoffittNews #lymsm www.onclive.com/view/optimizing-mcl-management-sequencing…
-
Sarah Cannon Docs reposted
Skip Burris, MD
@BurrisSkip
Proud of what this basket trial has revealed @SarahCannonDocs @BandVsCancer
Mike Thompson, MD, PhD, FASCO
@mtmdphd
Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study [Jul 30, 2021] @JavleMilind et al. @BurrisSkip @TheLancetOncol www.thelancet.com/journals/lanonc/article/PIIS1470-2045(2… #nct02091141 #precisionmedicine #hpbcsm
-
Sarah Cannon Docs
@SarahCannonDocs
Today's #tandem22 Meetings start now. Join us for presentations from Dr. Paul Shaughnessy and Misty Evans at 7 am and 11:30 am CT, today. For more details about where you can find our experts at this year’s meeting click here:
image.news.sarahcannon.com/lib/fe5d15707c62007d7d12/m/2/9… -
Sarah Cannon Docs
@SarahCannonDocs
This weekend we celebrate the 10-year anniversary of the Sarah Cannon Transplant and Cellular Therapy Network! Since our inception, we’ve performed 16,000+ transplants and much more. We are so proud of how far we have come and the direction we are going. #tandem22
-
Sarah Cannon Docs
@SarahCannonDocs
The treatment for any person may depend on a number of factors including the location, type of cancer, stage of cancer, as well as a patient's overall health. Learn more about common treatment options for head and neck cancer here: geo-blocked-site.azurewebsites.net.
-
Sarah Cannon Docs
@SarahCannonDocs
We are excited to be a part of #tandem22. Join us for presentations from Sarah Cannon Transplant and Cellular Therapy leaders, Jacklyn Stent, Misty Evans, and Annette Chewning, today in a series of presentations. image.news.sarahcannon.com/lib/fe5d15707c62007d7d12/m/2/9…
-
Sarah Cannon Docs
@SarahCannonDocs
If you have questions about cancer, we can help! Nurses are standing by to answer your questions and get you connected with the right resources. Call now: (844)482-4812.
#asksarah #cancerresources -
Sarah Cannon Docs
@SarahCannonDocs
Doris, a former teacher, has battled cancer four times since retiring. Read her journey of how a powerful immune therapy clinical trial helped her achieve remission here: geo-blocked-site.azurewebsites.net.
-
Sarah Cannon Docs
@SarahCannonDocs
While there are no current recommendations regarding screening for esophageal cancer, those at higher risk are often watched more closely. #esophagealcancer #esophagealcancerawareness
-
Sarah Cannon Docs
@SarahCannonDocs
.@MLJohnsonMD2 chairs, “Not Just Another irAE: Identification And Management of Immunotoxicities of Bispecifics and CAR-T in CAR T and BiTE: Finally Ready for Solid Tumors?!” Find your way to #aacr22 Theater B to learn about the latest in #carttherapy.
-
Sarah Cannon Docs
@SarahCannonDocs
Do you have questions about cancer? Call askSARAH, our helpline where specially-trained nurses are ready to help you with your questions. Call now: (844)482-4812.
#asksarah #cancerresources -
Sarah Cannon Docs
@SarahCannonDocs
If you missed @DavidRSpigel's morning session, be sure to stop by his poster on, “Phase I Study of MT-6402, A Novel Engineered Toxin Body (ETB) Targeting PD-L1, In Patients With PD-L1 Expressing Advanced Solid Tumors,” this afternoon at #aacr22.
-
Sarah Cannon Docs
@SarahCannonDocs
Friendly reminder to stop avoiding colonoscopies! We recommend screening start as early as 45 years old, and people with known risk factors should talk to their doctor about earlier or additional screenings. #coloncancer #cancerscreening
-
Sarah Cannon Docs
@SarahCannonDocs
Our CSO, @DavidRSpigel delivers #aacr22 poster presentation, “A Study Evaluating Targeted Therapies In Participants Who Have Advanced Solid Tumors With Genomic Alterations Or Protein Expression Patterns Predictive Of Response (MyTACTIC).” Visit section 34 to learn more now!
-
Sarah Cannon Docs
@SarahCannonDocs
.@MeredithMcKean, takes the stage at #aacr22 to present, “BT8009-100 Phase I/II Study Of Novel Bi-Cyclic Peptide And MMAE Conjugate BT8009 In Patients With Advanced Malignancies Associated With Nectin-4 Expression” be sure to join her session today from 3-5 p.m.
-
Sarah Cannon Docs
@SarahCannonDocs
Tomorrow, Kathleen Moore, MD, Director of Drug Development for Sarah Cannon Research Institute at the #stephensoncancercenter, will chair Clinical Trials Targeting The DNA Damage Response And KRAS be sure to stop in at 3 p.m., Great Hall AD. #aacr22
-
Sarah Cannon Docs
@SarahCannonDocs
Registered for AACR and looking for an informative e-poster? Search for Dr. Manish Patel’s, on “A Pharmacodynamic Platform Using Liquid Biopsy To Support Dose Selection For The ATR Inhibitor ART0380 (IACS-030380),” now!
-
Sarah Cannon Docs
@SarahCannonDocs
Happy World Health Day! Make your health a priority and use the below tips as your guide to stay healthy during and after cancer treatment. 🌍🌿 #worldhealthday
-
Sarah Cannon Docs
@SarahCannonDocs
You are not alone. We encourage you to lean on those around you for support as you walk through your cancer journey. You can read Barb's story, as well as other Sarah Cannon patient stories here: geo-blocked-site.azurewebsites.net.💙
-
Sarah Cannon Docs
@SarahCannonDocs
If you have questions about cancer, we can help! Nurses are standing by to answer your questions and get you connected with the right resources. Call now: (844)482-4812.
#asksarah #cancerresources -
Sarah Cannon Docs
@SarahCannonDocs
This month is a time to recognize and raise awareness for esophageal, head & neck, and testicular cancer. All month long, we will be sharing helpful information about these types of cancer.
Read more about risk factors, symptoms, treatment and more: sarahcannon.com/blog/. -
Sarah Cannon Docs
@SarahCannonDocs
Meet high school baseball star, Brady, who was diagnosed with acute myeloid leukemia (AML) after receiving the results of a routine lab test. Fast forward to his 17th birthday when an anonymous donor gave him the gift of life. Read his story here: geo-blocked-site.azurewebsites.net.
-
Sarah Cannon Docs
@SarahCannonDocs
We are incredibly grateful for our doctors’ dedication to our patients, colleagues and mission. Thank you for all you do! #doctorsday
-
Sarah Cannon Docs
@SarahCannonDocs
An in depth look into the realities of Sickle Cell Disease, as well as a new clinical trial conducted by Dr. Frangoul. Thank you to The @NewYorker for sharing this inspiring story! www.newyorker.com/science/annals-of-medicine/are-we-about…
-
Sarah Cannon Docs
@SarahCannonDocs
Visit the Sarah Cannon Expert Blog to learn more about symptoms and risk factors of Kidney Cancer here: geo-blocked-site.azurewebsites.net.
#kidneycancer #kidneycancerawareness -
Sarah Cannon Docs
@SarahCannonDocs
Myeloma is one of the three most common types of blood cancer. This Multiple Myeloma Awareness Month, learn about how it develops, as well as the signs and symptoms to look for. sarahcannon.com/blog/entry/what-is-myeloma-
-
Sarah Cannon Docs
@SarahCannonDocs
Do you have questions about cancer? Call askSARAH, our helpline where specially-trained nurses are ready to help you with your questions. Call now: (844)482-4812. #asksarah #cancerresources
-
Sarah Cannon Docs
@SarahCannonDocs
Your cancer care team is made up of a group of people specialized in different aspects of your cancer experience. Learn more about this journey, as well as tips for working with your cancer care team here: geo-blocked-site.azurewebsites.net.
-
Sarah Cannon Docs
@SarahCannonDocs
You will have numerous people involved in your care - from the time you are diagnosed until after your treatment ends. We encourage you to get to know your care team. Here are a few tips for working with your team: geo-blocked-site.azurewebsites.net.
-
Sarah Cannon Docs
@SarahCannonDocs
Though colonoscopies are the gold standard for colorectal cancer screening, there are a number of patient-friendly screening options that have become available for colon cancers. Learn more below: sarahcannon.com/blog/entry/preventing-colon-cancer-making…
-
Sarah Cannon Docs
@SarahCannonDocs
If you have questions about cancer, we can help! Nurses are standing by to answer your questions and get you connected with the right resources. Call now: (844)482-4812. #asksarah #cancerresources
-
Sarah Cannon Docs
@SarahCannonDocs
Fighting cancer is truly a team effort, and cannot be done alone. You will have numerous people involved in your care - from the time you are diagnosed until after your treatment ends. Read more below. sarahcannon.com/blog/entry/get-to-know-your-cancer-care-t…
-
Sarah Cannon Docs
@SarahCannonDocs
Happy International Women's Day to women all over the world! We are especially grateful to have a network of powerful women leaders at Sarah Cannon who go above and beyond for people facing cancer. #iwd #iwd22
-
Sarah Cannon Docs
@SarahCannonDocs
Skin cancer screening recommendations are below! Be sure to conduct regular self-exams and schedule skin exams with your doctor, if you are 20 years of age or older. #cancerprevention #cancerscreening
-
Sarah Cannon Docs reposted
Melissa L. Johnson
@MLJohnsonMD2
Dr Meredith Pelster summarizes DESTINY-Gastric01 (9% CR!), DESTINY-CRC01 (24% but not in HER2-low), Adagrasib+Cetuximab (ORR doubled with combo!!) HUMONGOUS amount of data. @SarahCannonDocs
-
Sarah Cannon Docs reposted
Melissa L. Johnson
@MLJohnsonMD2
New leader Meredith Pelster reviews the highs and lows of IO in GI malignancies. No luck in CRC but neoadj rectal PD1 in st2/3 MMRd is “potentially really exciting “!! @SarahCannonDocs
-
Sarah Cannon Docs
@SarahCannonDocs
Andy McKenzie, PhD lends a program overview and explains precision oncology updates and outlooks at #scsm22.
-
Sarah Cannon Docs reposted
Meredith McKean MD, MPH
@MeredithMcKean
Dr. Garmezy rocking his first Sarah Cannon annual meeting presentation this morning- exciting GU research updates @BGarmezy #scsm22
-
Sarah Cannon Docs reposted
Melissa L. Johnson
@MLJohnsonMD2
@MeredithMcKean delivering fantastic talk about advances in Cutaneous and Uveal Melanoma @SarahCannonDocs Annual meeting.
-
Sarah Cannon Docs
@SarahCannonDocs
.@MLJohnsonMD2 delivers an engaging presentation on “The Bleeding Edge of Lung Cancer Therapeutics Beyond CPIs” #scam22
-
Sarah Cannon Docs
@SarahCannonDocs
Dr. Garmezy presents, “The Future of GU Oncology: Novel Targets outside of the NGS Report,” in the second round of today’s #scsm22 breakout sessions.
-
Sarah Cannon Docs
@SarahCannonDocs
In her session this morning, @MeredithMcKean speaks to advances in the field while sharing her #scsm22 presentation, “Eye on the Prize: Progress in Cutaneous and Uveal Melanoma.”
-
Sarah Cannon Docs
@SarahCannonDocs
This morning, @ErikaHamilton9 is kicking off the #scsm22 breakout sessions with a presentation on, “Equity not Equality: Right Sizing Treatment for Breast Cancer in 2022”.
-
Sarah Cannon Docs
@SarahCannonDocs
Sarah Cannon Institute at @HCAVirginia is the first and only local hospital in southwest Virginia to offer high-dose rate (HDR) prostate brachytherapy. Learn more about this convenient and precise form of radiation therapy to treat prostate cancer below: www.wdbj7.com/2022/02/24/lewisgale-pulaski-first-southwes…
-
Sarah Cannon Docs
@SarahCannonDocs
.@DavidRSpigel closes out day one of our annual conference. Today, leaders and guest speakers premiered educational and scientific updates for Sarah Cannon’s community-based research network. We can’t wait to see what tomorrow has in store. #scsm22
-
Sarah Cannon Docs
@SarahCannonDocs
Research updates so nice, we had to attend them twice! Drs. @MLJohnsonMD2 and @MeredithMcKean share their respective research previously presented at ESMO and AACR-NCI-EORTC #scsm22
-
Sarah Cannon Docs
@SarahCannonDocs
Head of Cancer Immunotherapy Discovery at Roche Innovation Center Zurich, pRED, Pablo Umaña, PhD, joined us this afternoon to close out the keynote #scsm22 session with a presentation on immune therapy discovery.
-
Sarah Cannon Docs reposted
Rafeh Naqash, MD, FASCO
@thenasheffect
Phenomenal lecture at #phase1retreat @SarahCannonDocs by #levigaraway @genentech on using “ Bayesian” approach on selecting novel combination therapies
@BurrisSkip @DavidRSpigel @MLJohnsonMD2 @ErikaHamilton9 -
Sarah Cannon Docs
@SarahCannonDocs
Thank you, Dr. Levi Garraway, Executive Vice President, Head of Global Product Development & Chief Medical Officer at Roche and Genentech, for delivering an insightful keynote address on Targeted Therapy Discovery. #scsm22
-
Sarah Cannon Docs
@SarahCannonDocs
Welcoming attendees, Sarah Cannon CEO, @deehubie , kicks off our annual meeting alongside Chief Medical Officer, @BurrisSkip #scsm22
-
Sarah Cannon Docs
@SarahCannonDocs
Sarah Cannon’s 25th Annual Scientific Meeting is finally here! This weekend, research leaders from across our organization gather to discuss the latest oncology study advancements and insights. #scsm22
-
Sarah Cannon Docs
@SarahCannonDocs
Meet Multiple Myeloma Cancer Warrior and patient, Roger, a 55-year-old husband and father whose life mission was challenged when he began experiencing back pain. Read his full journey here: geo-blocked-site.azurewebsites.net.
-
Sarah Cannon Docs
@SarahCannonDocs
HiberCell has initiated a Phase 1a/b clinical trial of HC-7366 for the treatment of patients with advanced solid tumors with the first clinical trial site being with Sarah Cannon Research Institute at @TNoncology in Nashville, Tennessee. Read more here: www.globenewswire.com/news-release/2022/02/24/2391371/0/e….
-
Sarah Cannon Docs
@SarahCannonDocs
Sarah Cannon patient, Jimi Olaghere, says he feels like he’s been "reborn" after a pioneering new treatment for sickle cell disease. Listen to @BBCSounds as Jimi and Dr. Frangoul talk about what this could mean for people with sickle cell around the world. www.bbc.co.uk/sounds/play/m0013rbq
-
Sarah Cannon Docs
@SarahCannonDocs
This month is a time to recognize and raise awareness for Kidney Cancer, Colon Cancer, and Multiple Myeloma. All month long, we will be sharing helpful info about these types of cancer. Read more about risk factors, symptoms, treatment and more! geo-blocked-site.azurewebsites.net
-
Sarah Cannon Docs
@SarahCannonDocs
Meet Kate who was diagnosed with stage four Hodgkin lymphoma. Through her journey, she has developed a newfound dream of becoming a certified child life specialist so that she can help children in the same way that she was supported. Read her journey:geo-blocked-site.azurewebsites.net.
-
Sarah Cannon Docs
@SarahCannonDocs
This National Cancer Prevention Month, we encourage you to speak with your physician about a screening schedule that is tailored for you. Remember, early detection SAVES lives.
#cancerprevention #cancerscreening -
Sarah Cannon Docs
@SarahCannonDocs
If you have questions about cancer, we can help! Nurses are standing by to answer your questions and get you connected with the right resources. Call now: (844)482-4812. #asksarah #cancerresources
-
Sarah Cannon Docs
@SarahCannonDocs
Jennifer Smith was alongside her husband, Ryan, as he was diagnosed & treated for Acute Leukemia at Sarah Cannon Transplant & Cellular Therapy Program at @StDavidsSouth. She was so inspired by the exceptional care he received that she decided to go to nursing school.
(1/2)This media couldn't be displayed. See it on the original post.
Sarah Cannon Docs
@SarahCannonDocs
Five years later, Jennifer now works on the exact unit where her husband received his stem cell transplant and beat the disease. Read Ryan's full story here: geo-blocked-site.azurewebsites.net. #fightingcancertogether
(2/2) -
Sarah Cannon Docs
@SarahCannonDocs
When 9-year-old Sawyer was diagnosed with acute myeloid leukemia (AML), his parents were told that he only had a 20% chance of surviving his cancer, but Sawyer’s story doesn’t end there. Read his full story here: geo-blocked-site.azurewebsites.net.
-
Sarah Cannon Docs
@SarahCannonDocs
Breast cancer screening recommendations! If you are 20 years of age or older, this is for you. Prioritize your health and speak with your physician about a screening schedule that is right for you.💗 #cancerprevention #cancerscreening
-
Sarah Cannon Docs
@SarahCannonDocs
Do you have questions about cancer? Call askSARAH, our helpline where specially-trained nurses are ready to help you with your questions. Call now: (844)482-4812. #asksarah #cancerresources
-
Sarah Cannon Docs
@SarahCannonDocs
Today we are sharing Cancer Warrior Jeani's fight against myeloma and her positive experience with Nevada's first blood and marrow transplant program. Read more here: geo-blocked-site.azurewebsites.net.
-
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
New definition of clinical utility here:
1) ⬆️ outcomes
2) system and population benefits
3) pt access to prevention and tx strategies, identification of trials
4) opportunities for shared decision making
@OncoAlert #bcsm #gyncsm @SarahCannonDocs -
Sarah Cannon Docs reposted
HCA HealthONE
@HCAHealthONE
This World Cancer Day join us and @SarahCannonDocs as we battle against cancer with our patients. A support system is important for our patients, and we are here to help them throughout their journey.
#closethegap #fightingcancertogether -
Sarah Cannon Docs
@SarahCannonDocs
President @JoeBiden's (@POTUS) renewed focus on the Cancer Moonshot is welcome news! It's imperative that we build on the foundation created by the Cancer Moonshot, & commit to achieve these ambitious goals, together. Read our full statement here: sarahcannon.com/about/newsroom/2022-cancer-moonshot-re-la….
-
Sarah Cannon Docs
@SarahCannonDocs
Today is World Cancer Day! We’re joining organizations across the country and around the world who are working together to close the care gap. And at Sarah Cannon, we’re closing the gap by providing world-class cancer care close to home. 💙 #closethecaregap #worldcancerday
-
Sarah Cannon Docs
@SarahCannonDocs
It's National Cancer Prevention Month! This is your reminder to get screened because, early detection SAVES lives. #cancerprevention #cancerscreening
-
Sarah Cannon Docs
@SarahCannonDocs
If you have questions about cancer, we can help! Nurses are standing by to answer your questions and get you connected with the right resources. Call now: (844)482-4812.
#asksarah #cancerresources -
Sarah Cannon Docs
@SarahCannonDocs
By bringing together a network of globally-recognized cancer experts, we are collaborating & sharing best practices that address every aspect of the cancer journey, from screening & diagnosis, through treatment & survivorship. Find communities we serve: sarahcannon.com/about/index.dot.
-
Sarah Cannon Docs
@SarahCannonDocs
We're the lucky ones! Thank you for sharing your greatest gift of 2021, Anita. We are thankful for our Data Management teams across the network.
-
Sarah Cannon Docs
@SarahCannonDocs
Do you have questions about cancer? Call askSARAH, our helpline where specially-trained nurses are ready to help you with your questions. Call now: (844)482-4812.
#asksarah #cancerresources -
Sarah Cannon Docs
@SarahCannonDocs
January is Cervical Cancer Awareness Month—a time to learn about the disease and the importance of early detection as well as get screened. Read more below! #cervicalcancerawareness #cervicalcancer sarahcannon.com/blog/entry/what-to-know-about-cervical-ca…
-
Sarah Cannon Docs
@SarahCannonDocs
Sarah Cannon colleague, Kim Long, is sharing one of her greatest accomplishments of 2021. Great job, Kim! That is truly #caringlikefamily.
-
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
Did you know that @RedCross is super low on 🩸products including red cells and platelets?
Today, I donated platelets. Takes a little time, but otherwise no worse for the wear. Easy way to help your community- including those facing cancer.
@SarahCannonDocs @OncoAlert #bcsm -
Sarah Cannon Docs
@SarahCannonDocs
Here is your sign to become a blood donor this National Blood Donor Month and help those facing cancer. ⬇️
For blood donor requirements, please visit the Sarah Cannon Expert Blog here: geo-blocked-site.azurewebsites.net
#nationalblooddonormonth #giveblood #fightingcancertogether -
Sarah Cannon Docs
@SarahCannonDocs
This is GOOD news! Get to know the top 5 facts about cervical cancer, all designed to help reduce your risk of developing the disease here: geo-blocked-site.azurewebsites.net.
#cervicalcancerawareness #cervicalcancer -
Sarah Cannon Docs
@SarahCannonDocs
Bringing the most innovative medical minds together with the most passionate caregivers in their communities, we are transforming care and personalizing treatment.
Sarah Cannon Docs
@SarahCannonDocs
Sarah Cannon offers integrated cancer services, including oncology-trained nurse navigators, to patients from diagnosis through survivorship. Learn more at sarahcannon.com. 💙✨
#fightingcancertogether -
Sarah Cannon Docs reposted
Channing Dudley
@Chandudley11
Strategy Session @COBloodCancer @sarahcannon was energized and encouraging as this group never shies away from speaking up about better ways to care for our patients! Looking for to 2022 with this crew!
-
Sarah Cannon Docs
@SarahCannonDocs
If you have questions about cancer, we can help! Nurses are standing by to answer your questions and get you connected with the right resources. Call now: (844)482-4812.
#asksarah #cancerresources -
Sarah Cannon Docs reposted
OncLive SOSS
@OncLiveSOSS
.@DavidRSpigel, of @SarahCannonDocs discussed the focus of each presentation, which centered on immunotherapy vs chemoimmunotherapy in the frontline metastatic setting, the surgical perspective of treatment in early-stage NSCLC, and more #lcsm www.onclive.com/view/immunotherapy-continues-to-touch-all…
-
Sarah Cannon Docs reposted
OncLive.com
@OncLive
T-Charge minimizes the ex vivo culture time and reduces the manufacturing process time to less than 2 days. @SarahCannonDocs #lymsm www.onclive.com/view/ytb323-shows-encouraging-efficacy-in…
-
Sarah Cannon Docs
@SarahCannonDocs
Remembering the timeless wisdom of Dr. Martin Luther King, Jr. as we continue fighting cancer together each and every day. #mlkday #fightingcancertogether
-
Sarah Cannon Docs
@SarahCannonDocs
We are so grateful to have colleagues who care like family. Amazing job Cathy, Teresa, and the entire East Florida Division navigation team. #carelikefamily
-
Sarah Cannon Docs
@SarahCannonDocs
Sarah Cannon has been a clinical trial leader in the majority of approved cancer therapies over the last 10 years. Our recognized physician leadership is at the forefront of shaping new standards of cancer care based upon the latest research. 💙✨ #fightingcancertogether
-
Sarah Cannon Docs reposted
Erika Hamilton, MD, FASCO
@ErikaHamilton9
Reviewing 2021 summary today @SarahCannonDocs.
I'm left feeling grateful and humbled for our clinical trial volunteers 👩🧑🏻🦱. True heroes for progress.
Despite the 😷 🦠 , so much progress made- both at an individual pt level and as a #bcsm community.
Here's to 2022 🥂! -
Sarah Cannon Docs reposted
OncoAlert
@OncoAlert
Our amazing @OncoAlert 🚨faculty
@ErikaHamilton9 of @SarahCannonDocs
Presenting on the management of HER2+ MBC in 2021 at the #oncoalertcolloquium #breastcancer #bcsm
www.youtube.com/watch?v=Pd_V_4WzLQw -
Sarah Cannon Docs
@SarahCannonDocs
Do you have questions about cancer? Call askSARAH, our helpline where specially-trained nurses are ready to help you with your questions. Call now: (844)482-4812. #asksarah #cancerresources
-
Sarah Cannon Docs
@SarahCannonDocs
"We depend on the good will from the community to donate blood so that it's available for cancer patients who need it." - Robert Talley, hematologist/oncologist at Sarah Cannon Cancer Institute at @HCAMidwest
Read more here: geo-blocked-site.azurewebsites.net.
#nationalblooddonormonth -
Sarah Cannon Docs
@SarahCannonDocs
In an interview with @BNCNews Dr. @HFrangoul, discusses a break-through clinical trial & treatment for sickle-cell that has changed the life of patient, Victoria Gray, and what doctors are hopeful will lead to revolutionary change for thousands of others.
www.youtube.com/watch?v=ubSdL0NZ9gw -
Sarah Cannon Docs
@SarahCannonDocs
"Cancer research is the foundation of trying to move the field forward & find new therapies for patients." Dr. @DavidRSpigel, Chief Scientific Officer at the Sarah Cannon Research Institute, joins @iHeartRadio to discuss advancements in cancer research. www.iheart.com/podcast/1248-iheart-communities-public-685…
-
Sarah Cannon Docs
@SarahCannonDocs
People who live with cancer are at the heart of every decision we make. Find out more about how we are fighting cancer together at sarahcannon.com. 💙✨ #fightingcancertogether
-
Sarah Cannon Docs reposted
VJ Oncology
@VJOncology
@MeredithMcKean of Sarah Cannon Research Institute talks on DRAGON: SRK-181 alone or in combination with anti-PD-L1 treatment in patients with advanced solid tumors
Watch: 👉www.vjoncology.com/video/veprwfyydpm-dragon-srk-181-alone…👈
@sitcancer #sitc21 #immunoonc -
Sarah Cannon Docs reposted
OncLive.com
@OncLive
Shifting Regulatory Approval Pathway Is a Top Takeaway of 2021 in Lung Cancer @DavidRSpigel @SarahCannonDocs #lcsm #oncology www.onclive.com/view/shifting-regulatory-approval-pathway…
-
Sarah Cannon Docs
@SarahCannonDocs
Dr. @DavidRSpigel, Chief Scientific Officer at the Sarah Cannon Research Institute, joined @NBCLX to discuss advances in cancer early detection, advances in deciphering cancer genetics, and more top accomplishments for cancer research in 2021. Watch below! www.youtube.com/watch?v=ywcB2DdOF-A
-
Sarah Cannon Docs
@SarahCannonDocs
We are grateful for our admin colleagues! Thank you for sharing, Hannah. 👏
-
Sarah Cannon Docs
@SarahCannonDocs
If you have questions about cancer, we can help! Nurses are standing by to answer your questions and get you connected with the right resources. Call now: (844)482-4812.
#asksarah #cancerresources -
Sarah Cannon Docs
@SarahCannonDocs
Greatest gift of 2021 as told by Sarah Cannon colleague, Bethany Tidwell! Let's hear it for the late phase nursing team. 👏
-
Sarah Cannon Docs
@SarahCannonDocs
Happy New Year! We are wishing you all a wonderful 2022, as we continue fighting cancer together. 💙✨
#happynewyear #fightingcancertogether -
Sarah Cannon Docs
@SarahCannonDocs
After chronicling Sarah Cannon Research Institute and Children's Hospital at @TriStarHealth's patient, Victoria’s clinical trial experience, @NPR lends another update on her @CRISPRTX sickle cell disease journey. Close out 2021 with some good news below!
www.npr.org/sections/health-shots/2021/12/31/1067400512/f… -
Sarah Cannon Docs
@SarahCannonDocs
As 2021 comes to a close, we want to know your greatest gift of the year! Comment below and let's encourage each other this #newyearseve. ✨🎁
-
Sarah Cannon Docs
@SarahCannonDocs
Thank you, Shonna, for sharing your greatest gift of 2021 and going above and beyond for those facing cancer. 💙 @HCAHouston
-
Sarah Cannon Docs
@SarahCannonDocs
Do you have questions about cancer? Call askSARAH, our helpline where specially-trained nurses are ready to help you with your questions. Call now: (844)482-4812.
#asksarah #cancerresources -
Sarah Cannon Docs
@SarahCannonDocs
We love our ITG team! Thank you for going above and beyond in 2021, and making it possible for us to further our mission of fighting cancer together.
-
Sarah Cannon Docs
@SarahCannonDocs
Happy holidays from everyone at Sarah Cannon! ❄️
-
Sarah Cannon Docs
@SarahCannonDocs
This is what it's about -- bringing cancer care close to home! Thank you for sharing, Tonya! 💙
-
Sarah Cannon Docs
@SarahCannonDocs
Be sure to stay connected with your personal support network, and if you are alone or feel alone during the holidays, please call someone. You and your spouse/partner can get free emotional support from many cancer organizations. Learn more here: geo-blocked-site.azurewebsites.net. 💙
-
Sarah Cannon Docs
@SarahCannonDocs
The wonderful, Elizabeth McKiernan Taylor, put together @TheSacred12 care packages for those facing cancer this holiday season. We’re grateful for her & the volunteers that helped spread cheer by handing them out in our Nashville drug development unit yesterday. 💙#carelikefamily
-
Sarah Cannon Docs
@SarahCannonDocs
Sarah Cannon's @MLJohnsonMD2 sat down with @VerastemOncolog to share her path to oncology and her thoughts on biomarker testing. Watch the full interview below.
Verastem Oncology
@VerastemOncolog
Hear from Melissa Johnson, MD of @SarahCannonDocs, on why she chose medical oncology, and how #biomarkertesting has impacted how she approaches treating patients with #lungcancer, including those with specific mutations such as #kras #g12v. #nsclc #lcsm
-
Sarah Cannon Docs
@SarahCannonDocs
We asked Sarah Cannon colleagues to share their greatest gifts of 2021, and Gretchen Mitchell responded by nominating a fellow colleague who goes above and beyond for her team. Way to go Carrie! ✨
-
Sarah Cannon Docs
@SarahCannonDocs
If you have questions about cancer, we can help! Nurses are standing by to answer your questions and get you connected with the right resources. Call now: (844)482-4812. #asksarah #cancerresources
-
Sarah Cannon Docs
@SarahCannonDocs
We understand the holidays are not always joyous for someone who is dealing with health problems. Don’t ignore your emotional health; there’s no shame in asking for extra support to help you or your family cope with feelings of sadness, worry and anxiety. 💙❄️
-
Sarah Cannon Docs
@SarahCannonDocs
Do you have questions about cancer? Call askSARAH, our helpline where specially-trained nurses are ready to help you with your questions. Call now: (844)482-4812.
#asksarah #cancerresources -
Sarah Cannon Docs
@SarahCannonDocs
While everyone is experiencing the impact of COVID-19, it can be overwhelming to figure out how to help people you love during the holiday, especially family and friends who are immunocompromised. Learn more about how to support those facing cancer below: sarahcannon.com/blog/entry/how-to-support-someone-facing-…
-
Sarah Cannon Docs
@SarahCannonDocs
In just a few minutes, Dr. Ian Flinn will deliver an oral presentation as part of the “Cellular Immunotherapies: Cellular Therapies for Low and High Grade Lymphomas” #ash21 session. Be sure to catch these research updates today at 2:45pm EST.
-
Sarah Cannon Docs
@SarahCannonDocs
Congratulations Dr. Tony Goldstone, this year’s recipient of the #ash21 Mentor Award! Dr. Goldstone has not only been a mentor to many, but a vital contributor to our Sarah Cannon Transplant and Cellular Therapy Network, especially with our programs in the UK. 👏👏👏
-
Sarah Cannon Docs
@SarahCannonDocs
Today’s #ash21 poster sessions are about to begin. Stop by abstracts 2455 and 2609 to see what research our experts are presenting tonight.
-
Sarah Cannon Docs
@SarahCannonDocs
At 2pm EST, Drs Flinn and Tees co-authored research will be presented in an #ash21 oral presentation. Be sure to tune in and attend the session to hear the latest research. #fightingcancertogether
-
Sarah Cannon Docs
@SarahCannonDocs
.@BldCancerDoc, @CarlosBachier, and @BillupsRocky stopped by our #ash21 booth this morning. Learn more about about our Transplant and Cellular Therapy leadership team and program sarahcannon.com/service/our-leadership
-
Sarah Cannon Docs
@SarahCannonDocs
It’s not too late! There is still time in tonight’s #ash21 poster session to review research presented by our experts.
-
Sarah Cannon Docs
@SarahCannonDocs
Join Sarah Cannon experts Dr. Ian Flinn, @BerdejaJesus and @CarlosBachier in this evening’s poster sessions kicking off at 5:30pm EST #ash21
-
Sarah Cannon Docs
@SarahCannonDocs
Come visit us at booth #1117. Learn more about the Sarah Cannon Transplant and Cellular Therapy Network and how we’re advancing science and transforming care. #ash21
-
Sarah Cannon Docs
@SarahCannonDocs
HAPPENING NOW! @BldCancerDoc’s live Q&A on “How We Can Ensure Everyone Who Needs a Transplant Can Get One”. Learn more: ash.confex.com/ash/2021/webprogram/Session20406.html
-
Sarah Cannon Docs
@SarahCannonDocs
After 10 years of experience advancing science and transforming care, we always look forward to sharing our research. Be sure to follow along at #ash21 for research updates presented by our experts from across our network!
-
Sarah Cannon Docs reposted
-
Sarah Cannon Docs
@SarahCannonDocs
.@ErikaHamilton9 takes the #sabcs21 stage. Don’t miss hearing from our breast cancer and gynecologic cancer expert!
-
Sarah Cannon Docs
@SarahCannonDocs
Want a view from the trenches? Join @ErikaHamilton9 tonight as she participates in #sabcs21 panel session, "View from the Trenches: What will You do on Monday Morning?".
-
Sarah Cannon Docs
@SarahCannonDocs
Tonight be sure to stop by, @ErikaHamilton9 shares "Updated analysis of MCLA-128 (zenocutuzumab), trastuzumab, and vinorelbine in patients (pts) with HER2 positive/amplified (HER2+) metastatic breast cancer (MBC) who progressed on previous anti-HER2 ADCs" in a #sabcs21 poster.
-
Sarah Cannon Docs reposted
OncLive SOSS
@OncLiveSOSS
Melissa L. Johnson, MD, of @SarahCannonDocs, discusses the promise of DS-7300 in small cell lung cancer and other advanced solid tumors #lcsm www.onclive.com/view/dr-johnson-on-the-promise-of-ds-7300…
-
Sarah Cannon Docs
@SarahCannonDocs
If you have questions about cancer, we can help! Nurses are standing by to answer your questions and get you connected with the right resources. Call now: (844)482-4812. #asksarah
-
Sarah Cannon Docs
@SarahCannonDocs
We have specially-trained nurses ready to help you with any cancer questions and who can get you connected with the right resources. Call us at (844)482-4814.
#asksarah #cancerresources -
Sarah Cannon Docs
@SarahCannonDocs
While there will be a doctor on call for medical problems during times when the office is closed, it is always good to be extra prepared when it comes to medications, especially during the holidays. ❄️
-
Sarah Cannon Docs
@SarahCannonDocs
The holidays can pose challenges no matter where you are on your cancer journey. Here are tips and resources that may help you navigate the season. 🎄❄️ sarahcannon.com/blog/entry/11-tips-for-the-holiday-season
-
Sarah Cannon Docs
@SarahCannonDocs
Do you have questions about cancer? Call askSARAH, our helpline where specially-trained nurses are ready to help you with your questions. Call now: (844)482-4812.
#asksarah #cancerresources -
Sarah Cannon Docs
@SarahCannonDocs
Holiday celebrations are usually centered around food, and since you may have different eating habits because of surgery or side effects from treatment, it's a good idea to communicate any dietary restrictions to your family or host ahead of time. 🍴✨
-
Sarah Cannon Docs
@SarahCannonDocs
People who live with cancer are at the heart of every decision we make. This Giving Tuesday, consider donating to the Sarah Cannon Fund support families facing the cancer journey. Find out more and donate at sarahcannon.com/donate. #givingtuesday #fightingcancertogether
-
Sarah Cannon Docs
@SarahCannonDocs
Remember your family member has just received news that has turned their world upside down too and there is grieving with that type of change. 💙
Sarah Cannon Docs
@SarahCannonDocs
Additional Tips:
🔹 Be aware that your parent may become frustrated and lash out at you. Try to remain calm and not react in anger.
🔹 Carve out some quality time together, even if for brief moments, to do something that you both enjoy.
#nationalfamilycaregiversmonth -
Sarah Cannon Docs
@SarahCannonDocs
Happy Thanksgiving! This year we are thankful for ALL healthcare heroes including nurses, doctors, caregivers who continue to go above and beyond to care like family. 🍁🍂
#happythanksgiving #carelikefamily -
Sarah Cannon Docs
@SarahCannonDocs
If you are looking for a sign to quit smoking, this is it! Quitting will help not only reduce your risk of developing lung cancer, but also benefit your health in many other ways too. geo-blocked-site.azurewebsites.net #lungcancer #lungcancerawareness
-
Sarah Cannon Docs
@SarahCannonDocs
If you have questions about cancer, we can help! Nurses are standing by to answer your questions and get you connected with the right resources. Call now: (844)482-4812. #asksarah
-
Sarah Cannon Docs
@SarahCannonDocs
Lung cancer is the second most common type of cancer & the leading cause of cancer death. Here are three things you should know to about lung cancer, and how to help prevent it. Learn more on the Sarah Cannon Expert Blog: geo-blocked-site.azurewebsites.net.
#lungcancer #lungcancerawareness -
Sarah Cannon Docs
@SarahCannonDocs
Internal radiation (also called brachytherapy) is used to treat different types of cancer by placing radioactive material inside or near the tumor to kill cancer cells and shrink the tumor. Learn more about this treatment on the Sarah Cannon Expert Blog: sarahcannon.com/blog/entry/what-is-internal-radiation-and…
-
Sarah Cannon Docs
@SarahCannonDocs
This is a very serious reality, and while it is very important to educate yourself about all of the risk factors associated with lung cancer, smoking is the main cause of lung cancer. Learn more here: geo-blocked-site.azurewebsites.net. #lungcancer #lungcancerawareness #lungcancerprevention
-
Sarah Cannon Docs
@SarahCannonDocs
Today is World Pancreatic Cancer Day. To better understand cancer of the pancreas, it is helpful to know a little more about the pancreas itself. Learn more: geo-blocked-site.azurewebsites.net. #pancreaticcancer #pancreaticcancerawareness
-
Sarah Cannon Docs reposted
Verastem Oncology
@VerastemOncolog
Melissa Johnson, MD of @SarahCannonDocs, shares what you should know if you or a loved one is diagnosed with non-small cell #lungcancer and #clinicaltrials like the #ramp202 study. #lungcancerawarenessmonth #lcam #lcsm #nsclc
-
Sarah Cannon Docs
@SarahCannonDocs
The young adult years are a time of life when a person is starting and growing their families and careers. It can be a lot to juggle. Here our a few tips to set you up for success!
#nationalfamilycaregiversmonthPost not available here, view on X
Sarah Cannon Docs
@SarahCannonDocs
🔹 If you share caregiver duties with other people, make a plan with them up front and update it as needed to make sure your parent’s needs are covered.
🔹 If you work, talk to your boss and HR department about taking time off to help your parent.
Sarah Cannon Docs
@SarahCannonDocs
🔹 Don’t neglect your own family if you have a spouse and children. You have to prioritize what’s most important and what can be done later or by someone else.
-
Sarah Cannon Docs
@SarahCannonDocs
Do you have questions about cancer? Call askSARAH, our helpline where specially-trained nurses are ready to help you with your questions. Call now: (844)482-4812.
#asksarah #cancerresources -
Sarah Cannon Docs
@SarahCannonDocs
Today is World Kindness Day! Share with us in the comments something kind someone did for you while you were fighting cancer or undergoing cancer treatment. 💙 #worldkindnessday #bekind
-
Sarah Cannon Docs
@SarahCannonDocs
Want to know more about pancreatic cancer? Here is what you need to know about the 11th most commonly diagnosed cancer: sarahcannon.com/blog/entry/what-you-should-know-about-pan…
-
Sarah Cannon Docs
@SarahCannonDocs
.@LewisGaleMed showcases bronchoscopy robot to the community this #lungcancerawarenessmonth.
#fightingcancertogether www.wdbj7.com/2021/11/10/lewisgale-medical-center-shows-o… -
Sarah Cannon Docs
@SarahCannonDocs
In honor of Veterans Day, we asked our Veteran colleagues how serving in the military has been instrumental in our mission to fight cancer. Today and every day, we honor those who serve. Thank you to our Veterans! 💙🇺🇸 #veteransday
-
Sarah Cannon Docs
@SarahCannonDocs
After being diagnosed with breast cancer & seeking treatment at Sarah Cannon Cancer Center, Sharla McCoy, veteran country music producer & McCoy & Associates CEO/owner, is cancer free and sharing the news with radio audiences across the country. Read more: www.allaccess.com/net-news/archive/story/212617/sharla-mc…
-
Sarah Cannon Docs
@SarahCannonDocs
Many caregivers are young adults, in their 20s and 30s, taking care of a parent with cancer. Caregiving during this time brings many of its own challenges, as the young adult may have more duties to juggle. #nationalfamilycaregiversmonth
-
Sarah Cannon Docs
@SarahCannonDocs
If you have questions about cancer, we can help! Nurses are standing by to answer your questions and get you connected with the right resources. Call now: (844)482-4812. #asksarah
-
Sarah Cannon Docs
@SarahCannonDocs
If you currently use tobacco products, speak with your care team about smoking cessation."It's never too late to quit smoking," says @MLJohnsonMD2, MD Associate Director Lung Cancer Research and Drug Development. #lungcancer #lungcancerawareness
-
Sarah Cannon Docs
@SarahCannonDocs
We know caregiving can be a tough. To get started on this journey, be sure to first learn about your parent's cancer type and how to care for them. Read about their cancer, treatment, and side effect management on the Sarah Cannon Expert Blog. sarahcannon.com/Blog
-
Sarah Cannon Docs
@SarahCannonDocs
.@ErikaHamilton9, MD, discusses the utility of CDK4/6 inhibitors in hormone receptor–positive, HER2-negative breast cancer. Watch below.
www.onclive.com/view/dr-hamilton-on-the-utility-of-cdk4-6… -
Sarah Cannon Docs
@SarahCannonDocs
.@BurrisSkip, III, MD, FASCO, FACP, discusses the integration of sacituzumab govitecan-hziy into the treatment landscape of metastatic triple-negative breast cancer. Watch below. www.onclive.com/view/dr-burris-on-the-integration-of-saci…
-
Sarah Cannon Docs
@SarahCannonDocs
This month is a time to recognize and raise awareness for Lung Cancer, Stomach Cancer, and Pancreatic Cancer. All month long, we will be sharing more information about these types of cancer. #lungcancer #stomachcancer #pancreaticcancer
-
Sarah Cannon Docs
@SarahCannonDocs
Thank you, @NashMedNews, for spotlighting our Sarah Cannon Transplant and Cellular Therapy Program at @TriStarHealth for its unique position to treat blood cancers and blood disorders and offer innovative treatment options right here in Nashville. issuu.com/graham-sanderspublishingllc/docs/nmn.aug-sept.2…
-
Sarah Cannon Docs
@SarahCannonDocs
With the increase in liver cancer incidence rates and death rates, it is important to educate yourself on risk factors for liver cancer, especially hepatitis. Learn more below. sarahcannon.com/blog/entry/what-you-should-know-about-liv…
-
Sarah Cannon Docs reposted
Verastem Oncology
@VerastemOncolog
This #lunghealthday, hear from Melissa Johnson, MD of @SarahCannonDocs, on the importance of #biomarkertesting in #nsclc to identify existing and emerging targeted therapies, including investigational VS-6766 for #kras mutant #nsclc in the enrolling #ramp202 study. #lcsm
-
Sarah Cannon Docs
@SarahCannonDocs
Watch as Dr. Ian Flinn discusses findings from the DUO trial and the effect of dose modifications on response to duvelisib #cll #sll
jnccn360.org/cll/videos/effect-of-dose-modifications-on-r… -
Sarah Cannon Docs
@SarahCannonDocs
@dave6408 looks forward to sharing the latest in immunotherapies and targeted therapies. Retweet and share with us what you’re excited to see @ASCO this weekend #asco19
-
Sarah Cannon Docs
@SarahCannonDocs
Important data released in Journal of Clinical Oncology led by Dr. Ian Flinn on ‘DYNAMO: A Phase II Study of Duvelisib (IPI-145) in Patients With Refractory Indolent Non-Hodgkin Lymphoma’. @VerastemOncolog Learn more about the advancements in research ascopubs.org/doi/full/10.1200/JCO.18.00915
-
Sarah Cannon Docs
@SarahCannonDocs
On this #doctorsday our CMO, @burrisskip shares why he loves being a doctor #fightingcancertogether
-
Sarah Cannon Docs
@SarahCannonDocs
Tonight from 6-8 at #ash18, remember to check out Dr. Flinn's characterization of the long-term efficacy and safety of duvelisib monotherapy in patients w/ relapsed/
refractory CLL/SLL #fightingcancertogether -
Sarah Cannon Docs
@SarahCannonDocs
GU111/ D5082C00002 is now enrolling patients across the US with advanced/metastatic PRCC. Visit sarahcannon.com/gu111




























































































































































































































































































































































































































































































































































